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Abstract 
 
Introduction: Anorectal anomalies (ARA) are a range of congenital conditions ranging 
from a slight malposition of the anus to complex anomalies of the hindgut and urogenital 
organ. Despite advanced surgical and treatment modalities, voluntary bowel control is poor 
following surgical care with high rates of faecal incontinence (FI), and also constipation 
after all grades of reconstructive surgery. The main aim was to determine the impact that FI 
and constipation has on psychosocial functioning in the context of ARA in comparison to 
patients with idiopathic constipation (IC) and healthy controls. We also investigated the 
pathophysiological mechanisms that might contribute to poor bowel function in patients with 
ARA. 
Methods: Study comprised 52 patients (19 females; range 11-43 years) with ARA, 46 (13 
females; range 11-31 years) IC and 51 healthy controls (26 females; range 11-42 years). 
Constipation and FI were evaluated using KESS and Vaizey scores respectively (a higher 
score indicating greater symptom severity). Psychometric tests included: Gastrointestinal 
Quality of Life Index, Children's Depression Inventory/Beck Depression Inventory, General 
Health Questionnaire-28, State-Trait Anxiety Inventory/Children, Pennebaker Inventory of 
Limbic Languidness, Big Five Inventory, Level of Hopefulness, Cognitive Emotion 
Regulation Questionnaire and Weinberger  Attitude Inventory.  Physiological investigations 
were undertaken in 32 adults, presenting with a history of previous surgery for ARA and 
urge FI. Physiological assessment included: anal manometry; rectal sensation (balloon 
distension); pudendal nerve function (motor latencies); endo-anal ultrasound; colonic transit 
and proctography.  
Results: Significantly higher KESS scores were found in patients with IC (<0.0001) 
compared to ARA and healthy controls and significantly higher Vaizey scores found in  - 3 
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 patients with ARA (<0.0001) and IC (0.0002) compared to healthy controls. Poorer 
GIQOL scores were found in patients with IC compared to healthy controls (p<0.001) and 
ARA compared to healthy controls (p<0.01).  There was a significant relationship between 
poor quality of life and high KESS scores in ARA and IC (p = 0.003) and high Vaizey 
Incontinence scores (p = 0.02). Patients with ARA did not have higher psychiatric morbidity 
in comparison to IC and healthy controls. Personality traits and level of hopefulness 
appeared the same across the three groups. IC significantly put less emphasis on their 
general physical health (p<0.0001) in comparison to ARA and healthy controls. ARA 
significantly used more ‘positive reappraisal’ and ‘putting into perspective’ as their main 
coping mechanism compared to healthy controls.  Anorectal physiology was abnormal in all 
subjects with ARA, involving multiple mechanisms. Anal resting tone and squeeze 
increments were attenuated in 23/32 and 17/32 patients respectively. Both anal sphincters 
were deficient on endosonography in the majority of patients with ARA.  Evidence of 
pudendal neuropathy in 11/13 (85%) patients studied. Rectal sensation and emptying was 
abnormal in 17/22 (77%) and 9/14 patients (64%) respectively. Eight out of 17 patients had 
delayed colonic transit (47%). 
Conclusions: Symptoms of FI and constipation are major determinants for poor quality of 
life in patients with ARA.  Contrary to our expectations, they share similar bowel and 
psychosocial functioning to patients with IC. Adolescents with ARA and IC had minimal 
psychiatric morbidity, yet experience condition-specific psychosocial problems affecting 
their daily life. The chronic nature of the patient’s problem appeared to have stimulated 
psychologically protective factors such as positive coping strategies. While the structural 
integrity of the anal sphincters is the major factor contributing to continence, this study 
confirms that extra-sphincteric mechanisms, particularly rectal sensory function, may be 
equally important. 
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1.0 INTRODUCTION 
 
“A properly functioning rectum is an unappreciated gift of the greatest price”  (Potts, 1959). 
One is unable to embark on the task of writing about congenital anorectal anomalies (ARA) 
without being overwhelmed by the complexity of these conditions – the continuous debate 
about the pathological anatomy, nomenclature of different forms and the ideal surgical 
technique to use.  In addition, this chapter will investigate the ongoing bowel difficulties that 
patients with ARA live with after reconstructive surgery.   
 
1.1 THE RECTUM AND ANAL CANAL 
 
Normal faecal continence is maintained by a complex integrated functional unit – including 
the rectum, anal canal and pelvic floor musculature (Fleshman, 1993, Rao, 2004a, Rao, 
2006).  Other factors involved in the maintenance of continence include normal stool 
frequency and consistency, and rectal compliance (Rasmussen, 1994, Deutekom et al., 
2007). A summary of the normal human anatomy will be firstly reviewed prior to discussing 
the pathophysiology of ARA. 
 
1.1.1 Developmental importance of the anorectum in humans 
 
There are a number of developmental stages involved in the structure of the normal anatomy 
of the lower end of the anus, rectum and genitourinary tract.  The primitive gut develops 
during the fourth week of gestation when the embryo folds and incorporates the dorsal part 
of the yolk sac into the embryo (Moore K, 2003).  A lining of the primitive gut called the 
 27 
 
endoderm gives rise to most of the epithelium and glands of the digestive system, 
biliary passages and parenchyma of liver and pancreas.  The epithelium of the cranial 
(mouth) and caudal (anal pit) ends of the digestive tract originate from the proximal and 
distal ectoderm known as the stomodeum and proctodeum respectively (Figure 1.1 D). The 
primitive gut is divided into three parts: foregut, midgut and hindgut. Considerable emphasis 
will be placed on the hindgut, since this is the area of anatomical interest for this thesis.  
 
The hindgut endoderm includes the left one third to one half of the transverse colon; the 
descending colon and sigmoid colon; the rectum and the superior part of the anal canal; and 
the epithelium of the urinary bladder and most of the urethra (Moore K, 2003, Moore, 1999). 
The hindgut continues into the caudal part of the embryo where it develops a large chamber, 
called the ‘cloaca’  (Latin: a sewer) (Rao, 2004a, Moore K, 2003).  Once the hindgut is 
distinguished  in the embryo, a fingerlike diverticulum (Moore K, 2003, Healey JE, 1990) 
called the ‘allantois’ (a tubular extension of the cloaca that receives urinary wastes from the 
foetus), appears from the hindgut and continues into the yolk stalk.  Fusion of the yolk stalk 
and body stalk produces the umbilical stalk or umbilical cord (Figure 1.1 A).   
 
By the fourth week of development, the cloaca and the cloacal membrane are present (Figure 
1.1).  The cloacal membrane differentiates the internal from the external parts of the cloaca 
(Fonkalsrud Eric W, 2004).  This membrane is composed of endoderm (inner layer) of the 
cloaca and ectoderm (outer layer) of the proctoderm or anal pit (Moore K, 2003, Healey JE, 
1990).  The proctodeum (anal pit) is an invagination of surface (epidermal) ectoderm that 
forms in the hindgut and develops into the anus (Figure 1.1 D).  The cloacal membrane 
ruptures making the hindgut continuous with the outside of the embryo through the anus.  At 
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 its cephalic part, the cloaca accepts laterally the mesonephric ducts which ascend to the 
vas deferens in the male, and the metanephric ducts develop into the ureters in both sexes 
(Healey JE, 1990).   
 
During the fourth and sixth weeks of foetal development, a band of mesenchymal cells 
called the urorectal septum grows caudally, until it forms a complete partition that separates 
the cloaca into the dorsal (posterior) anal canal and ventral (anterior) urogenital sinus that 
retains connection to the allantois (Fleshman, 1993, Moore K, 2003, Moore, 1999) (Figure 
1.1 A).  Forklike extensions are formed, as the septum grows towards the cloaca, producing 
infoldings of the lateral walls of the cloaca.  These folds eventually fuse, dividing the cloaca 
into two parts (Figure 1.1 D1 and F1):  (i) the rectum and cranial part of the anal canal 
dorsally; (ii) and the urogenital sinus ventrally.  The urogenital sinus mainly gives rise to the 
urinary bladder and urethra.  In the adult, the area of fusion of the urorectal septum with the 
cloacal membrane is defined by the perineal body, tendinous centre of the perineum (Moore 
K, 2003).   This is the landmark of the perineum where many muscles meet.  Additionally, 
the urorectal septum divides the cloacal sphincter into: anterior part which develops into the 
superficial transverse perineal, bulbospongiosus, ischiocavernous muscles and posterior part 
by becoming the external anal sphincter (Moore K, 2003), the pudendal nerve supplying all 
these muscles.   
 29 
 
Figure 1.1: Stages in the partitioning of the cloaca into the rectum and 
urogenital sinus by the urorectal septum.  A, C and E view from the left side 
at 4, 6 and 7 weeks respectively. B, D and F enlargements of the cloaca region. 
B1, D1 and F1, transverse sections of the cloaca at the levels shown in B, D and 
F respectively (Moore K, 2003).  
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 Finally, when the separation of the cloaca is complete (seventh week), the cloacal 
membrane bursts,  resulting in separate openings for the anal canal behind and the urogenital 
ostium in front (Moore K, 2003, Healey JE, 1990).  Between the tenth to twelfth weeks of 
gestation, there is continued elongation of the urethra and anal canals, but the external 
genitalia are not yet developed.  It is by the fourteenth to sixteenth of gestation, that male 
and female differentiation is established (Fonkalsrud Eric W, 2004).  The following account 
will later focus on how most ARA seen, result from abnormal partitioning of the cloaca by 
the urorectal septum into the rectum and anal canal posteriorly and the urinary bladder and 
urethra anteriorly (Moore K, 2003).  
 
1.1.2 Normal anatomy of the anorectum in humans 
 
There is no doubt, that that there is no area of greater confusion than in the understanding of 
the musculature of the anorectal region, both in the normal and in ARA.  Thus the following 
account will attempt to provide a detailed description of these structures.  
 
The terminal segment of the gastrointestinal tract extends from the third sacral segment to 
the anus and is divided into: the rectum and the anal canal (Healey JE, 1990).  Surgeons 
generally define the anal canal as the part that starts at the anorectal junction (i.e. the point 
passing through the levator ani muscles) and terminates at the anal verge (Keighley, 1993, 
Gordon PH, 2007). Anatomists however, acknowledge the anal canal as the part of the 
intestinal tract that extends from the dentate line to the anal verge.   
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1.1.2.1 Pelvic floor muscles 
Anatomists have traditionally described the levator ani as a broad muscular sheet attached 
anteriorly to the pubic bone (Standring, 2004).  The levator ani makes up most of the pelvic 
floor, which is divided into parts named according to their attachments and the pelvic 
structures to which they are related.  These include: ischiococcygeus, iliococcygeus and 
pubococcygeus (Figure 1.2 A, B).  Pubococcygeus is further subdivided to the pelvic 
structures to which they relate, i.e. pubourethralis and puborectalis in the male, 
pubovaginalis and puborectalis in the female (Standring, 2004). The pubococcygeus makes 
up the main part of the levator ani, which arises from the anterior half of the obtruator fascia 
and back of the pubis (Gordon PH, 2007, Moore, 1999).  The main role of pubococcygeus is 
to act as a lateral compressor of the visceral canals which cross the pelvic floor (Standring, 
2004).  Fibres from ischiococcygeus (Figure 1.2 A, B) attach to the sacrum and coccyx with 
its remaining parts joining to the midline.  The posterior part of the levator ani is the 
iliococcygeus, which arises from the ischial spine (Moore, 1999, Standring, 2004).  The 
ventromedial segment is termed the pubovisceralis muscle as it holds the urethra, vagina, 
and anorectum within its sling like fibres. It is drawn caudally by the viscera passing through 
it to which it is attached.  The pubovisceralis is part of the levator, separated from it by its 
function, closing the urogenital and anorectal hiatuses by contraction.  Further division of 
this muscle, a segment composed of fibres passing, but intimately in contact with, the 
anorectum in the shape of a U-loop is named the puborectalis (Figure 1.2 A, B).  The 
puborectalis plays an important role in maintaining the angle between the anal canal and 
rectum (Bailey H, 2004).  There is a close relationship between the puborectalis portion of 
the levator ani and the external anal sphincter (EAS) (Bailey H, 2004). The puborectalis 
muscle passes directly backward from the back of the pubic symphysis and the 
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Figure 1.2: Anatomy of the pelvic floor muscles.   (A) A pelvic view of the levator 
ani to show its various components, particularly the ischiococcygeus and iliococygeus, the 
pubococcygeus and puborectalis, (B) The levator ani viewed fro the perineum (Gordon PH, 
2007). 
 
A 
B 
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  superior fascia of the urogenital diaphragm, runs backward alongside the anorectal 
junction continuing with its fellow muscle (i.e. pubococcygeus), straight behind the rectum, 
where they form a ‘U-shaped loop’ that slings the rectum to the pubis (Rasmussen, 1994, 
Gordon PH, 2007, Standring, 2004).  It is the puborectalis part which supports the EAS and 
assists in creating the anorectal angle.  Neighbouring muscles such as iliococcygeus and to 
lesser extent, the ischiococcygeus, help puborectalis in maintaining anorectal and urinary 
continence (Standring, 2004).   
 
 
1.1.2.2 Sphincteric Mechanisms 
The anal canal can be divided endosonographically into three sections (Davies, 2006). The: 
1. high anal canal: a level midway between the inferior border of the puborectalis and 
complete formation of the external sphincter ring anteriorly. 
2. middle anal canal: completion of the external ring anteriorly in combination with 
maximal internal sphincter thickness.  
3. low anal canal: immediately caudal to the termination of the internal sphincter, it 
comprises the superficial external sphincter.  
 
The walls of the anal canal are formed by an important sphincter complex consisting of two 
overlapping muscular tubes including of the internal anal sphincter (IAS) and the external 
anal sphincter (EAS) (Figure 1.3) (Sangwan and Solla, 1998, Rasmussen, 1994, Deutekom 
et al., 2007, Keighley, 1993, Rao, 2004a, Moore, 1999, Healey JE, 1990, Nivatvongs 
Santhat, 1997, Smith, 1987, Lamah and Kumar, 1999, Ellis, 2002).  The IAS is an 
involuntary and thickened muscle (0.2-0.5 cm thick) which is a downward continuation of 
the inner circular muscle coat of the rectum (Figure 1.3) (Bailey H, 2004, Ellis, 2002, Rao, 
2004b) surrounding the entire anal canal, reaching from the anorectal ring to 1 to 1.5 cm 
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 below the dentate line (Rao, 2004a, Rao, 2004b, Sangwan and Solla, 1998).  As shown 
above, the anal canal can be divided into three sections where the IAS is found to surround 
the upper two, with two-thirds of its length above the anal valve line (pectinate line). Its 
lower border is identified by the intersphincteric groove on the skin, thus defining the upper 
limit of the low canal zone (Davies, 2006).  The EAS is a voluntary muscle which encircles 
the IAS, extending further downwards, curving medially to take up a position just below and 
lateral to the lower edge of the IAS, close to the skin of the anal orifice (Gordon PH, 2007, 
Ellis, 2002). The EAS is thicker than the IAS (i.e. 0.6 cm to 1.0 cm thick) (Keighley, 1993, 
Lunniss and Phillips, 1992) and a rather complex structure from skin up to levator ani, 
divided into strata of which are circular, some disposed anteroposteriorly, anchored 
anteriorly at the perineal body, and posteriorly to the skin or coccyx (Burleigh, 1983).  It is 
at this level that a palpable groove is found called the intersphincteric groove or plane which 
is a surgically significant to allow surgeons access for operations on the sphincter muscles 
(Gordon PH, 2007, Rao, 2004a, Rao, 2004b, Sangwan and Solla, 1998).  Despite the fact 
that both sphincters are separate, they are integrated in function (Rao, 2004a, Bailey H, 
2004).  At the level of the anorectal ring, fibres of the levator ani and puborectalis are joined 
by the longitudinal muscle coat of the rectum, which is known as the conjoint longitudinal 
muscle (Figure 1.3) (Gordon PH, 2007, Lunniss and Phillips, 1992).   
 
The pectinate (dentate) line is found approximately at the midpoint of the anal canal, 2cm 
from the anal verge (Healey JE, 1990, Nivatvongs Santhat, 1997).  This line is covered with 
squamous epithelium below and stratified epithelium above the line (Healey JE, 1990, 
Nivatvongs Santhat, 1997).  Located about 1.5 cm proximal to the pectinate line is the 
anorectal line, which may signify the true embryological separation between the rectum and 
anal canal (Healey JE, 1990, Nivatvongs Santhat, 1997). The main relations of the anal canal 
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 include posteriorly the fibrous tissue between the coccyx (anococcygeal body/raphe); 
laterally to ischiorectal fossae containing fat; and anteriorly to the perineal body separating it 
from the bulb of the urethra in the male or the lower vagina in the female (Ellis, 2002).   
 
Figure 1.3: Anatomy of the anal canal showing the anal sphincters (Gordon PH, 2007) 
 
1.1.2.3 Nerve Supply of the Normal Rectum and Sphincters 
 
The second, third and fourth sacral segments of the spinal cord are the nerve centres of the 
arcs that subserve the receptors and effectors of the rectum, anus, bladder, and urethra, and, 
together with higher centres in the brain, are responsible for continence. These centres in the 
spinal cord also subserve cutaneous sensation in the anal canal to the level of the valves and 
in the perianal region. The sympathetic supply, however, arises in the second, third and 
fourth lumbar segments (Figure 1.4) (Holschneider, 2006). 
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 Branches from the anterior roots of the third and fourth sacral nerves unite to form the 
main nerve pathway to the ilio-pubococcygeus muscles.  The pudendal nerve (Figure 1.4), 
which arises from the anterior division of the second, third and fourth sacral nerves clings to 
the lateral wall of the pelvis in the pudendal, or Alcock’s canal (Holschneider, 2006).  It 
supplies the peripheral aspects of the deep surface of the levator ani, iliococygeus, 
pubococcygeus and puborectalis (Roberts, 2005) through its inferior hemorrhoidal and 
perineal branches, which cross the ischioanal space to enter the muscle . It also supplies 
EAS, as well as providing sensory fibres to the anal canal perineum (Snooks and Swash, 
1984). There is evidence of dual nerve supply to the muscles of continence which are 
provided by transcutaneous stimulation of the spinal cord and cauda equina.  At the vertebral 
level of L1, stimulation is associated with  a rapid response in the puborectalis muscle (Rao, 
2004a).   The IAS is visceral in origin consisting of smooth muscle innervated by the 
intrinsic enteric nervous system: autonomic (sympathetic, parasympathetic and nitrinergic 
(Burleigh, 1983, Davies, 2006).  The sympathetic (L1 and L2) fibres are supplied via the 
hypogastric nerves which are excitatory and the parasympathetic (S2-S4) innervation 
through the pelvic nerves which are inhibitory (Keighley, 1993).  The EAS, is supplied by 
the inferior rectal branch of the  pudendal nerve which arises from the anterior primary rami 
of the second, third and fourth sacral spinal nerves (Keighley, 1993) (Figure 1.4).   
 
The perineal branch of the fourth sacral nerve, a nerve that must be distinguished from the 
perineal branches of the pudendal nerve, enters the ischiorectal fossa medial to the ischial 
spine on the caudal and lateral aspects of the coccygeus muscle, and its branches are directed 
medially to the posterior fibres of the puborectalis sling and EAS (Wilson, 1967). This nerve 
can be of surgical risk, especially when deep lateral cuts are directed from the vicinity of the 
coccyx and anococcygeal body.  
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Figure 1.4: The sacral and coccygeal nerve plexuses  (Gordon PH, 2007)  
 
 
 
 
 
 
 
 
 
 
 
1.1.3 Normal physiology of the anorectum in humans 
 
1.1.3.1 Mechanism of continence 
A well-functioning, compliant rectum or neorectum is needed for the continence mechanism 
(Rasmussen and Christiansen, 1996).  This is maintained by the structural and functional 
integrity of the rectum, anus and adjoining pelvic floor musculature along with the 
integration of somatic and visceral muscle function with sensory information under local, 
spinal and central control (Gordon PH, 2007, Rao et al., 2004).  The continence mechanism 
dependent on several factors including the following: normal anal sphincter and pelvic floor 
function; rectal compliance, capacity  and sensations; colonic transit and stool consistency 
and central nervous system control (Hobday et al., 2001).  Neuropathways will be briefly 
discussed in relation to continence as formal discussion goes beyond the scope of this thesis. 
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 Stool weight and volume does vary from individual to individual, yet it is the frequency 
of the passing stool that plays an important role in continence.  The colonic transit time is 
rapid when the large bowel content is liquid because the left colon does not store fluid well 
(Gordon PH, 2007).  To ensure normal faecal control one should ask whether the faecal 
contents are solid, liquid or gas, as some patients may be continent for solid stool, but not 
necessarily for liquid or gas.  Stool can build up in the rectum for a variable time period 
before the urge to defecate is experienced.  The ability of the rectum to retain stool is known 
as reservoir continence.  The lateral angulations found in the sigmoid colon and the valves of 
Houston (Figure 1.3), provide a mechanical barrier and retard progression of stool.  It is the 
weight  of the stool that tends to accentuate these angles and thus enhance their barrier effect 
(Gordon PH, 2007).  The high-pressure zone found in the anal canal and the anorectal angle 
offers a mechanical barrier to defaecation (Rasmussen, 1994, Standring, 2004) and the rectal 
curvatures and transverse folds as mentioned above, may also contribute to a lesser extent 
(Bharucha, 2004).   
 
It is the activity of the anal sphincters and the puborectalis muscle, which are responsible for 
the zone of high pressure inside the anal canal (Gordon PH, 2007, Standring, 2004).  Since 
the IAS is innervated by the autonomic nervous system, it is not subject to voluntary control.  
 Thus, this muscle exists in a continuously tonic state and is essential for maintaining the 
closure of the resting pressure of the anal canal and initiates the act of defecation by reflex 
dilation in response to rectal distension (Gordon PH, 2007, Rao, 2004b, Standring, 2004, 
Rasmussen and Christiansen, 1996).  The EAS contributes a small amount to anal resting 
pressure, but is responsible for the squeeze pressure.  Without this high resting pressure in 
the anal canal, we would be unable as humans to prevent leakage of mucus and gas (Gordon 
PH, 2007, Moore, 1999, Lunniss, 2007).   
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Figure 1.5: Flap valve mechanism (Gordon PH, 2007) 
 
 
 
 
 
 
 
 
 
 
Faecal continence is also helped by the acute anorectal angle, which is due to the continuous 
tonic activity of the puborectalis muscle and EAS (Gordon PH, 2007).  The persistent tonic 
contraction of these muscles is based on a proprioceptive reflex mechanism where the 
receptors are situated in the striated muscles of the pelvic floor and the ganglia in the 
lubosacral spinal cord (Parks et al., 1962).  The tonic contraction produced by the 
puborectalis muscle, creates what is called a ‘flap valve’ (Figure 1.5).  It is the puborectalis 
muscle which creates a forward pull that maintains  the angle, giving rises to a flap-like 
valve whereby the anterior rectal wall is pushed downwards onto the anal canal when the 
intra-abdominal pressure during weight lifting, straining, laughing and coughing rises, thus 
stopping the passage of faeces into the anal canal (Parks, 1975), although the contribution of 
the anorectal angle has been challenged in the literature, where it has been suggested that the 
puborectalis functions by sphincteric occlusion of the anal canal (Bartolo et al., 1986).  Thus, 
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 for defecation to occur, the flap valve must be opened, by lengthening the puborectalis, 
lowering the pelvic floor and obliterating the angle (Keighley, 1993). 
 
Reflex responses from both anal sphincters are essential for the maintenance of anal 
continence.  Both anal sphincters work simultaneously to create the reflex response.  This 
occurs by a brief conscious contraction of the EAS, puborectalis and pelvic floor 
musculature which propels the contents in an oral direction (Sun et al., 1990), allowing the 
IAS to recover following relaxation in response rectal distension (RAIR).  It is therefore 
during this sampling response, that continence will be sustained by synchronous contraction 
of the EAS, which permits time for impulses to reach conscious awareness (i.e. the 
individual can decide how to respond) (Keighley, 1993). Naturally, as the colon 
accommodates to its new volume, stretch receptors are no longer activated by afferent 
stimuli and thus the rectal pressure remain low and the urge to defecate is abated. 
 
Extrinsic afferent neurones mediate the conscious sensation of urgency which is activated by 
mechanoreceptors.  It is these afferents which monitor the filling state and contraction level 
of the rectum (Ruhl et al., 1998). The ability of the rectum to adapt to the imposed stretch is 
called ‘rectal compliance’, which allows rectal contents to be accommodated for and for 
defaecation to be delayed.  Under normal conditions, the viscoelastic properties of the rectal 
wall allow it to maintain a low intraluminal pressure during filling, so that continence is not 
threatened. 
1.1.2.2 Mechanism of defaecation 
The process of defaecation is simply the act of evacuating faecal material from the rectum, 
yet it is a rather complex mechanism that involves both a reflex response and voluntary 
 41 
 performance.  The reflex response is initiated due to the sudden distension of the rectal 
wall, resulting from mass movements of the colon wall moving the faecal bolus into the 
rectum (Keighley, 1993, Gordon PH, 2007, Smith, 2002).  As mentioned previously, when a 
faecal bolus enters the rectum, the stretch receptors (which reside within the muscles of the 
pelvic floor) register a sensation and an urge to defecate (Keighley, 1993, Gordon PH, 2007, 
Smith, 2002).  There are four components to the reflex response: 1) increased activity in the 
sigmoid colon; 2) distension of the rectum; 3) reflex contraction of the rectum; and 4) 
relaxation of the IAS and EAS (which are normally closed).   We know that the process of 
defaecation is basically due to an intrinsic reflex response which is mediated by impulses in 
the intramural nerve plexi.  It is reinforced by an autonomic reflex transmitted in the spinal 
cord (Figure 1.6).  This involves parasympathetic nerve fibres which arise from the sacral 
spinal cord and innervates the terminal colon.  Thus, when faeces enters the rectum, 
distension of the wall activates receptors which send afferent signals that spread through the 
myenteric plexus in order to initiate peristaltic waves in the descending and sigmoid regions 
of the colon and rectum (Smith, 2002).  As long as faecal matter is retained in the 
descending and sigmoid colon, the rectum remains empty and the individual feels no urge to 
defecate.  It is the distension of the left colon which initiates these peristaltic waves, 
propelling the faecal mass downward into the rectum (Gordon PH, 2007).  Thus, as the wave 
approaches the anus, the sphincters are inhibited, and they relax.  If the EAS is relaxed 
voluntarily when the faeces are pushed towards it, defaecation will proceed.  
Parasympathetic signals intensify the peristaltic waves, and enhance the effect of the 
intrinsic neurones to cause increased motility, contraction of the rectum, and finally 
relaxation of the sphincters (Figure 1.6) (Smith, 2002).    
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 It is beyond the scope of this thesis to discuss in detail the pharmacological properties of 
the mechanism of defecation, thus a basic overview will only be provided. Both the origin 
and the propagation of the propulsive waves, and in all probability the segmental 
contractions, are regulated via the intraluminal bowel wall plexus. Excitatory impulse is 
produced by the distension of the bowel wall by the stool bolus, after transversing the 
submucous plexus and being transmitted by the myenteric plexus.  This further leads, to a 
cholinergic contraction proximal to the bolus and to a nonadrenergic, noncholinergic 
(NANC) relaxation that is mediated by nitric oxide (NO) containing inhibitory neurons, 
aboral to the bolus.  Adrenalin modulates the acetylcholine release at cholinergic synapses. 
Nitric oxide has been recognised as a neurotransmitter that mediates relaxation of the smooth 
muscle of the gut including many other peptidergic peptides (VIP), substance P, neurokinin 
A and many others involved in the peristaltic reflex (Holschneider, 2006).   
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Figure 1.6: Neural control of the defaecation process.  The basic reflex 
operates via the intramural plexi, and the spinal parasympathetic reflex 
reinforces the basic reflex. Control is also exerted by the conscious brain. 
Labels – 1 components of the basic reflex and 2 components of the spinal 
sympathetic reflex (Smith, 2002).   
 
 
 44 
 
1.2 ANORECTAL ANOMALIES 
 
1.2.1 Definitions 
 
Anorectal anomalies (ARA) are a complex group of congenital anomalies resulting from 
abnormal development of the hindgut, allantois and sometimes the Mullerian duct, leading to 
incomplete or partial urorectal septal malformations (Davies et al., 2004, Rintala, 2005, 
Moore, 2006). Studying the morphology of ARA in human newborns, Bill and Johnson (Bill 
and Johnson, 1958) and later Gans and Friedman (Gans and Friedman, 1961) stated that in 
most forms of ARA the fistula may represent an ectopic anal opening. From these 
observations, they concluded that the rectum actually migrates during normal development, 
from a rather high position to the normal area of the anal opening. Thus, if this process of 
migration is stopped before the anus has reached its definitive position in the area of the 
perineum; an ectopic anal canal would result.  Yet, embryological evidence wasn’t used to 
support this theory.  In 1986, van der Putte  (van der Putte, 1986) modified the theory of a 
rectal or anal migration. This was done by studying normal and abnormal pig embryos, 
where it was proposed that a shift or rotation of the dorsal cloaca takes place. This shift 
should bring the dorsal cloaca down to the area of the tail groove, thus establishing there the 
future anal opening.  
 
There are a number of existing classifications for ARA which are usually based on the level 
of bowel termination in relation to the perineum and descriptively on the site of the fistulous 
bowel outlet.  In both sexes ARA can be divided into high, intermediate, and low anomalies 
as related to the level of the puborectalis portion of the levator ani muscle and whether there 
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 is a fistula to the urinary tract in males or the vagina in females. In this thesis the 
Wingspread International Classification will be used (Table 1.1) which has been widely used 
in the literature, but it is important to keep in mind that categorising and describing such 
classifications can be difficult due to variations in the literature (Rintala, 2005) and our 
limited understanding of the embryology of ARA (Lambrecht and Lierse, 1987). There are 
few classifications in use in different centres throughout the world, making comparisons 
difficult.  Furthermore, the number of variations seen in ARA makes the classification and 
operative treatment difficult. The key difference between the different types of ARA lies in 
the relationship of the terminal bowel to the pelvic floor muscles and of the levator ani 
muscle in particular.   
 
Table 1.1: Wingspread International Classification 
CLASSIFICATION FEMALE MALE 
High 1. Anorectal agenesis 
A. Rectovaginal fistula 
B. Without fistula 
2. Rectal atresia 
1. Anorectal agenesis 
A. Rectovesical fistula 
B. Without fistula 
2. Rectal atresia 
Intermediate 1. Rectovaginal fistula 
2. Rectovestibular fistula 
3. Anal agenesis without fistula 
1. Rectourethral fistula  
2. Anal agenesis without fistula 
 
Low 1. Anovestibular (perineal ) fistula 
2. Anocutaneous (perineal) fistula 
3. Anal stenosis 
1. Anocutaneous fistula 
2. Anal stenosis 
Rare Persistent cloaca anomaly 
Rare malformations 
Rare malformation 
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 1.2.2 Classification and investigations in a newborn with an anorectal anomaly 
 
The provisional diagnosis of an ARA and grading of its severity is usually straightforward in 
the newborn. In most patients, the type of anomaly can be determined by careful clinical 
examination and radiological investigation. The most important issue is to ascertain the level 
of the anomaly, because this determines the operative treatment in the neonatal period 
(Rintala, 2005).  The importance of a complete medical history should not be neglected in 
order to focus on the examination of the perineum. A detailed evaluation and examination 
including family antenatal and birth history is necessary.  Prenatal ultrasonography has a low 
sensitivity and specificity for the detection of ARA. A normal anus is visualised as a circular 
rim of hypoechogenicity in the perineum together with a central linear echogenic stripe. The 
absence of this circular rim is described as imperforate anus or anorectal malformation on 
the prenatal scan (Bekhit, 2006).  Harris retrospectively viewed prenatal scans of children 
with ARA and demonstrated dilated colon on prenatal ultrasonograms (Harris et al., 1987). 
In this thesis, diagnosis will be discussed in relation to the classification of the anomaly for 
male and female below.  
 
A low defect is classified when the developing bowel passes down through the pelvic floor 
musculature and anal sphincters (Hutson, 1999).  The patient will have an ectopic anal 
opening in the perineum (Rintala, 2005).  The most common type of low ARA found in 
males is called an anocutaneous fistula whereby the anus is covered by an excessive 
posterior  fusion of the genital folds, with a fistula running forward subcutaneously to open 
along the midline of the perineum, scrotum or penis (Rintala, 2005, Cook, 1990).  The anus 
is found somewhat displaced anteriorly, but the voluntary sphincter complex surrounds the 
main part of the anal canal.  From the bowel termination, a narrow fistula runs anteriorly for 
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 a variable distance within the median bar.  This is diagnosed by distinctive appearance 
of perineum, fistula orifice visible or obscured by speck of meconium, fistulous track filled 
with meconium or probe is able to pass directly back along the fistula into anal canal 
(Murphy, 2006).   A stenotic anus at the normal site may be due to partial covering by 
genital folds or to partial perforation of the anal membrane. A common term ‘anal stenosis’ 
is usually used to include both types, although most will be covered deformities.  It is 
usually diagnosed by perineal appearance of hypertrophied folds (Murphy, 2006). 
 
Low ARA are relatively found more frequently than high ones in females, with greater 
diversity in the fistulous opening than in the male.  The anatomy, however, is similar in most 
respects to the equivalent lesion in the male.  The anovestibular fistula lies close to the 
vaginal orifice and a probe passed into it will run subcutaneously in contrast to the direction 
of a rectovestibular fistula (Figure 1.7 2-B) (Cook, 1990).  Also seen frequently in females is 
a perineal fistula (anterior perineal anus) (Figure 1.7 2-A) which is a normal looking anus 
found just behind the vestibule. In about half of the cases, the anterior anus is stenotic, and 
normal voluntary sphincters surround the posterior half of the anus but are very thin between 
the anal opening and the vestibular fourchette (Rintala, 2005).  A ‘covered’ anal stenosis 
whereby the anal (fistula) opening is abnormally narrow (stenosed) is also common (Pena, 
2000).   
 
Anorectal anomalies are classified intermediate, when the bowel passes down into the 
levator ani muscle but does not reach the anal canal sphincters. In females, the most common 
defect is rectovestibular fistula (Figure 1.7 2-B), where the ectopic anus opens to the 
posterior vestibular fourchette, and the urethra and the vagina have normal appearances. In 
such cases, the opening can be difficult to see because of its small size and position under 
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 the vestibular fourchette (Rintala, 2005).  This is diagnosed by the appearance of three 
orifices in vestibule, urethra, vagina and a fine rectal fistula in fossa navicularis A 
rectovaginal fistula (with fistula) is when the fistula is found just above the hymen. The 
puborectalis muscle surrounds the caudal bowel, although the fistula may penetrate the sling 
anteriorly (Murphy, 2006).  Anal agenesis (without fistula) is when the rectum terminates 
blindly at the upper border, with caudal end of blind gut near lower end of vagina. This is 
diagnosed with urethral and vaginal orifices with no distinguishing mark at the anal site.  
High anomalies in females include anorectal agenesis (without fistula), where the rectum 
ends blindly at any level in the pelvis above the levator, the blind strand if present, connects 
with vagina or perineum. Diagnosis is based on two perineal orifices (urethra and vagina) 
and no anus. Rectovesical fistula is when the rectum enters bladder between two separate 
vaginae which form a common cloaca at the bladder outlet, which is diagnosed by the 
appearance of a single cloacal orifice.  Rectovaginal fistula is when the vagina is usually 
normal, rectal fistula opens in midline posteriorly, orifice largish (Figure 1.7 2–C).  This is 
diagnosed by the appearance of normal two orifices in vestibule and evidence of meconium 
from the vagina. Rectal atresia is when the rectum terminates at any level, hence a short or 
long fibrous cord to the sacrum or to the distal bowel. On investigation, a normal anus is 
present but obstruction on digital examination (Murphy, 2006).  A female patient who has 
only one external opening in the perineum has what is called a cloacal malformation – the 
rectum, vagina and urethra united to form a common recto-urogenital channel which opens 
at the perineum with a single opening.  The opening may be found anywhere between the 
anal site and the base or tip of the clitoris. In most cases, the common channel opens 
between the normal vaginal site and the clitoris. The length of the common channel is 
variable; an anterior location of the external opening usually suggest a long common channel 
(Rintala, 2005). 
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 Male patients, who have no detectable opening in the perineum, have a fistulous 
communication between the high-ending anorectum and the urethra.  Usually, the urethral 
opening of the communication is found at or below the level of the prostate (Rintala, 2005). 
In high defects, bowel development is arrested superiorly to the pelvic floor muscles 
(Hutson, 1999).  The most common high defect found in males is anorectal agenesis with a 
rectoprostatic urethral fistula (Figure 1.7 1-C).  In rectoprostatic fistula, the rectal pouch lies 
above the level of the levator plate. On investigations, no anus or distinguishing diagnostic 
sign is evident and gas or meconium can be found in urine (Murphy, 2006).   In rectobulbar 
fistula, the rectum terminates above the bulbocavernosus muscle by a wide fistula into the 
bulb (rectobulbar), or enters the urethra more distally as a fine fistula. The voluntary 
sphincter complex is always found to be hypoplastic, and the degree of hypoplasia has been 
shown to be associated to the severity of the sacral deformities, which are usual in these 
patients (Rintala, 2005).   On diagnosis, there is often no distinguishing perineal sign, but 
there may be a thin perineum, hypospadias, or cleft scrotum and probe passes along urethra 
into rectum (Murphy, 2006).  Rectal atresia in males, as in females is rare and is possibly 
acquired later in development than those deformities described as ageneses.  In this case, the 
anus and anal canal are correctly sited and connected to the blind ending rectum by a cord of 
tissue which passes through the sphincter muscle complex (Cook, 1990).  Anorectal 
agenesis, as in females, the rectum ends blindly at any level in the pelvis above the levator 
without a fibrous cord to the urethra or perineum.  
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Figure 1.7:  Classification of anorectal anomalies. Reprinted with kind permission of 
Springer Science and Business Media (Pena, 1995) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MALE DEFECTS (1 – A-D) 
FEMALE DEFECTS (2-A-D) 
A B 
A. low defect, perineal fistula. B. Rectourethral bulbar fistula 
C D 
C. Rectourethral prostatic fistula. D. Rectobladder neck fistula 
A B 
A. Perineal (cutaneous) fistula. B. Vestibular fistula. 
C 
D 
C. Low rectovaginal fistula. D. High rectovaginal fistula 
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 1.2.3 Epidemiology 
Anorectal anomalies are a relatively uncommon congenital cause of intestinal obstruction in 
the newborn. The incidence of ARA has been reported as 1 out of every 3000-5000 births. A 
male predominance found in Western communities, with 55-70 percent of patients in larger 
series having been males (Pena, 2000, Rintala, 2005, Cuschieri, 2001).  Anorectal anomalies 
may also be more frequent in developing countries (Moore, 2006).  Evidence of both 
geographical and ethnic differences have been observed in ARA (Shija, 1986, Louw, 1959, 
Louw, 1965). It has been found that ARA form a significant clinical burden in Africa, where 
incidence has been found in 1:1,800 birth in Cape Town (Louw, 1965) and other parts of 
Africa such as Zimbabwe (Shija, 1986) and Nigeria (Adeyemo, 1997). Yet, despite these 
findings, there are others who have found no differences (Smith, 1988, Kiesewetter, 1964). 
There appears to be gender differences with respect to ARA. In general the male: female 
ratio associated with ARA is almost the same, with a 55:44 male: female ratio previously 
reported in large collective series (Endo et al., 1999, Smith, 1988). More severe 
malformations tend to be more common in male patients and tend to present with higher 
incidence of associated anomalies (Santulli, 1971, Ratan et al., 2004, Endo et al., 1999)  In 
females with ARA, it is reported that the majority will have a defect of the low variety with a 
fistula to the perineum, fourchette or vestibule (Okada et al., 1992, Ratan et al., 2004, Endo 
et al., 1999). Cloaca anomalies are relatively rare, with an incidence of  1 in 50,000 births 
(Pena, 2000, Rintala, 2005).  In both sexes, previous  reports have shown the incidence of 
low ARA to be less than with high ARA (Javid et al., 1998).     
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 1.2.4 Aetiology 
 
The aetiology of ARA remains likely multifactorial (Falcone et al., 2007).  Despite our lack 
of understanding of the normal development and pathologic variations found in ARA, the 
critical period of organogenesis is understood to be at or before the 6-7
th
 week of gestation 
(Kluth D, 1995).  Abnormal development would have to commence in early embryogenesis, 
possibly due to the limitations in the dorsal portion of the cloacal membrane resulting in 
persistent attachment of the hindgut to the urogenital sinus, resulting in the associated fistula 
(Kluth D, 1997).  This may imply that the stimuli that induce abnormal development of the 
anorectum work throughout the developing foetus and may cause maldevelopment of several 
organ systems (Rintala, 2005).  It is important to note that these anomalies not only lead to 
increased foetal  mortality, but also result in significant morbidity (Ratan et al., 2004).  
 
Despite the paucity of information on the genetic associations of ARA in humans and a 
fairly low familial incidence, the probability of a genetic association has increased due to the 
association with other chromosomal abnormalities and syndromes (Towne, 1972, Kaufman 
et al., 1974, Lowe et al., 1983)Approximately 36.4% are isolated lesions and 63.6% are 
associated with other anomalies (Cuschieri, 2001). Chromosomal defects are associated in 
8% and a family history may be present (Cuschieri, 2001). In a large review of patients, 15% 
of cases had underlying chromosomal abnormalities, of which trisomies 21, 18 and 13 
formed the largest group (Davies et al., 2004).  Yet, ARA occur commonly in multi-anomaly 
sequences, such as the VACTERL (vertebral (e.g. hemisacrum), anorectal (e.g. malrotation, 
gastrointestinal duplication, duodenal obstructions, Hirschsprung’s disease), cardiac (e.g. 
atrial/ventricular septal defects, tetralogy of Fallot, truncus arteriosis), tracheo-oesophageal, 
renal and limb (e.g. syndactyly, craniofacial anomalies) and CHARGE (colobomata, heart 
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 disease, atresia choanae, retarded growth, genital anomalies (in males) and ear) 
associations (Davies et al., 2004, Moore, 2006). Czeizel et al (1985) suggested that babies 
with the VACTERL association were more likely to be male and of low foetal weight 
(Czeizel and Ludanyi, 1985). Levitt et al (1997) found that a tethered cord occurred in 24% 
patients, and this association was particularly noted amongst the patients with severe 
anorectal defects, sacral hypodevelopment, myelodysplasia, presacral mass’, sacral 
hemivertebrae, or a single kidney (Levitt et al., 1997).     
 
Genitourinary malformations form the main group of associated anomalies in ARA due to 
the closely associated embryology of the systems (Cook, 1990).  Urinary tract abnormalities 
have been shown to occur in 20-54% of patients with ARA (Metts et al., 1997, McLorie et 
al., 1987, Belman, 1972, Hoekstra, 1983, Munn, 1983, Parrot, 1985).  The most common 
upper tract anomaly has been found to be renal dysgenesis, which is seen in association with 
high ARA (Davies et al., 2004).  Urological problems have also been found to be associated 
with a high incidence of fistulas encountered in ARA.  Unlike in anorectal dysfunction, 
vesicoureteric dysfunction has the potential to cause permanent damage to other organs 
(Davies et al., 2004).  Thus, due to the long term sequel of upper urinary tract damage, one 
of the main aspects of ARA treatment includes the preservation of renal function and the 
prevention of urinary tract infection.  Those with a persistent cloacal anomaly, exhibit a 
relatively neuropathic dysfunction that is also commonly associated with spinal 
abnormalities, or iatrogenic injury to sacral nerves.  In patients with high ARA, genital 
abnormalities are also frequently seen (Davies et al., 2004).  Males have a higher incidence 
of genital anomalies occurring in low malformation and gastrointestinal anomalies (Ratan et 
al., 2004).  Davies et al (2004) found that undescended testes and hypospadias were the most 
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 frequent anomalies detected in males, with septate vagina most commonly seen in 
females (Davies et al., 2004).   
 
It is uncommon to find genetically determined syndromes with ARA.  There are however 
reasons to believe that there is a genetic component involved (Smith, 1988, Van Gelder, 
1961).  There is no real association between birth order, maternal age and relationship to 
parity has been established, although a slight preponderance among first-born infants has 
been suggested (Smith, 1988). As early as in the 1950s, it was acknowledged that the 
incidence of a malformation in a sibling, of a patient with ARA is increased and has been 
shown to be as much as 1 in 100, compared with an incidence of about 1 in 5000 in the 
general population (Falcone et al., 2007).  Yet, it has also been suggested that heredity plays 
a minor role in ARA due to the low familial incidence (Murken, 1976).  Since then, there 
have been several reports indicating families with 2 or more affected members and 
associations of ARA with multi-system syndromes. Particularly in patients having Townes-
Brock’s syndrome (Towne, 1972), Currarino’s syndrome and Pallister-Hall syndrome  
(Falcone et al., 2007). Not only is there evidence of increased incidence of ARA in patients 
with trisomy 21, but that 95% of patients with trisomy 21 and ARA have imperforate anus 
without fistula, compared with 5% of all patients with ARA.  Thus, it is likely that the 
mutation of a range of different genes can result in ARA, or that the aetiology of ARA is 
multigenic (Falcone et al., 2007).   
 
Falcone at al (2007) (Falcone et al., 2007) showed in their large case series, an increased 
association of specific types of ARA, namely, perineal or vestibular fistulas, with affected 
family members.  Based on their findings, parents of children with perineal or vestibular 
fistulas can now be told that there is a 3% chance of another family member being affected 
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 (Falcone et al., 2007).  Additionally, parents of boys born with a perineal fistula or girls 
born with a perineal/vestibular fistula can now be counselled that there is a 7% or 5% 
chance, respectively, of having a family member with a congenital ARA.  There was also 
less family transmission among patients with either cloaca or prostate fistulas. 
   
There is also a considerable body of evidence from animal experiments to substantiate the 
genetic associations. There have been animal studies in lines of mice (Kluth et al., 1991), 
pigs (Vianna and Tobias, 2005) and even in some breeds of dogs (Van der Putte and 
Neeteson, 1984) with inherited ARA which point to genetic causes of ARA. Gene targeting 
in mice has also demonstrated the importance of a number of genes, acting in isolation or in 
combination, for normal hindgut development. Thus, it is very likely that ARA is similar to 
the prototypical congenital anomaly of the digestive system, Hirschsprung’s disease, which 
also affects about 1 in 5,000 live births (Bates, 2002, Kapur, 1999, Tam and Garcia-Barcelo, 
2004) 
 
1.2.5 Surgical Management in ARA 
 
1.2.5.1 Historical reference to anorectal anomalies and surgery 
It is beyond the scope of this thesis to go into detail about the historical journey of ARA, 
however, it is interesting to note that this condition was recognised in animals since the time 
of Aristotle in the third century BC (Grosfeld, 2006).  Soranus was the first paediatrician 
(from Rome), who changed the attitude in the second century AD by not allowing neonates 
with ARA to die and who described dividing a thin anal membrane and dilating the opening 
(Scharli, 1978). It is important to note that ARA was a source of concern from earlier times, 
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 yet no record has been found of surgical intervention until the seventh century 
Byzantine physician Paul of Aegina (625–690 AD) - author of the Epitome of Medicine, 
which was first printed in Greek by the Aldine Press in Venice in 1528 (Gurunluoglu and 
Gurunluoglu, 2003).  He opened the bowel by piercing the anal membrane and used a 
wedge-shaped tent dilator in the seventh century (Matas, 1897).  Galen in 1576 described the 
anal sphincters, levator muscles and coccyx (Grosfeld, 2006). There some records regarding 
ARA until 1676, when Cooke treated a child by making a small incision over a blind anal 
membrane and dilated the aperture with elder pith.  He emphasised the importance of the 
sphincteric mechanism to other medical professionals who aimed to duplicate his success 
(Cooke, 1685, Cule, 1965).  In 1693, Saviard was the first to attempt treatment of high 
bowel termination by plunging a trocar through the perineum (Grosfeld, 2006). This was 
followed by Benjamin Bell in 1787 who underwent a dissection in two newborns via the 
perineum to locate the rectal ampulla (Cook, 1990).  Prolonged ‘bouginage’ was required to 
preserve the open passage using a sponge tent, gentian root, or other substances that swell 
with moisture (deVries, 1984). Bell also managed to describe instances of rectovaginal and 
bladder fistulas.   
 
The colostomy became well recognised in the eighteenth century in France.  Littre (1710) 
performed a autopsy in an infant with rectal atresia and proposed that the bowel be brought 
to the surface of the abdomen to function as an anus (Grosfeld, 2006).  Durret in 1793 
performed the first successful sigmoid colostomy (termed an ‘inguinal colostomy or 
procedure of Littre). Roux (1834) identified the significance of keeping the perineal 
dissection strictly in the midline and preservation of the EAS (Grosfeld, 2006, Matas, 1897). 
Amusat was the first individual who sutured the rectal wall to the skin edges in 1853, which 
has been considered the first actual anoplasty.  This was the landmark procedure at the time 
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 and gained wide acceptance, and was used frequently for the rest of the nineteenth 
century.  Several techniques were further used from splitting, dislocating or excising the 
coccyx in order to gain better exposure, and some surgeons even opened the pelvic 
peritoneum to obtain greater length of bowel.  The first indication of a combined abdominal 
and perineal exploration was by Neil McLoed in 1880.  In 1886, McCormac was one of the 
few to suggest a two-stage procedure preliminary colostomy and subsequent anoplasty 
(McCormac, 1886).  In 1887, Matas combined a sacral approach to rectal atresia with 
sacrotomy to aid exposure in instances of high-lying anomalies and predicted that this would 
be the route of choice of these procedures in the future (Matas, 1897).  During the pre 1900 
era, appreciation of the pelvic and perineal anatomy was influenced by the observation of 
Vesalius (1543), Galen (1576) and Santorini (1724) who described the anal sphincters, the 
levators, and the coccyx (Grosfeld, 2006).  Textbooks of Surgery in 1908 recommended 
colostomy as a life-saving measure only, otherwise the perineal approach was employed for 
all other cases (Keen, 1908).   
 
Debate about surgical management continued over the centuries from a number of surgeons 
(Grosfeld, 2006).  Following World War II, things began to change with introduction of 
antibiotics and improvements in anaesthesia had a positive influence on reducing the septic 
complications associated with bowel surgery.  The abdominoperineal approach initially 
explored by McLoed, was well accepted eventually and further modified by Norris in 1943 
(Norris et al., 1949) and Rhoads in 1944, whereby successfully tried one-stage 
abdominoperineal procedures in several neonates (Rhoads et al., 1948).  Rhoades, Piper and 
Randall in 1948, published the first description of the above operation (Rhoads et al., 1948). 
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 There are several operative techniques that took into consideration the importance in 
understanding the anatomical basis of continence.  This was firstly appreciated by Stephens’ 
sacroperineal (or sacro-abdominoperineal) approach, first described in 1953, which will be 
discussed in detail later, with emphasis on the role of the levator ani muscle and lack of 
significance of the EAS and IAS (Stephens, 1953, Grosfeld, 2006). Others included Rehbein 
and Kiesewetter who both advocated submucosal resection to avoid damaging pararectal 
nerves and muscles (Kiesewetter and Chang, 1977, Kiesewetter et al., 1976). Because of the 
high incidence of faecal incontinence (FI) in the abdominoperineal approach, in 1963 
Kiesewetter and Pittsburgh modified Stephens’ operation by performing the 
abdominosacroperineal procedure (Kiesewetter and Turner, 1963).  This procedure involved 
using the abdominal approach isolating the fistula and the sacral route to enter the 
supralevator space by splitting the pubococcygeus and iliococcygeus in the midline.  Unlike 
Stephens, Kiesewetter believed the EAS was present and worth saving.  Two years earlier 
(1961), Smith had identified the normal sized EAS in 15 out of 16 autopsied cases of 
imperforate anus (Smith, 1961).  Kiesewetter and Nixon found the EAS muscle present in all 
nine cases studied at autopsy, but found a gap between the sphincter and the puborectalis 
muscle (Sukarochana and Kiesewetter, 1968). Another significant moment in the 
reconstruction of the anorectum is Mollard’s anterior dissection to define the puborectalis 
muscle which was considered a key role in continence.  This was first reported in 1975 using 
an anterior perineal approach for high ARA (Laberge et al., 1983, Mollard et al., 1978).   
Finally, the posterior sagittal approach first described by deVries and Pena which became 
well accepted due to the wide exposure it gave by dividing the entire pelvic floor (Pena and 
Devries, 1982).  In the 1970s and early 1980’s comparing results among authors became 
difficult due to the different subjective criteria for grading and definitions used to assess 
function of ARA – this still in the case today (Grosfeld, 2006).   
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1.2.5.2 The anatomy debate in anorectal anomalies 
Stephens (1986) has laid maximum stress on the puborectalis sling being the principle 
muscle responsible for maintaining continence (deVries and Cox, 1985, N'Guessan and 
Stephens, 1986).  Despite this, De Vries and Pena (1982) avoid reference to a specific sling: 
‘too much emphasis has been placed on the value of the puborectalis for continence’ and 
they prefer to accept the concept of a muscle complex which includes the fusion of levator 
and EAS muscles (Pena and Devries, 1982, deVries and Pena, 1982). This paradigm is in 
direct conflict to studies which clearly demonstrate the anatomical and physiological 
function of these muscles. In practice clinically if the puborectalis is damaged, and the EAS 
left intact, the patient is left faecally incontinent. Conversely, if the EAS is divided too 
extensively (e.g. during fistula-in-ano surgery) whilst the puborectalis is left undamaged, the 
patient may leak mucus but is not necessarily incontinent (Holschneider et al., 2001).   
 
As anatomists have noted for centuries and Smith (Smith, 1987, Holschneider et al., 2001) 
summarises: 1) the lowest and most medial fibres of the levator do not have this so called 
‘sling’ like structure from the pubis anteriorly, back to and behind the rectum, and forward 
again to the pubis; 2) behind the bowel the rest of the levator acts on the floor of the pelvis; 
3) the EAS is a intricate structure from skin up to levator divided into strata, some of which 
are circular, with some fibres orientated anteroposteriorly, attached at the perineal body, and 
posteriorly to the skin or coccyx; 4) it is difficult to distinguish between the lowest levator 
fibres and the deep part of the EAS; 5) the EAS is further divided by cephalic to caudal 
bands derived from the pubococcygeal part of the levator and the longitudinal muscle coat of 
the rectum (smooth muscle); and 6) the IAS is the expanded end of the circular smooth 
muscle of the rectum (Smith, 1987). Reflecting on the current knowledge of anatomy which 
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 has been known for centuries, the whole muscle complex is not merely a striated muscle 
complex; in fact it has been suggested that it be called a‘sphincteric muscle complex’ 
instead. This would allow it to include all its elements (Smith, 1987). Pena and De Vries 
(Pena and Devries, 1982), do show appreciation that there is a muscle complex, but derive 
their observations purely on operative material and unfortunately counter-intuitively during 
their operative technique, the full extent of the  puborectalis is divided before actual 
recognition of the muscle.  
 
Poor functional outcomes may result from anal sphincteric dysfunction (N'Guessan and 
Stephens, 1986, deVries and Pena, 1982) either as a result of organ dysgenesis or from 
iatrogenic damage during surgery, yet the EAS is always represented in ARA (Pena and 
Devries, 1982, deVries and Pena, 1982).  Embryological and histological studies have shown 
that the IAS is also present in ARA (Holschneider et al., 2001, Lambrecht and Lierse, 1987), 
and that the integrity of the IAS is important for a good functional result following repair of 
ARA (Rintala and Lindahl, 1995, Fukata et al., 1997). These findings have led to surgical 
techniques that try to preserve as much of the distal bowel as possible.  Defects of the EAS 
typically result in urge incontinence whilst IAS pathology usually results in passive leakage 
(Gladman, 2005). However, the anal sphincter is only one contributor to the normal 
continence mechanism with ‘suprasphincteric’ contributions from the rectum and colon 
considered increasingly important (Siproudhis et al., 2005, Bharucha et al., 2005, Chan et 
al., 2005a). In particular, reduced or increased sensation and compliance can compromise 
continence. Our preliminary data on the pathophysiology of incontinence in a series of 
patients with repaired ARA confirm these finding and will be later discussed in detail 
(Athanasakos et al., 2008). 
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1.2.5.3 Operation rational based on the anatomy in ARA 
Despite modern developments, modern surgical techniques are unable to offer normal 
anorectal function in many children who are born with ARA (discussed in detail later). A 
significant number of these children suffer from FI or severe constipation.  Some have 
urinary incontinence and others have poor sexual function as adults. Given the known 
importance of sphincter preservation during surgery, there remains controversy as to the 
exact surgical techniques used to perform anorectal reconstruction.  Some procedures lead to 
division of the sphincter complex (deVries and Cox, 1985, N'Guessan and Stephens, 1986) 
as opposed to pull through techniques with efforts to conserve particularly the IAS (Smith, 
1987).  The consequences of scarring on function can result in a relatively narrow and 
incompliant sphincter after preservation.  This can lead to a particularly unfavourable 
clinical pattern of obstructed defecation, overflow and megarectum, which is commonly 
encountered in those with poor functional outcome.  
 
1.2.5.3.1 Surgery for low ARA 
Generally low ARA are repaired in the neonatal period with relatively simple perineal 
procedures that do not require a proximal colostomy (Nivatvongs Santhat, 1997). As 
mentioned previously, males who have a perineal (cutaneous) fistula can be treated during 
the neonatal period, since the anal canal is at least partly within the voluntary EAS complex, 
thus the operation can be limited to a simple opening of a passageway for the bowel contents 
(Rintala, 2005). The anocutaneous fistula, can be treated by a classic ‘cutback’ procedure, 
which  involves a haemostat placed in the anus and the tissue is cut back with cautery 
precisely in the midline to the posterior border of the EAS (Fonkalsrud Eric W, 2004).  
Another approach is the ‘V-Y anoplasty’ of the fistula, where the anterior fistula or anal 
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 orifice is opened posteriorly, simply dividing the perineum to the EAS, which is 
identified by muscle stimulation (Rintala, 2005, Fonkalsrud Eric W, 2004, Nivatvongs 
Santhat, 1997). The skin is incised in a Y fasion and the sphincter muscles are retracted 
posteriorly.  A long posterior midline incision is then performed in the rectal pouch to 
convert the Y incision to a V, widening the opening extensively.  The mucosal edges of the 
bowel termination are then sutured to the perineal skin (Nivatvongs Santhat, 1997).  In many 
females and sometimes in males the anterior margin of the anus is found to lie too far 
anteriorly to use the Y-V  anoplasty technique (Nivatvongs Santhat, 1997).  Under these 
circumstances to use the ‘anal transposition’ is more appropriate, creating an anterior 
perineal skin bridge and a satisfactory perineal body in the processes.  One way of doing this 
is known as the ‘tennis racket’ incision (i.e. around the fistula extending back in the midline 
to the posterior extent of the EAS).  This is followed by complete dissection of the fistula 
from the vagina in the female and transposition of the rectum to a position within the EAS; 
resulting in the formation of a neoanus.  The perineal body is then reconstructed (Nivatvongs 
Santhat, 1997).  Some surgeons use anal transposition by limited ‘posterior sagittal 
anorectoplasty’ (PSARP) for anocutenous fistulae which will be discussed later. There is 
evidence to suggest that this procedure is more extensive and more prone to operative 
complications than the cutback. However, there is no evidence that PSARP would give 
better outcomes than a simple cutback in low anomalies.  In fact, it can be argued that 
restoration of normal anorectal anatomy is of great concern for both the cutback and PSARP 
procedures due to the division of the sphincteric mechanism (Pakarinen et al., 2006, Rintala, 
2005). 
 
Females with perineal (cutaneous) fistula usually require more extensive surgery, as the anal 
canal is less contained within the sphincter complex than in males. Today the most 
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 commonly used approach for female perineal fistula is the ‘limited PSARP’. The timing 
of the operation is critical; it is safer to proceed with surgery during the first two or three 
days of life, because meconium is then less likely to be colonised by pathogenic bacteria.   
 
 
1.2.5.3.2 Surgery for intermediate and high ARA 
It has been suggested, all ARA in males without an anal opening in the perineal region need 
an initial colostomy to relieve the obstruction. However, some surgeons prefer to use the one 
stage reconstruction during the neonatal period without a protective colostomy for high 
anomalies (Rintala, 2005). One of the main concerns related to a neonatal single-stage repair 
without a colostomy is that it involves more or less blind dissection of the rectal termination 
and recto-urinary fistula in a meconium-stained field, without precise information of the 
exact anatomy of the defect (e.g. radiological, endosonography) (Rintala, 2005).  Generally, 
the pull through procedure is performed between 9 and 18 months of age. There is no doubt, 
that several approaches have been suggested yet no single approach has superior results, and 
all have drawbacks.  However, all the procedures share four objectives: 1) to place the rectal 
pouch on the perineum, 2) to eliminate rectal obstruction, 3) to position the pull through 
rectum as normally as possible within the striated complex muscle and 4) to close the 
rectourinary fistula (Rintala, 2005).   
 
Today, the ‘abdominoperineal’ exploration is credited to Rhoads (Cook, 1990). Although 
this method enables the surgeon to free the blind-ending rectum very close to the rectal wall, 
it may lead to nerve injury in the true pelvis and damage the blood supply to neighbouring 
organs.  This is of particular concern, if as in most cases, the lowest part of the rectal pouch 
descends distally to the fistula (Rehbein, 1959, Cook, 1990), is distended as in newborns, is 
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 filled with meconium or has a thin wall (Cook, 1990, Browne, 1951). Swenson and 
Donnellan adopted a similar approach to Rhoads, in which there was no sacral exposure 
(Swenson and Donnellan, 1967).  Yet, they took into consideration Stephen’s concept, to 
define the correct plane through the puborectalis sling from the abdominal route, and feeding 
the neorectum through this sling to the perineum (Smith, 1987, Swenson and Donnellan, 
1967).  The main drawback with this technique is defining the puborectalis from the 
abdominal route (where it is hidden behind the bladder and pelvic fascia), thus interfering 
with pelvic parasympathetics outside the rectum, and the EAS is not well defined.   
 
Other repairs with similar appreciation of defining the puborectalis include the Stephens and 
Smith’s ‘sacroperinal approach’ (Pena, 1995, Ong and Beasley, 1991). Stephens (Stephens, 
1953), was the first to recognise the essential prerequisite for continence; that is the 
placement of the neorectum through the levator complex, especially its puborectalis position. 
Simplistically, through a relatively short sacrococcygeal incision, the plane of the 
puborectalis is firstly made by right-angled forceps pressing against a metal sound in urethra 
or vagina; the fistula is ligated from within the rectum and the rectum mobilised either 
through the sacral or abdominal incisions, and threaded down through the sling, where it is 
anastomosed to skin flaps (Stephens, 1953, Smith, 1987). It is important to note that in this 
procedure the puborectalis is defined and interference with the bladder nerve supply is 
limited; the anus is skin-lined for sensation; and the procedure may be completed by the 
sacral route alone (for intermediate anomalies) or the abdominal route (if further bowel 
mobilisation is required in high anomalies) (Stephens, 1953, Smith, 1987).  However, some 
surgeons have found that the puborectalis sling itself is not visualised in this procedure, 
especially by a surgeon inexperienced, where the forceps may diverge from the midline 
either missing the puborectalis entirely or penetrating it eccentrically.  Access to the fistula 
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 and urethra is to some degree limited with a potential chance of damaging the latter, and 
there is lack of recognition given to the EAS, which is penetrated blindly (Stephens, 1953, 
Smith, 1987).  Despite this, Stephens procedure revolutionised the treatment of anorectal 
anomalies, particularly at the time when it was introduced, and most importantly formed the 
basis of every advance since then. 
 
Modifications of the ‘anterior perineal approach’ described originally by Mollard are still 
used by some surgeons today (Smith, 1987). Mollard accessed the sphincter complex by a 
curved transverse perineal incision anterior to the new anus. A plane to the fistula and to the 
puborectalis is thus opened up directly behind the urethra (or vagina) with positive detection 
of both fistula and levator being visualised (Smith, 1987). The benefit of this procedure is 
the clear recognition of puborectalis, yet once again limited detection of the EAS.     
 
Throughout the 19th and early 20th centuries, perineal exposure of the anorectal region was 
the standard approach (Smith, 1987).  De Vries and Pena (N'Guessan and Stephens, 1986, 
Smith, 1987), reintroduced the perineal approach to the rectum despite the fact that this 
procedure fell into disrepute as it lacked the respect of the sphincteric musculature which 
often resulted in very poor results (Smith, 1987).  However, today the most well accepted 
and used operation for repairing high and intermediate ARA is Pena’s PSARP (Pena and 
Devries, 1982, Rintala, 2005). Basically, the dissection is aided by electrostimulation of all 
muscle fibres, starting with precise definition of the maximum confluence of EAS 
components at the proposed anal site (Rintala, 2005, N'Guessan and Stephens, 1986). Each 
muscle is divided in the sagittal plane, this includes going through the external-puborectalis 
complex, allowing a wide access to divide a fistula under vision, mobilise and taper the 
terminal rectum, and then reconstitute all muscle elements accurately around the neorectum 
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 in precisely the correct anatomical position (Rintala, 2005, N'Guessan and Stephens, 
1986, deVries and Pena, 1982, Smith, 1987).  This procedure is unique from other 
procedures discussed above, in that the fistula can be directly visualised and therefore, 
damage to the urethra is minimised by the wide exposure of the fistula (Rintala, 2005, 
N'Guessan and Stephens, 1986, deVries and Pena, 1982, Smith, 1987). Despite these 
advantages, the concept of intentionally dividing surgically the entire muscular complex on 
which the continence mechanism depends on, especially the deep portion (EAS, 
puborectalis), is of great concern.  
 
The ‘Durham Smith’ or ‘perineal rectoplasty’ procedure is used in patients with an 
intermediate or high ARA (such as rectoprostatic urethra fistula/high rectovaginal fistula) 
(Smith, 1987).  This procedure is similar to Pena and De Vries in that an incision from the 
sacrum to the proposed anal site is made, using electrostimulation to define all muscles.  The 
subcutaneous and superficial components of the EAS are divided sagittally, as are the levator 
portions (iliococygeus and ischiococcygeus muscles) but not the combined puborectalis, 
pubococcygeus, and deep portion of the EAS.  These essential muscles are kept intact with 
total preservation of the essential musculature for continence (Smith, 1987). 
   
In some high anomalies, there is insufficient mobilisation of the rectum and this has been 
corrected using a perineal route: the ‘perineal abdominoperineal rectoplasty’ (Smith, 1987).  
It is initiated in the perineum, with preservation of the deep sling of the muscle complex, 
which is defined by a Penrose drain.  This is followed by placing the patient in the lithotomy 
position (the patient lies on their back with the hips and knees flexed and the thighs apart). 
This is followed by opening the abdomen and mobilising the bowel; the rectal pouch is 
preserved and by submucosal sleeve dissection (Romualdi, 1960), the fistula is divided from 
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 within; the neorectum, tapered if necessary, is brought down within the rectal sleeve to 
the base of the pouch through which a hole is made to identify the Penrose drain, preserving 
any circular muscles of the rectal pouch (Smith, 1987). From the perineum the tapered bowel 
is then pulled down through the undamaged sling, and the anoplasty completed by the Nixon 
technique (Smith, 1987).    
 
Lately, some surgeons have chosen to repair high ARA using the laparoscopic approach. 
This involves ‘laparoscopic’ mobilisation of the rectal termination and fistula closure and 
subsequent pull-through of the fistula to the anal site through the sphincter funnel, which is 
identified by muscle stimulation (Rintala, 2005).  This procedure still remains in its infancy 
and there is a lack of follow up results at present. This approach generally involves less 
manipulation of the voluntary sphincteric complex than the PSARP procedure mentioned 
above (Rintala, 2005).  
 
As mentioned previously, the most common ARA in females is the vestibular fistula.  The 
treatment still remains controversial, yet most surgeons prefer to do a colostomy to begin 
with in order to minimise the risk of potentially deleterious complications (Rintala, 2005).  It 
has been  well accepted for vestibular fistula to do a simple neonatal ‘cutback’ procedure in 
order to make the anal opening wide enough for passage of stool (Rintala, 2005).  A 
traditional alternative to a cutback has been ‘anal transposition’ to the normal anal site.  This 
operation which is of medium complexity has been suggested as it produces excellent 
cosmetic results and a normally situated anal opening (Demirbilek and Atayurt, 1999). 
Today the preferred method for repairing a rectovestibular fistula is limited PSARP (Rintala, 
2005, Demirbilek and Atayurt, 1999).   
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 One of the most challenging groups among female patients with anorectal anomalies are 
those with persistent cloaca (Rintala, 2005, Demirbilek and Atayurt, 1999). Unusual 
arrangements of the urogenital and rectal anatomy exists, thus there is no particular standard 
operation for a cloaca. Therefore, there is no doubt that a neonate with a cloacal anomaly 
requires close attention in comparison to other types of ARA. Reconstructive surgery for a 
cloacal anomaly requires precise and detailed description about the anatomical defect 
present. The significant anatomical issue is the length of the common channel, since this  
dictates the type of procedure that is necessary for full reconstruction (Rintala, 2005, 
Demirbilek and Atayurt, 1999). 
 
In conclusion, there still remains no ideal operative procedure for patients with ARA. It 
needs to be stressed that surgeons today, need to pursue physiological means of 
investigations postoperatively (e.g. anorectal manometry, endosonography, barostatis 
measures) in order to move forward in this challenging area.  But before one begins to 
suggest new surgical interventions, the surgeon must first appreciate the anatomical and 
physiological significance of preserving structures important to the continence mechanism to 
achieve any improvement in their patients.    
 
1.2.6 Outcomes for patients with ARA 
 
The treatment of ARA either by perineal, sacral, abdominal, or combined approach is 
technically demanding and requires strict adherence to the finer anatomical and 
physiological details to achieve good results. Despite surgical advances mentioned in the 
previous section, voluntary bowel control is frequently poor following surgical care for ARA 
(Heikenen et al., 1999) with high rates of faecal incontinence (FI), and also constipation after 
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 all grades of reconstructive surgery (Rintala and Lindahl, 1995, Ong and Beasley, 1991, 
Rintala et al., 1993b).  With regard to continence, poor functional outcome may be due to 
anal sphincteric dysfunction either as a result of organ dysgenesis or from iatrogenic injury. 
The integrity of both the IAS and the EAS are important for a good functional result 
following repair of ARA (Rintala and Lindahl, 1995, Ong and Beasley, 1991, Rintala et al., 
1993b). Traditionally, sphincteric dysfunction was considered as the sole contributory factor 
to FI. However, patients without a history of ARA and with an anatomically intact and 
normal functioning sphincter complex can also experience episodes of FI, indicating that 
there must be other pathophysiological mechanisms contributing to their symptoms 
(Williams et al., 2001, Lunniss, 2007). It is now clearly recognised that disturbances of 
‘extra-sphincteric’ sensorimotor function are also crucial to the development of symptoms of 
FI (Bharucha, 2004, Bharucha et al., 2005, Chan et al., 2005a, Salvioli et al., 2001, Williams 
et al., 2001, Lunniss, 2007).  Further discussion is necessary to understand the symptoms 
of FI and constipation in the context of ARA and furthermore, to comprehend the 
pathophysiological mechanisms involved in these symptoms.  
 
1.2.6.1 Faecal incontinence  
1.2.6.1.1 Definition 
Even though the task of defining faecal incontinence (FI) is difficult, as it varies amongst the 
literature a great deal.  For this thesis, FI may be defined as the ‘involuntary  loss of stool or 
soiling at a socially inappropriate time or place’ (Lamah and Kumar, 1999), or ‘the 
involuntary loss of flatus, liquid or stool that is a social or hygiene problem’ (Chatoor et al., 
2007).  Clinically, FI has been classified into three specific types: 1) urge incontinence 
 70 
 which is the unwanted loss of stool despite active attempts to inhibit defecation; 2) 
passive incontinence which is unwanted loss of stool without patient awareness or 3) a 
combination of urge and passive incontinence (Deutekom et al., 2007).   
 
1.2.6.1.2 Epidemiology 
It is important to appreciate that FI affects all ages and both sexes and is estimated to affect 
approximately 2%  to 7% of the adult population (in the US and Europe) with an equal 
prevalence in males and females (Perry et al., 2002, Deutekom et al., 2007, Kalantar et al., 
2002, Walter et al., 2002, Whitehead et al., 1999)increasing to up to 15% in the elderly 
(Roberts et al., 1999).  Additionally, 63% of affected elderly patients are women (Perry et 
al., 2002).  This finding relates to the commonest aetiologies, in particular obstetric perineal 
trauma, which remains one of the most common aetiological factors in young women 
(Chatoor et al., 2007). However, reports of the prevalence and incidence of FI in the 
community show significant variation. This can be due to many factors such as sampling, 
non-response and self selection.  Enck et al (1991) has shown that 5% of patients with FI had 
incontinence symptoms noted in the medical charts, data from which therefore highlights 
bias that systematically underestimates the real prevalence of FI (Enck et al., 1991). 
Functional FI which is defined as recurrent uncontrolled passage of faecal material in a 
person, who has no underlying neuropathic or structural aetiologies, occurs in about 1.4% of 
children aged seven years (Whitehead et al., 1999).  
 
There is a relationship with FI and social and psychological disability. One of the reasons for 
this is that FI is such a distressing and embarrassing symptom and has a major impact on 
quality of life (Chatoor et al., 2007).  A patient suffering from FI, is not suffering from a 
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 purely physical, but also psychological disability that comes with it, leading to social 
isolation and loss of independence (Chatoor et al., 2007).  Faecal incontinence also 
constitutes a substantial economic burden to individual patients and health care resources 
(Chatoor et al., 2007, Malouf et al., 2001). Most importantly, the social embarrassment 
experienced by sufferers means they are often unwilling to admit to symptoms, and doctors 
are reluctant to embarrass patients by asking about it (Malouf et al., 2001, Bharucha, 2003). 
Therefore, we are likely to grossly underestimate the true prevalence of this disabling 
condition. 
 
1.2.6.1.3 Diagnosis 
A clear diagnosis of FI starts with a detailed history of the patient’s complaint, which 
requires a good rapport between patient and clinician (Tuteja and Rao, 2004). The type of 
incontinence may imply the cause of the symptom; e.g. passive soiling of stool suggests an 
IAS or sensory problem, urge incontinence suggests EAS or luminal disease (Chatoor et al., 
2007). Questions need to be directed to the volume of stool lost, the frequency of episodes of 
incontinence, how long they can defer defaecation for (if needed) and the social implications 
it has on them, in order to have an insight into the type and severity of FI and its severity.  A 
history of obstetric or symptoms of other pelvic floor problems (urinary incontinence, pelvic 
floor prolapsed) should also be elicited (Table 1.2).  
 
Once a detail history has been accomplished, clinical examination should begin by checking 
for perianal excoriation and dermatitis from prolonged exposure to faeces, and for damaged 
sphincters (Chatoor et al., 2007).  Physical examination should be performed without prior 
enema or laxative use.  In patients with FI related to constipation, a large mass of stool in the 
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 rectum on digital examination and/or in the colon on abdominal palpitation is usually 
found (Whitehead et al., 1999). If the patient is able to contract the EAS, efferent 
denervation is unlikely. Rectal prolapse can be evaluated by asking the patient to strain as if 
defecating while seated on a commode chair. On observation, perineal scarring, small perinal 
body size and a wide genital hiatus implies obstetric trauma. The digital examination should 
assess for pelvic floor dyssynergia (decreased anal canal pressures reliably exclude the 
diagnosis of pelvic floor dyssynergia, but abnormal findings require confirmation) 
(Whitehead et al., 1999).  However, if the history and physical examination do not support a 
clear diagnosis of function FI, further tests are required such as physiological investigations 
(e.g. endosonography), which will be discussed later in this thesis.  
 
1.2.6.1.4 Pathophysiology 
The mechanism of normal continence relies on, amongst other factors, a complex 
physiological communication between motor and sensory components of the anorectum 
(Rao, 2004a, Rao, 2006, Cheetham et al., 2001, Chan et al., 2005c).  Thus abnormalities of 
one or more of these mechanisms, that maintain continence may results in FI.  It is valuable 
in clinical practice to classify incontinence according to underlying pathophysiology, as this 
will hopefully dictate appropriate and better management for the patient.  Anal sphincter 
disruption or weakness (i.e. due to obstetric or congenital) (Table 1.2), pudendal neuropathy, 
impaired rectal accommodation, or incomplete evacuation may all contribute to the 
pathogenesis of FI. These changes may be a consequence of local, anatomical or systemic 
disorders. Thus it is important to keep in mind throughout this thesis that the origin of FI is 
multifactorial (Table 1.2).    
 73 
 As mentioned in our understanding of the normal anatomy of the anorectum, the anal 
sphincter consists of two muscular components: the IAS and EAS. The IAS contributes 
about 85% of the total pressure of the anal canal at rest (Cooper and Rose, 2000).  The EAS 
is recruited to increase anal canal pressure, especially when continence is challenged (e.g. 
raised intra-rectal or intra-abdominal pressure) (Chatoor et al., 2007, Cheetham et al., 2001). 
Impairment of the IAS can result in decreased resting pressures, leading abnormalities such 
as passive FI. Dysfunction of the EAS leading to decreased squeeze pressures has been 
linked to urge FI (Deutekom et al., 2007, Engel et al., 1995, Gee and Durdey, 1995).  In our 
practice, sphincter dysfunction accounts for the majority of cases of FI (GI Physiology Unit, 
Royal London Hospital). As in other tertiary referral centres, trauma to the anal sphincter 
during childbirth, followed by iatrogenic injury after anal surgery are the two most common 
identifiable causes of sphincter injury (Table 1.2) (Kamm, 1998, Lunniss et al., 2004).  
Dysfunction of the IAS can arise due to many factors including structure damage, usually 
during childbirth or anal surgery or in the absence of structural damage either due to primary 
idiopathic degeneration or secondary to tissue disorders such as scleroderma (Kamm, 1998). 
As stressed throughout this thesis, there are contributions of other pelvic floor muscles 
responsible for the mechanism of continence which can easily be under-appreciated.  
Fernandz-Fraga et al (2002) demonstrated that levator ani weakness is strongly associated 
with severity of FI (Fernandez-Fraga et al., 2002).   
 
Nevertheless, patients with an anatomically intact and normal functioning EAS also 
experience episodes of urge FI, indicating that other pathophysiological mechanisms may 
contribute to symptoms. It is known that alterations in suprasphincteric mechanisms 
influence continence but their precise role in urge FI remains undetermined (Rao, 2004a, 
Rao, 2006, Rao, 2004b). The reservoir function of the colorectum may be compromised, for 
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 example, by disturbance of sensorimotor function.  As visceral sensory and motor 
mechanisms of the anorectum and colon are themselves inextricably linked, alterations in the 
motor component may effect change in sensory function, and vice versa.  Faecal 
incontinence is influenced by higher cortical centres and spinal reflexes, stool consistency, 
rectal compliance and capacity and, anal sphincter function (Hill et al., 2002). 
 
Anatomically, the rectum and anal canal lie adjacent to one another; yet they are innervated 
by different sensory pathways. In the rectum, sensory information comes via the 
parasympathetic pathways to reach the dorsal horn of the spinal cord, whereas the sensory 
pathway from the anal canal is via the pudendal nerves (somatic).  But there may be a degree 
overlap evident in the transition zone.  These pathways originate from the sacral plexus (S2, 
S3 and S4) and are closely related anatomically at this level.  The branches of the pudendal 
nerve, providing efferent and afferent pathways to the EAS and perineum, are susceptible to 
stretch injury, which may result in muscle weakness and FI. Examples of such injuries may 
occur during childbirth (Snooks and Swash, 1984, Sultan et al., 1994, Tetzschner et al., 
1997, Rieger and Wattchow, 1999), with chronic straining of stool or secondary to rectal 
prolapse (Snooks and Swash, 1984, Kiff et al., 1984, Engel and Kamm, 1994). It is now 
known that structural damage to the anal sphincteric mechanism is the underlying cause in 
most patients (Kamm, 1998, Burnett et al., 1991, Law et al., 1991, Deen et al., 1993, Nielsen 
et al., 1993) rather than pudendal neuropathy, and true isolated neuropathy may be rare 
(Vaizey et al., 1998). Having said this, there is a strong relationship between pudendal 
neuropathy and EAS weakness in patients with FI, which suggests that pathological process 
affecting pudendal nerve conduction impairs anal sphincter function (Hill et al., 2002).  
The rectum has both viscous and elastic properties which allows it to maintain low 
intraluminal pressure, even if the volume is large (Arhan, 1976).  Thus, the rectum has the 
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 ability to adapt to an imposed stretch enabling rectal contents to be accommodated and 
defaecation to be delayed, known as rectal compliance. However, if this mechanism is 
altered, decreased rectal capacity and heightened sensory perception (known as 
‘hypocompliance’ i.e. a stiffer rectal wall) or increased rectal capacity and blunted sensory 
perception (‘hypercompliance’ i.e. more elastic rectal wall) will result. In cases where a 
patient is suffering from FI, the rectum is often poorly compliant (Salvioli et al., 2001, 
Rasmussen et al., 1990), resulting in reduced reservoir function/capacity and symptoms of 
urgency/frequency of defecation (Rasmussen et al., 1990). This is due to the functional 
reduction in rectal volume.  
 
Rectal sensory function is regularly quantified by recording the threshold volumes required 
to elicit a range of rectal sensations (first sensation, urge sensation, and maximal tolerance 
volume) (Farthing and Lennard-jones, 1978).  In the rectal wall, mechanoreceptors are 
present, however, the rectum itself is not needed for certain sensations, as patients with a 
coloanal anastomoses or ileal pouch are able to feel the desire to defecate (Gladman et al., 
2006). Thus, it is possible that such stretch receptors located in the puborectalis, levator ani 
and sphincteric musculature contribute to sensory discrimination (Rasmussen, 1994).  Injury 
to the afferent nerve pathways will therefore disturb sensory perception which may be 
associated with FI, as intact sensory function is an integral part of the continence mechanism 
(Vasudevan et al., 2007, Gladman, 2005).  If the afferent pathway is altered,  hyposensitivity 
(elevated sensory threshold), can result, which has been associated with patients with 
idiopathic FI (Gladman et al., 2003) (Hancke and Schurholz, 1987). Decreased sensory 
thresholds of the rectum (hypersensitivity) maybe responsible for the heightened perception 
of rectal filling and act as an independent trigger of FI (Chan et al., 2005c).  Our knowledge 
on rectal sensation in the context of patients with ARA remains limited, however, it is 
 76 
 expected that the rectum will be affected by sacral neurodysgenesis and by the nature of  
the reconstructive surgery (Smith, 1987, Emblem et al., 1997, Emblem et al., 2007). 
 
Table 1.2: Aetiology of Faecal Incontinence (FI) 
Aetiology Examples 
Anal sphincter weakness Traumatic: obstetric, iatrogenic related to surgical procedures: 
haemorrhoidectomy, sphincterotomy, fistulotomy, anorectal 
infection, colectomy, pouch procedures.  
Non-traumatic: scleroderma, IAS thinning of unknown aetiology. 
Puborectalis muscle Ageing, excessive perineal descent, trauma. 
Neuropathy Stretch injury, obstetric trauma, diabetes mellitus, cauda equina 
syndrome.   
Urogynaecological Pelvic organ prolapse 
Associated with urinary incontinence 
Anatomic disturbance of 
the pelvic floor 
Fistula, rectal prolapse, descending perineum syndrome 
Congenital  Anorectal malformation 
Anal agenesis 
Inflammatory conditions Crohn’s disease, ulcerative colitis, radiation proctitis. 
Central nervous system 
disease 
Dementia, stroke, brain tumours, spinal cord lesions, multiple 
system atrophy (Shy-Drager syndrome), multiple sclerosis.  
Diarrhoea Irritable bowel syndrome, postcholecystectomy diarrhoea. 
Inflammatory bowel disease 
Infectious diarrhoea 
Laxative abuse 
Malabsorption 
Drugs (any that cause diarrhoea) 
Foods (caffeine, alcohol, aspartamine) 
Sexual Anal intercourse (non-consensual more than consensual) 
Psychiatric illness Behavioural 
 
This table is an integration of several resources (Rao, 2004b) (Chatoor et al., 2007) 
(Andrews and Bharucha, 2005) (Cooper and Rose, 2000) 
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1.2.6.2 Constipation 
 
1.2.6.2.1 Definition 
As with FI, defining constipation is difficult due to the variation and subjectivity found 
amongst the literature.  It is important to remember when discussing constipation, that it is 
not a disease, but a symptom. Constipation is a symptom reported by patients who believe 
that there is a disturbance of the events that they perceive to comprise normal defaecation. 
Patients use a variety of symptoms with the term constipation, including those apparently 
directly related to defaecation e.g. infrequency of bowel action, loss of urge to defecate, 
straining, incomplete, painful or unsuccessful evacuation, or more diverse symptoms such as 
abdominal pain, bloating or nausea. It is beyond the scope of this thesis, to discuss 
constipation in great depth.  Clayden and Agnarsson (1991) defined constipation as 
(Clayden, 1991); 
“. . . the difficulty or delay in the passage of stools (not a description of the hardness of the 
stool, although this is often but not always associated) (Clayden & Agnarsson, 1991 p. 1).   
The evaluation of the degree of severity (i.e. mild, moderate, and severe) is highly 
subjective, limiting comparisons between various reports.  This thesis has adopted Clayden’s 
definition with the following modifications. Constipation is defined as one or more of the 
following:  
i) Difficulty or delay in the passage of stools 
ii) Difficulty in passing stools because they are hard or small 
iii) Pain when passing stools 
‘Acquired constipation’ which is not due to an aganglionic segment of the colon, rectum or 
anal canal often commences in childhood. The principle symptom is one of soiling due to 
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 overflow incontinence around a solid faecal bolus (Silverberg, 1984).  Many of these 
children have behavioural problems and complex social background. ‘Idiopathic 
constipation’ is a diagnosis which is made by exclusion of all other causes of altered bowel 
habits. Typically the colon is of normal length and diameter on barium enema and of normal 
appearance on colonoscopy, although there may be areas of melanosis coli (Holdstock et al., 
1970). A subgroup of patients with functional constipation has persistent dilation of the 
rectum and/or colon, termed idiopathic megarectum (Gladman et al., 2007, Holdstock et al., 
1970).  This means a large capacity rectum as a result of underlying nerve supply 
abnormalities or muscle dysfunction, which remains large after disimpaction of the rectum 
(van der Plas et al., 2000).  
 
1.2.6.2.2 Epidemiology 
Constipation is the second most commonly self-reported gastrointestinal symptom, affecting 
between 2-34% of (Clayden and Keshtgar, 2003) populations studied (Drossman et al., 1982, 
Sonnenberg and Koch, 1989, Camilleri et al., 1994). As found in FI, the lack of consistency 
in the description of constipation may be responsible for such vast discrepancies in 
estimation of prevalence and epidemiological factors associated with constipation.  
 
Constipation is also a common problem in children, accounting for about 3% of 
consultations in an average paediatric practice and as much as 25% in a paediatric 
gastroenterology clinic (Taitz et al., 1986, Loening-Baucke, 1993, de Lorijn et al., 2004). 
Only those children unsuccessfully treated by their general practitioners are referred, and this 
percentage highlights the severity and longevity of childhood constipation and soiling.  
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 Constipation, with, or without soiling occurs often in children, and is one of the ten 
most common problems seen by general paediatricians (Clayden and Keshtgar, 2003, 
Cladyen, 2005, Mason et al., 2004).  No specific organic cause can be found in 
approximately 90% of the children (Hinton and Lennard-Jones, 1968, Hinton et al., 1969). 
The diagnosis is mainly based on clinical history and physical examination. Patients and/or 
their parents refer to the number of stools per week, to stool volume, to difficulty in 
defecation, and/or to sensation of abdominal fullness (Clayden and Keshtgar, 2003, Cladyen, 
2005). 
 
1.2.6.2.3 Diagnosis 
Most clinicians can make a decision based on history and physical examination regarding 
investigations for constipation which may include blood tests for electrolyte imbalances, 
thyroid function, calcium metabolism, rectal biopsy, radiological studies, anorectal 
manometry (Halverson and Orkin, 1998, Clayden and Keshtgar, 2003).  A plain abdominal 
radiograph is frequently used to confirm the presence of retained stool or enlargement of the 
colon or rectum (Barr et al., 1979, Rockney et al., 1995, Keshtgar et al., 2004a).  Anatomic 
studies such as colonoscopy or barium enema may reveal pathology of the patient’s 
symptoms (Halverson and Orkin, 1998).  Rectal biopsy is a gold standard for diagnosis of 
Hirschsprung’s disease where there is a lack of ganglion cells in submucosa on haematoxylin 
and eosin staining and presence of hypertrophic nerve fibres in lamina propria or 
acetylcholinesterase staining.  
 
In patients with constipation, the term megarectum is often used indiscriminately. For some 
it means a large rectal mass on rectal examination, while for others it means a wide rectum 
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 on an abdominal x ray, the presence of impaired rectal sensation, or the finding of large 
maximal rectal volumes on anorectal manometry (van der Plas et al., 2000, Clayden, 1992, 
Schnaufer et al., 1970, Leon et al., 1987, Meunier et al., 1984, Verduron et al., 1988). 
Dilation of the rectum may be evident on a plain radiograph of the abdomen, although 
diagnosis on this basis is somewhat subjective because no specific criteria exist. Therefore, 
the diagnosis is usually made when the rectal diameter at the pelvic brim is greater than 
6.5cm on a lateral radiograph obtained during double contrast barium enema (Preston and 
Lennard-Jones, 1985).   A simple radiopaque marker study with plain abdominal films taken 
three to five days later is adequate for detecting transit abnormalities (Gladman, 2005, 
Hinton et al., 1969). Studies have found an important delay in the rectosigmoid colon in 
patients with constipation (van der Plas et al., 2000, Benninga et al., 1995).  
 
1.2.6.2.4 Pathophysiology 
The pathophysiology of chronic idiopathic constipation is not fully understood and it is 
beyond the scope of this thesis to go into great detail. The most widely accepted hypothesis 
found in paediatrics, is that fear of defecation and voluntary retention of stools lead to the 
formation of a functional megarectum with loss of rectal sensitivity and of the normal need 
to defecate, causing overflow incontinence and non-voluntary expulsion of faeces, or 
encopresis (Loening-Baucke, 1984b). Most studies in small children have investigated 
various anorectal functional parameters because the distal bowel is more accessible to study 
by methods such as manometry (Arhan et al., 1972, Loening-Baucke and Younoszai, 1982, 
Loening-Baucke, 1984b, Loening-Baucke, 1984a, Keren et al., 1988, Meunier et al., 1984, 
Loening-Baucke and Cruikshank, 1986). 
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 It is important to keep in mind when taking a history of the patient, to exclude common 
disorders causing constipation including endocrine and metabolic diseases such as diabetes 
mellitus or hypothyroidism; neurological diseases such as spinal cord injury or multiple 
sclerosis, rectoanal problems such as anal strictures or proctitis, iatrogenic conditions such as 
constipation due to drug, previous surgeries or dietary factors such as a low residue diet.   
 
Chronic idiopathic constipation may be due to a disorder in the mechanism of defecation, 
sometimes known as outlet obstruction or anismus (Watier et al., 1983, Duthie and Bartolo, 
1992).  These patients have difficulty in rectal evacuation due to a failure of the puborectalis 
muscle and external sphincter to relax during attempted defecation, or due to a hypertonic 
IAS. Alternatively, constipation may be due to colonic inertia or a failure of the bowel to 
propel its contents in an orderly prograde manner. This disorder of colonic motility may be 
confined to a segment of the colon or the rectum or to the whole of the large bowel (Arhan et 
al., 1981, Poisson and Devroede, 1983, Metcalf et al., 1987). Colonic inertia is usually 
identified by the delay in the excretion or passage of radio-opaque markers, isotopic scans or 
a failure of the colon to respond to a stimulant (Hinton et al., 1969, Touchais et al., 1988, 
Krevsky et al., 1986, Preston and Lennard-Jones, 1986, Roe et al., 1986, Shouler and 
Keighley, 1986, Bassotti et al., 1988, Varma and Smith, 1988). 
 
Those with significant loss of the ability to sense distension may have passive (overflow) 
incontinence. The symptoms related to faecal impaction are a decreased defecation 
frequency, passing massive stools, abdominal pain, abdominal distension, and overflow 
incontinence (Clayden, 1992, Meunier et al., 1984, Stabile et al., 1992, Callaghan and 
Nixon, 1964, Preston and Lennard-Jones, 1985).  Studies in children with constipation have 
shown relations between night time soiling and paediatric slow transit constipation and 
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 between faecal overflow incontinence and the presence of rectal faecal impaction 
(Benninga et al., 1996).  Karlbom et al (2004) found constipation with symptoms of 
infrequency defecation to be associated with impaired rectal sensitivity (Karlbom et al., 
2004). Patients with infrequent defecation have shown increased rectal compliance which 
could be due to either lower muscular tone in the rectal wall or to altered viscoelastic 
properties of the rectal wall. Engel and Kamm (Engel and Kamm, 1994) previously reported 
that straining has acute, as well as chronic effects on pudendal nerve function. Stretch, neural 
ischemia and venous stasis are possible effects of straining. This is a mechanism for 
development of sensitivity impairment in patients with outlet obstruction. Hosie and Spitz 
(1997) demonstrated an association with a thickened IAS and children (5 months and 13 
years) with idiopathic constipation using endosonography (Hosie and Spitz, 1997). Children 
who had constipation displayed significant thickening of the IAS independent of of the 
length of the history, however no difference in the morphology of the EAS between the 
control and constipation group.  Keshtgar et al (2004) also demonstrated thickening of the 
IAS in patients with constipation (144 patients) which significantly correlated with duration 
and severity of symptoms, size of megarectum, and amplitude of rectal contraction.  It was 
suggested that the pathogenesis was secondary to the continuous presence of faeces in the 
rectum, resulting in chronic abnormal stimulus to the IAS, which leads to hypertrophic 
changes in the rectum wall and IAS (Keshtgar et al., 2004b).  
 
1.2.6.2.5 Is the age of the child a useful guide to the main cause of constipation? 
One of the main focuses of this thesis is idiopathic constipation in children above 11 years of 
age. It is beneficial to take into consideration the age and developmental stage of the child 
when it comes to the diagnosis and practical management of patients with IC (Table 1.3). 
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 Firstly, symptoms of constipation occurring in the newborn should raise the suspicious 
of an obstructed large bowel by a short aganglionic segment in Hirschsprung’s disease or 
ARA with anal stenosis (Clayden and Keshtgar, 2003, Cladyen, 2005).  This is essential 
especially if the newborn presented with other structural problems such as VACTERL 
related anomalies. In infancy (beyond 4 weeks of age) toddlers and preschool age, it could 
be due fluid/feed intake or if early constipation (e.g. due to prematurity or gastro-
oesophageal reflux disease) has gone unreported and the family have been using regular anal 
treatments or procedures (suppositories, enemas, or digital evacuation). In severe cases of 
feeding problems and constipation, especially in association with gastro-oesophageal reflux 
and poor thriving, rare gut motility problems such as intestinal pseudo-obstruction should be 
considered (Table 1.3) (Schuffler et al., 1978, Krishnamurthy et al., 1993).  
 
Withholding is a common behavioural factor of constipation in young children which can be 
due to psychological stressors (Mason et al., 2004, de Lorijn et al., 2004) or fear of using the 
toilet or potty (Clayden, 2004, Cladyen, 2005) or episodes of painful defaecation, often due 
to constipation.  Repeatedly withholding involves ignoring the urge to defecate, and 
eventually the stool retained in the rectum becomes impacted leading to constipation 
(Rogers, 2003, Clayden and Keshtgar, 2003). Clayden & Keshtgar (2003) presented a case 
study of a 2 year old boy to illustrate this point: 
“The boy has been noticed to have episodes of straining, as if to defecate, throughout the day and he 
eventually screams as he passes a large hard stool often streaked with fresh blood. Over the past two 
weeks, the intervals between the stools have extended to four days. He tends to hide behind the 
furniture during these episodes of straining and resists contact with his parents even though he 
appears afraid. He has no problems with defecation either as a newborn or as an infant, but since 
age 1 year had occasional dry stools described as ‘rabbit droppings’ by his mother. This has been 
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 explained a result of his high cows’s milk intake and poor eating. He has a family history of a 
similar but milder problem occurring in his older sister at the same age. . .” (Clayden and Keshtgar, 
2003) 
Clayden et al (2003) suggested that this boy may have a familial predisposition to delayed 
defecation by having a unusually larger rectal capacity than the norm (Clayden and 
Keshtgar, 2003).  This behaviour allows the boy to accumulate stool instead of passing it as 
his rectal contractions, provoke the rectoanal inhibitory reflex which leads to more 
prolonging (Clayden and Keshtgar, 2003, Callaghan and Nixon, 1964).  He has learned to 
perceive this sensation as the precursor to anal pain and thus strains to withhold the stool by 
contracting his EAS and associated pelvic floor muscles by a change of posture (extended 
legs, arched back – known as the ‘banana posture’). Hiding behind the furniture allows the 
boy not to become distracting during the withholding period, as he knows what it is like to 
allow the stool to descend. Repeated treatment failures have a psychosocial impact on the 
child and family (Clayden, 1991) and psychosocial problems may lead to non-compliancy 
with treatment regimes whether it is medication, toileting regimes, diet or behaviour 
modification, which then maintains the constipation (Clayden, 1991). 
 
School age children who have constipation become more of an issue of struggle with the 
resulting overflow FI (Clayden and Keshtgar, 2003, Cladyen, 2005).  It has been often 
found, that the childs’ constipation has gone unnoticed for many months or years where the 
continuous loose stool in the underclothing has been accepted as laziness, immaturity or 
attention seeking. Childhood constipation is often compounded by FI that becomes the 
dominant complaint as peer and social pressures increase with age (Clayden and Keshtgar, 
2003). Most childhood constipation clinics report a 2-3 to 1, male to female ratio whereas 
with adults there is a marked female predominance. It has been suggested that constipation 
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 in children is mostly caused by the conscious or unconscious postponement of 
defecation (withholding behaviour) due to learned behaviour and pain with evacuation of a 
large faecal bolus (de Lorijn et al., 2004) or problems with faecal retention in the 
megarectum with overflow FI or it is the early onset of more adult type pancolonic slow 
transit constipation (Clayden and Keshtgar, 2003).  
In older children and teenagers with persistence of the megarectum and FI, there is a 
tendency for increasing denial and dissociation that infuriates their parents and teachers, 
limits the effectiveness of psychological input and sabotages any physical treatments 
(Clayden and Keshtgar, 2003, Cladyen, 2005, Ludman and Spitz, 1996).  This leads to poor 
compliance of medication, disregarding routine use of the lavatory, and ignoring FI when it 
occurs. 
 
There is continuous debate over the association between constipation and psychosocial 
problems, and whether constipation causes psychosocial problems or vice versa (Benninga et 
al., 2004).  Benninga et al (2004) mentions some of the terms use to describe this: 
“psychogenic constipation and some consider that unexplained encopresis is triggered by 
unconscious anger” (Benninga et al., 2004). Studies have found that psychosocial and 
behavioural problems are the main cause of chronic idiopathic constipation (Coughlin, 2003, 
Southwell et al., 2005). Coughlin (2003) says “psychosocial and behavioural factors are 
often the source of constipation in children” (p297), but does not acknowledge the role that 
psychosocial and behavioural problems can have in maintaining constipation (Coughlin, 
2003). Some studies have found the importance of behavioural disturbances or personality 
disorders, suggesting that constipation and encopresis require psychiatric treatment (Gabel et 
al., 1986, Friman et al., 1988). 
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Table 1.3: Inter-related physical and psychological factors in childhood constipation 
Borrowed from (Clayden and Keshtgar, 2003) 
Early physical factors 
Familial high capacity stools 
High milk, low fibre intake 
 
Hard non-malleable stools 
Anal fissure 
Perianal group A streptococcal infection 
Cow’s milk allergy/eosinophilic proctitis 
Medication – for example, diuretics, 
analgesia.  
Rare: Hirschsprung’s disease, anal stenosis, 
hypocalcaemia, hypothyroidism, celiac 
disease.  
Early behavioural factors 
Poor or faddy eating 
Fear of pain related withholding of faeces 
Avoidance of defecation 
Too early or coercive pot training 
Pot/lavatory refusal 
Parental anxiety, tension, and anger 
Fear of medication (particularly by anal 
route) 
Later physical  
Hypertrophied rectum (megarectum) 
Residual stool (faecaloma/faecalith) 
Episodic rectoanal inhibition and overflow 
faecal soiling.  
Poor rectal sensation 
Less common: child abuse (anal sexual 
abuse), celiac disease, cerebral palsy, lead 
poisoning.  
Later behavioural 
Embarrassment/shame related to soiling 
Parental blame/anger related to soiling and 
lavatory refusal  
Teasing and bullying related to incontinence 
Dissociation and denial  
Medicine and lavatory routines refusal 
Decreased mobility/activity.  
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 1.2.7 Management of symptoms of faecal incontinence and constipation 
 
A brief account will be discussed about some of the current treatment modalities for 
constipation and FI in childhood.  But before we embark on the cocktail of laxatives given to 
children with FI and constipation or discuss the advanced treatment modalities up for 
suggestion, we need appreciate the need to firstly educate our audience, the child and family 
involved.  There is no point in offering solutions, without the patients and carers involved, 
understanding the purpose and physiological mechanism involved in dealing with these 
symptoms on a day to day basis.  Thus, education about basic physiological mechanisms 
involved in continence, at an early stage should be introduced.  They need to be aware, that 
the rectum regularly contracts when impacted and so any soft or loose stool in the vicinity of 
the IAS will leak out, especially as the persistently full rectum produces very little sensation 
during its contractions. As the leaking stool is of the same temperature as the skin, it is not 
surprising that the child is unaware of this type of FI (Cladyen, 2005, Clayden and Keshtgar, 
2003).  Then there is the balance between effective emptying of the rectum and the ability to 
reach the lavatory in time is particularly difficult if the child needs high dosage laxatives to 
avoid faecal impaction. The amount and timing of the dose along with a good fluid intake 
will hopefully encourage a stool to be passed at a regular time of the day.  
 
1.2.7.1 Medication 
The goal of treatment for patients of any age suffering with FI and/or constipation is to 
restore continence and to improve the quality of life.  Pharmacological therapies involve 
using a variety of drugs (Table 1.4), each with a different mechanism of action to improve FI 
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 and constipation.  All laxatives act in the lumen of the colon. Some form a greater bulk 
(bran, carboxymethyl-cellulose, ispaghulla, sterculia) (Table 1.4). Others soften the stool 
(Arachis oil, liquid paraffin, docusate sodium or calcium salt, given as an enema) which 
facilitates the expulsion of the bolus (Table 1.4) (Briejer et al., 1999). Other laxatives are 
able to stimulate the mucosa and induce secretion and mass movements.  These include i) 
antranoids such as senna, aloe and dantron; ii) polyphenol derivatives such as 
Phenolphthalein, Bisacodyl, Sodium Picosulphage and; iii) miscellaneous compounds such 
as Castor oil, Glycerol and Docusate Sodium or Calcium salt (Table 1.4)  (Briejer et al., 
1999). Osmotic laxatives (Movicol, Mannitol, Sorbitol, Lactitol, Lactulose, Magnesium 
salts, Phosphates, Sodium citrate) (Table 1.4) aim to increase the fluid content of the stool 
and facilitate expulsion of the bolus by lubricating and softening it (Briejer et al., 1999).    
 
Clayden & Keshtgar (2003) have suggested that the first stage for a child with a hard stool 
extending to the umbilicus on abdominal palpation is to soften it. Examples of softeners 
include Lactulose, Sodium Docusate and Polyethylene Glycol (Macrogol) (Table 1.4) 
(Clayden and Keshtgar, 2003). There is no doubt, that the evacuation phase is one of the 
most challenging areas for the clinician and the patient. The risk of using forceful but 
effective physical means to clear the stool must be balanced against the stress caused to the 
anxious child as this may intensify the psychological factors that operate in the persisting 
problem (Clayden and Keshtgar, 2003). This can be achieved with multi-disciplinary support 
from the clinician, surgeon, specialist stoma nurses, parents and most of all, the child. If the 
mass is not evacuated spontaneously, then a high dose of stimulant laxative such as Senna 
(‘sennakot’), Bisacodyl or Sodium Picosulphate may successful clear the retained stool 
(Table 1.4).  However, this risks increasing FI, provoking abdominal pain to such a degree 
that it undermines the child and family’s confidence in the medication that will be so 
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 essential in the maintenance phase (Clayden and Keshtgar, 2003). Suppositories and 
enemas are effective but disliked to the point of phobia in some children (e.g. Glycerol rectal 
suppositories). Other medications can include Polyethylene glycol (Klean-Prep, Golytely or 
Movicol) (Table 1.4). If the child has had to undergo any of the evacuation methods, there is 
a degree of motivation from child and family to avoid that being needed again. They are 
likely to start to take regular stimulant laxatives regularly if they have had the rationale for 
the treatment explained carefully. Once the pattern of defecation has been established, 
parents are tempted to reduce the medication to see if it is still necessary. Unfortunately, this 
is likely to provoke a relapse that might even require a repeat of the rigours of the evacuation 
phase (Clayden and Keshtgar, 2003) (Table 1.4).  
 
But what happens if the patient is not responding to treatment? Firstly, we need to address 
the issue of compliance of the medication and whether it is being taken regularly or properly. 
Sometimes it is the intensity of the child’s behavioural response to the defecation problems 
that blocks the effectiveness of the medication regimen. Rewards for overcoming the fear of 
pots/lavatories in the form of star charts are surprisingly effective especially if the design of 
the star or token is changed with time and parents encouraged using their creativity in 
designing the chart (Clayden & Keshtgar). Dealing with the denial and dissociation problem 
of the older child is more likely to need expert psychological input (Clayden and Keshtgar, 
2003, Ludman and Spitz, 1996).  
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Table 1.4: Medication for symptoms of faecal incontinence (FI) and constipation 
Borrowed from: (Clayden and Keshtgar, 2003) 
 
Medication  Advantage  Disadvantage 
Lactulose Increase colonic water and gut 
flora, acceptable to most 
children 
Appears to lose effectiveness over 
time, increases ‘wetness’ of 
soiling.  
Docusate Emulsifying effect on hard 
faeces 
Increases ‘wetness’ of soiling, 
taste often disliked by children. 
Liquid 
paraffin/mineral oil 
Increases lubrication of hard 
stools 
Disliked by most children, 
increases soiling penetration into 
clothing, theoretical lung 
aspiration risk.  
Methylcellulose 
 
Senna 
Provides fibre and bulk 
Provides rectal filling and 
contraction after a time delay 
that helps school age children 
plan their day 
Only the tablet form is currently 
licensed. 
Provokes abdominal pain and 
increases soiling if used when 
large retain stool is in rectum.  
Sodium picosulphate Provokes rectal filling and 
contraction after shorter time 
delay than senna 
May be difficult to find the ideal 
time in day for use in school age 
children 
Polyethylene 
glycol/macrogol 
(Kleanprep/Movicol) 
Flushes unabsorbable water 
into colon without having to 
resort to enemas.  
High volumes needed to clear 
large stools may be difficult to 
drink and require hospital 
admission for nasogastric tube.  
Enema/suppository Direct immediate action on the 
loaded rectum.  
Provokes fear/humiliation in 
children and young people unless 
able to administer it themselves.  
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1.2.7.2 Advanced treatments when medication fails  
When the child has undergone rigorous measures of medication or compliance has become 
an issue for the patient, other treatment modalities need to be seeked. In children anal 
dilation or IAS partial myectomy under anaesthetic have been done for constipation because 
of the perception that there is a degree of hypertrophy and increased activity of the IAS as 
part of the pathophysiology of the idiopathic megarectum. It is believed that these 
procedures reduce the anal sphincter tone and allow pain-free defecation. In a double blind 
randomized controlled trial of sixty children who underwent anal dilation versus no dilation 
for treatment of chronic idiopathic constipation, no significance was found in outcome with 
regards to improvement in symptom severity score between these two groups at 3 and 12 
months follow up (Keshtgar et al., 2005).  Sphincterotomy and sphincter myectomy involves 
division or excision of upper half of IAS, respectively. The purpose of these procedures is to 
treat idiopathic constipation in children caused by IAS achalasia in Hirschsprung’s disease 
(Clayden and Lawson, 1976, Loening-Baucke, 1984a).  Improvements have been shown in 
symptoms using these techniques which were attributed to shortening and widening of the 
functional anal canal after anal stretch and myectomy which allows the faecal bolus to reach 
the sensory sampling area and be expelled easily. However, one should note the detrimental 
effects of any procedure that weakens the sphincters may not become apparently for many 
years.   
 
Newer treatment is botulinum toxin injections in the treatment of chronic idiopathic 
constipation without risking permanent damage and weakness of anal sphincter (Keshtgar et 
al., 2007b). Botulinum toxin inhibits the local release of acetylcholine from presynaptic 
cholinergic nerves (Simpson, 1981) which would cause loss of junctional acetylcholine 
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 receptors and result in loss of excitatory sympathetic input to the IAS tone. Jones et al 
(Jones et al., 2004) has suggested that the major effect of botulinum toxin on the IAS is 
through blockade of sympathetic stimulation, which is caused by a reduction in the release of 
noradrenalin neurotransmitters at the neuromuscular junction. The effect of botulinum toxin 
in reducing contractions of striated and smooth muscle fibre is focal, transient and reversible 
without having a systemic effect. Such injections have been used in children for the 
treatment of constipation after a pull-through operation for Hirschsprung’s disease (Langer 
and Birnbaum, 1997) and in adults for the treatment of anal fissures (Brisinda et al., 1999). 
Basically, the rationale is that during the period of maximum activity of the toxin in reducing 
the sphincter pressure, ordinary laxatives and lavatory routines allow the rectum to begin to 
shrink. By the time the toxin has worn off, the frequency and the completeness of defecation 
will have improved due to; the partial resolution of the megarectum, as well as the boost to 
confidence that is produced by symptom improvement. Thus, botulinum toxin achieves the 
same effect as myectomy, of the IAS done chemically, by reducing the resting sphincter 
pressure for a short period.  Physiological results have indicated that botulinum toxin is 
equally effective and perhaps less invasive than myectomy of the IAS, yet results only lasts 
short term (Keshtgar et al., 2007b). Anal plugs have been designed to temporarily occlude 
the anal canal. It has been shown that these plugs can be useful in patients with impaired 
anal canal sensation, those with neurological disease and those who are institutionalised or 
immobilised (Mortensen and Humphreys, 1991).  
 
A surgical treatment offered to children suffering from chronic constipation and FI is the 
antegrade continence enema (ACE), also known as the Malone antegrade continence enema. 
The ACE stoma was first used in the 1990s for children with faecal soiling due to 
neuropathic (neurological) disorders such as Spina Bifida (Yerkes et al., 2003) and is now 
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 also used to treat chronic constipation and FI. The ACE is a catheterisable stoma usually 
made using the appendix, which allows access to the colon via the abdomen. It is seen as a 
more pleasant alternative to rectal washouts because it allows easier administration of 
enemas to promote complete colonic emptying (Malone, 2004). The empty rectum prevents 
soiling, whilst regular colonic emptying prevents constipation. The ACE stoma has been 
shown to benefit patients with neuropathic rectum or where there residual sphincter zone is 
extremely narrow or weak after repair of ARA (Keshtgar et al., 2004b).  The procedure is 
well tolerated and effective in achieving more regular and predictable stools with reduced 
episodes of incontinence. However, one needs to keep in mind that the ACE stoma is 
unlikely to be successful unless the psychological factors or fear or dissociation are 
addressed but the quality of life of the child who is enema dependent is likely improved if 
spared the apparently endless repetition of the ‘per anal’ treatments they dread.  There has 
been mixed perceptions about the success of the ACE.  Studies have found that the ACE 
stoma is an effective treatment for constipation and soiling (Yerkes et al., 2003, Searles et 
al., 2000, Herndon et al., 2004, Hutson et al., 2001, Clayden, 2004).  Other studies have not 
rated the ACE as highly (Rubin and Dale, 2006) due to the instances of repeated treatment 
failures and they identify that complication are common (stomal stenosis and pain with the 
enemas) (Dey et al., 2003).  The literature also highlights that the ACE is believed to be less 
successful in the treatment of children younger than five years of age, and those with chronic 
idiopathic constipation because of increased non-compliancy (Ekmark and Adams, 2000, 
Dey et al., 2003, Herndon et al., 2004, King et al., 2005).  However, studies (King et al., 
2005) (Yerkes et al., 2003, Ekmark and Adams, 2000) have found that the ACE stoma 
significantly improves the quality of life of children with chronic idiopathic constipation. 
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 Biofeedback therapy is based on the principle of operant conditioning which has been 
shown to improve bowel function and FI (Engel et al., 1974, Rao, 1998). Tuteja & Rao 
(2004) illustrate the main purpose of this therapy is to: improve the strength of the anal 
sphincter muscles improve the coordination between the abdominal, gluteal and anal 
sphincter muscles during voluntary squeeze and following rectal perception and enhance the 
anorectal sensory perception.  After biofeedback therapy, symptomatic improvement has 
been reported in 70 to 80% of patients with either incontinence or obstructive defecation 
(Rao, 1998, Norton et al., 2006, Norton et al., 2003, Lunniss, 2007).  Yet, evidence is 
contracdictory as to which patients are most likely to benefit from a biofeedback 
programme, and there are no clear predictors of success or failure (Whitehead et al., 2001, 
Norton et al., 2006).   
 
The above is achieved by using a rectal balloon (anal manometry) device, patients are taught 
to contract the EAS when they perceive balloon distension. The perception of balloon 
distension can be reinforced by using visual tracings (or in some cases verbal or auditory) of 
balloon volume and anal pressure, and the procedure is repeated with progressively smaller 
balloon volumes. Some studies have shown improvement after a year of therapy, yet 
ongoing controlled studies are needed (Tuteja and Rao, 2004).  
 
A surgical technique that involves the continuous electrical stimulation of the gracilis 
muscle, which is surgically transposed around the anal canal, is called ‘graciloplasty’ 
(Rotholtz and Wexner, 2001, Wexner et al., 2002, Williams et al., 2001).  Electrical 
stimulation facilitates anal tone by converting type II (fast-twitch, fatigue-prone) to type 1 
(slow-twitch, fatigue resistant) muscle fibres. After having the surgery, studies have found a 
reduction in the frequency of incontinent episodes in some but not all of their patients 
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 (Wexner et al., 2002, Chapman et al., 2002).  A review showed this technique to be 
associated with 2% mortality and a significant risk of re-operation (Chapman et al., 2002).  
 
Sacral nerve stimulation was first reported for use in patients with urinary difficulties 
(urinary incontinence) in the 1960s (Habib, 1967).  Sacral nerve stimulation (for 
neuromodulation) is a relatively new technique for treating FI and is used in patients with an 
intact or repaired sphincter complex (Matzel et al., 1995).  It is a less invasive technique and 
its main advantage is that a temporary procedure can be carried out prior to the final 
operation to make a reliable estimate of its outcome. The procedure involves placing a 
percutaneous electrode in a sacral foramen (usually S3) and if a two week test period is 
successful a permanent pulse generator can be implanted. Recent studies suggest that notable 
improvement can be achieved with little impact (Matzel et al., 1995, Jarrett et al., 2004, 
Malouf et al., 2000).  Vaizey et al (1999) investigated the efficacy and possible mode of 
action of short term stimulation of sacral nerves in patients with FI and a structurally intact 
EAS (Vaizey et al., 1999b).  It was found that sacral nerve stimulation does decrease 
episodes of FI. The actual mechanism as to why this procedure only seems to work in some 
patients remains unknown.  Although, it has been implied that the effect may be mediate via 
facilitation of striated sphincter muscle function and via neuromodulation of sacral reflexes 
which regulate rectal sensitivity, contractility and anal motility (Vaizey et al., 1999b).  It has 
also shown changes in sacral nerve reflexes and rectal sensitivity (Vaizey et al., 1999b, 
Rosen et al., 2001, Malouf et al., 2000).  It has also been suggested that sacral nerve 
stimulation might modulate higher cortical function through alterations in corticoanal 
exitability (Turnbull et al., 1999)  The cortical part of the human anal spincter and pelvic 
floor can be mapped non-invasively to the motor cortex in healthy subjects, and after 
stimulation of the the pudendal nerve or lumbosacral roots can produce shorterm increases in 
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 corticoanal excitability (Turnbull et al., 1999).  Thus, there is indication that nerve 
stimulation can modulate motor cortical centres relecvant to anal function, and that this 
might be important in altering continence behaviour.  The cost of this treatment is of great 
concern because the total cost of the equipment for both temporary and permanent sacral 
nerve stimulation is approximately £7000 (Kenefick and Christiansen, 2004).  
 
Others measures include excision of the megarectum, when all other treatments have failed 
and there is clear evidence of the extreme capacity of the rectum (Cheu and Grosfeld, 1992, 
Lee et al., 2002, Keshtgar et al., 2007a).  As a last resort, colorectal resections have been 
used in the most extreme cases, where patients have failed to respond to care provided my 
multidisciplinary teams. The technique involves resection of the lower sigmoid colon, which 
is often almost normal in calibre, to the lower third of the rectum below the peritoneal 
reflection, without tapering of this part of the rectum.  The sigmoid colon is spatulated to 
match the calibre of the rectal ampulla (Williams et al., 2000).  Results have illustrated that 
resections rarely show a complete and immediate cure in the context of idiopathic 
constipation (Keshtgar et al., 2004a).  Keshtgar et al (2007) investigated 62 children born 
with ARA, 16 of who had resection of their megarectum. In this study about a half (n = 7) 
became continent (Keshtgar et al., 2007a).   
 
1.3 PHYSIOLOGICAL ASSESSMENT 
 
Physiological assessment will be briefly discussed in this section with greater detail in 
Chapter 2.   
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 A detailed interview in collaboration with the patients’ clinical history and physical 
examination is the first step in diagnosing a patients’ bowel problem.  Yet, to gain a 
thorough comprehension of the patients’ symptoms, physiological assessment is needed for 
the aetiology of the incontinence or constipation to be deduced, coexisting pathology to be 
excluded and a decision regarding choice of suitable, rather than empirical therapy to be 
made on individual basis. For this thesis, we will discuss briefly some of the physiological 
tests usually undertaken as a form of assessment for FI and constipation. These tests should 
provide characterization of the sensory and motor disorders responsible for presenting 
symptoms, and thus promote evidence based guidance of management strategy.  
 
1.3.1 Anorectal manometry  
 
Anorectal physiological investigations play an essential role in the assessment of patients 
with FI and/or constipation, because they provide an objective measurement of motor and 
sensory function. Furthermore, it provides measurement of pressures in the anal canal, to 
evaluate the muscular contraction and relaxation of the sphincters (Azpiroz et al., 2002, Rao 
and Patel, 1997).  It is a widely used and well established tool to specifically assess for:  
functional deficits in anal sphincter tone the presence or absence of rectoanal reflexes normal 
or abnormal rectal sensory function and compliance 
 
The major draw back when using this tool is that lack of uniformity regarding equipment 
and technique among different institutions. Lack of standardised method makes it difficult to 
compare between research centres; therefore, each individual institution is encouraged to 
develop its own control values or, if using normative data from the literature, adopt similar 
methodology (Gladman, 2005). The main purpose for using this tool is to identify the 
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 functional anal canal length and to record the maximum resting anal canal pressure and 
voluntary anal squeeze increment. A station pull through (Gladman, 2005) continuous pull 
through or stationary technique is usually employed.  
 
The IAS contributes approximately 85% of the total pressure in the anal canal and is chiefly 
responsible for anal continence at rest (Fernandez-Fraga et al., 2002). In patients with FI, the 
functional anal canal length has been found shorter compared to normal control subjects 
(Gladman, 2005).  Several studies have shown that symptoms of passive FI (unwanted loss 
of stool without patient awareness) are related to low resting anal tone due to impairment of 
the IAS (Salvioli et al., 2001) (Read et al., 1984) (Gladman, 2005) (Engel et al., 1995, 
Vaizey et al., 1997).  This is usually due to IAS rupture (e.g. obstetric trauma, iatrogenic 
injury), but also may be secondary to smooth muscle degeneration. Urge FI (unwanted loss 
of stool despite active attempts to inhibit defecation) has been related to EAS dysfunction 
(Chan et al., 2005a). Symptoms of urge or ‘stress’ FI often correlate with low anal squeeze 
pressures along with reduced squeeze duration. Although low or poorly sustained voluntary 
anal squeeze pressures implies EAS weakness, standard manometry alone cannot 
differentiate between compromised muscle integrity or impaired innervation, or both, as a 
cause of that weakness. Anal squeeze pressures has been demonstrated to be relatively 
sensitive and specific for discrimination of patients with FI; nevertheless, the correlation 
between anal canal pressures and incontinence is not perfect, given the range of normal 
values and the contribution of various other factors that are crucial to anorectal continence. 
Resting and squeeze pressures may be normal in idiopathic constipated patients but a few 
have increased resting internal sphincter activity (Kamm, 1987).  Heikenen et al (1999) 
found in ARA, low anal resting and squeeze pressure were associated with FI (Heikenen et 
al., 1999).  
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Relaxation of the cauda anus in response to rectal distension called the ‘rectoanal inhibitory 
reflex’ (RAIR) is believed to play an important role in the continence mechanism. The 
normal RAIR has been found to be most likely mediated by both the sacral cord and 
myenteric neurones (Kaur et al., 2002). This reflex can be elicited by simply inflating a 
rectal bag or balloon; the anal response can be measured using a manometric probe (Azpiroz 
et al., 2002).  Abnormal RAIR in response to rectal distension has been described in the 
literature in patients with FI (Sangwan et al., 1996, Sangwan et al., 1995, Zbar et al., 1998, 
Sun et al., 1990).  It has been found that in FI, there is a greater relaxation of the IAS in 
response to rectal distension (Kaur et al., 2002) (Farouk and Bartolo, 1993, Duthie and 
Bartolo, 1992). Presence of a normal RAIR in which distension of a rectal balloon causes 
relaxation of IAS excludes Hirschsprungs’ disease (Keshtgar et al., 2004b). In patients with 
idiopathic constipation, RAIR has shown to be preserved (Poisson and Devroede, 1983, 
Bartolo et al., 1988).  The clinical significance of the IAS has been brought to our attention  
with the advent of sphincter saving surgery and has lead to a renewed interest in the RAIR 
and its role in continence (Smith, 1987).  Studies have shown that greater IAS relaxation in 
patients with FI occurs in response to rectal distension at each volume when compared with 
both healthy controls and constipated patients (Kaur et al., 2002, Farouk and Bartolo, 1993).   
The excitatory component of the RAIR is caused by the brief contraction of the EAS which 
maintains the anorectal pressure gradient. It has been shown that parametric assessment of 
the RAIR may correlate with FI where a more rapid recovery of the inhibitory wave occurs 
in patients with demonstrable EAS atrophy (Kaur et al., 2002, Zbar et al., 1998).  This 
suggests that IAS plays a significant role, especially in patients in whom the EAS function is 
impaired.  
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1.3.1.1 Rectal sensation 
Intact anorectal sensation is fundamental to normal defaecation and continence. In clinical 
practice, rectal sensation is most easily assessed by simply volumetric distension using 
intrarectal balloon (Bharucha, 2006) and anal sensation is measured by recording thresholds 
to electrical stimulation (Roe et al., 1986).  
 
Rectal sensory function is most normally quantified using simple latex balloon distension 
(Bharucha, 2006, Chan et al., 2005a, Chan et al., 2005b).  It is an important factor in the 
defaecatory stimulus, because distension has been implied to initiate rectal wall contractions, 
creating the desire to defecate (Denny-Brown and Robertson, 2004, Duthie and Gairns, 
1960, White et al., 1940).  The technique involves using inflation, which include i) ramp 
(continual) or ii) intermittent which can be either phasic (volumes injected and then 
withdrawn) or stepwise (volumes are maintained between inflations) in nature. Thresholds 
for first sensation, desire to defecate and maximum toleration as volunteered by the patient, 
are recorded. Alterations of afferent pathways can result in elevated thresholds, 
‘hyposensitivity’ (Gladman et al., 2005) which has been seen in patients with idiopathic FI 
(Gladman et al., 2003, Hancke and Schurholz, 1987). Decreased sensory thresholds, 
‘hypersensitivity’ may be responsible for the heightened perception of rectal filling and act 
as an independent trigger of FI (Gladman, 2005).  When faecal contents reach the rectum, 
resulting in the desire to defecate, a mainly voluntary increase in EAS activity will result in 
delay of defaecation. But, when patients are unable to generate adequate maximal squeeze 
pressures, this will inevitable lead to incontinence, i.e. urge FI (Engel et al., 1995, Chan et 
al., 2005c). Those with rectal hypersensitivity typically complain of urgency/urge 
incontinence and increased frequency of defecation.  Association between higher thresholds 
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 for rectal sensory perception has been shown with autonomic neuropathy, congenital 
neurogenic anorectal malformation (spina bifida, Hirschsprungs’ disease, 
myelomeningocele) and functional and somatic alterations of the rectal reservoir, such as 
megarectum and descending perineum syndrome (Hancke and Schurholz, 1987). Both 
abnormalities have been reported in some patients with FI (Tuteja and Rao, 2004, Lubowski 
and Nicholls, 1988, Gladman et al., 2003, Vasudevan et al., 2007, Rogers et al., 1988). 
Rectal sensation is known to be impaired in patients with a megarectum (Gladman et al., 
2003) and constipation (Vasudevan et al., 2007); it is also abnormal in children with 
idiopathic constipation (van der Plas et al., 2000).  
 
1.3.1.2 Rectal Compliance 
 
The rectum has elastic properties that allow it to maintain low intraluminal pressure, even if 
the volume is large (Arhan, 1976). Compliance is the pressure/volume relationship during 
rectal distension.  This can be measured by injecting air into the intrarectal bag and 
measuring the pressure or using a barostat that distends the rectum to given pressure levels 
and determines the volume at each distending step (Azpiroz and Malagelada, 1987, 
Whitehead and Delvaux, 1997, Gladman et al., 2005, Bharucha, 2006). Intra-balloon 
(intrarectal) pressure and the balloon volume must be monitored simultaneously; compliance 
is calculated as change in volume divided by change in pressure (∆V/∆P) over that part of 
the pressure-volume curve between first sensation and maximum toleration. Changes in 
compliance can affect continence. If compliance is decreased, smaller volumes of stool can 
cause increased pressure and impair rectal storage function (Cooper and Rose, 2000).  In a 
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 proportion of patients with FI, the rectum has been shown to be poorly compliant (i.e. 
the rectal wall is ‘stiffer’, primarily related to urgency (Gladman, 2005). Studies have shown 
in constipated patients to have increased rectal volumes at constant defecation urge and 
maximum tolerable volume (Gladman et al., 2005, Gosselink et al., 2001).  When increased 
volume tolerance and compliance are found in a patient with FI, an underlying constipation 
contributing to the incontinence should be suspected (Rasmussen et al., 1990). 
  
1.3.2 Endoanal Ultrasonography 
 
The imaging modalities currently used to examine the anal sphincter complex and levator ani 
muscle are endoanal ultrasonography (EUS) and endoanal magnetic resonance (EMR) 
(Fukata et al., 1997, Nievelstein et al., 2002, Nielsen et al., 1993, Hussain et al., 1995, 
deSouza et al., 1997, Keshtgar et al., 2004b, Keshtgar et al., 2008).  EUS is for the 
evaluation of sphincter integrity and now provides the cornerstone for clinical investigation 
of patients with FI (Emblem et al., 2007, Keshtgar et al., 2008). It has also been suggested 
that endosonography is a validated technique that can be applied with confidence to children 
with repaired ARA (Keshtgar et al., 2007a).   
 
Given the predominately cylindrical nature of the anal structures, imaging is best suited to a 
360 degree axial view obtained at right angles to the lumen, and this is achieved using a 10-
megahertz (MHz) transducer attached to a mechanically rotating endoprobe. Although 
operator-dependent, sensitivity and specificity approach 100% for the identification of 
anatomical defects if carried out by an experienced research doctor. Structural damage to 
either the IAS or EAS can be identified clearly, as well as degenerative changes in the 
smooth muscle.  
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In incontinent patients, EUS has revealed that obstetric trauma followed by anal surgery, are 
the major risk factors. Of those physiological and imaging techniques available for the 
evaluation of patients with FI (Tankova et al., 2001) and patients with ARA (Jones et al., 
2003, Athanasakos et al., 2008, Fukata et al., 1997, Emblem et al., 2007, Emblem et al., 
1997) ultrasound is the test most likely to influence a change in management. Keshtgar et al 
(2004) investigated children with chronic idiopathic constipation using endosonography and 
found that the thickness of IAS correlated with duration and severity of symptoms, size of 
megarectum, amplitude of rectal and IAS activity and age of children (Keshtgar et al., 
2004b).  Based on ultrasonographic findings (in conjunction with other test results), rational 
treatment can be planned, including the selection of patients who may benefit from surgery.  
 
A sphincter defect may be diagnosed on the basis of discontinuity, thinning and/or scarring 
of the sphincters, and/or asymmetry of the anal canal (Sudol-Szopinska and Jakubowski, 
2002).  The 3D modification of 2D endosonography offers a longitudinal perspective and 
has improved the appreciation of spatial relations in the anal canal
 
 (Gold et al., 1999) 
extending the utility of 2D endosonography. The interpretation is less operator dependent, 
and the data are able to be stored for review. Several studies have now examined the 
application of 3D endosonography in healthy volunteers (Knowles et al., 2008) and in the 
assessment of patients with FI (West et al., 2004, Gold et al., 1999). 
 
1.3.3 Electrophysiology 
 
The pudendal nerve supplies sensory fibres to the anoderm of the distal anal canal and motor 
fibres to the EAS, and arises from the sacral roots S2, S3 and S4. It has been shown 
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 previously that in healthy volunteers, anal sensory function, but not distal rectal 
sensitivity, could be blunted by distal pudendal nerve blockade, supportive of separate 
distinct afferent innervation (Vasudevan et al., 2007) (Chan et al., 2005b). The pudendal 
nerve terminal motor latency (PNTML) is a measurement of the conduction time from 
stimulation of the pudendal nerve at the level of the ischial spine to the evoked EAS 
contraction. This is achieved using a disposable glove-mounted stimulating and recording 
electrode (St Mark’s pudendal electrode) connected to a suitable recorder. Prolonged 
latencies are suggestive of pudendal neuropathy and have been demonstrated in incontinent 
patients who have suffered obstetric trauma, have excessive perineal descent or a recognised 
neurological disorder (Hill et al., 2002) (Gooneratne et al., 2007). Although, ‘grouped’ data 
show that incontinent patients with bilaterally prolonged PNTMLs have reduced anal 
squeeze pressures compared to controls, thus supporting the concept that neuropathic 
process impairs EAS function, the sensitivity and specificity of this test is poor; many 
patients with delayed latencies have squeeze pressure within the normal range and vice versa 
(Gooneratne et al., 2007, Hill et al., 2002). This lack of agreement is likely to be due to 
methodological limitations: 
• PNTMLs increase with age, independent of continuous status 
• The PNTML reflects the function of the fastest conducting motor fibres, and thus 
normal latencies may be recorded in a damaged as long as some fast-conducting 
fibres remain  
• The test is operator-dependent and may be technically difficult to perform in some 
patients.  
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 Thus, recording of PNTML may contribute little to the management of individual 
patients with FI and its routine use should now be questioned. It has been found that 
unilateral pudendal neuropathy is a common abnormality in individuals with FI and has been 
significantly associated with both attenuated resting pressure and squeeze increments 
(Gooneratne et al., 2007). Yet, unilateral prolongation of PNTMLs is probably without 
clinical significance.  
 
1.3.4 Evacuation Proctography 
 
Evacuation proctography (defecography) is a radiographic test (contrast material is placed 
into the rectum), whereby anorectal anatomy and pelvic floor motion are recorded on video 
and the subject is asked to rest, squeeze, cough or expel the contrast (Gladman, 2005, 
Andrews and Bharucha, 2005) It is during these manoeuvres, that the anorectal angle and the 
position of the anorectal junction are shown.  Such observation allows the identification of 
excessive perineal descent, internal rectal intussusceptions, rectocoele, sigmoidcoles, or 
enteroceles (Andrews & Bharucha). Passive (overflow) incontinence or post-defecation 
leakage may occur secondary to disorders of rectal evacuation (Gladman, 2005, Ferrante et 
al., 1991). 
 
1.3.5 Transit Studies 
 
Methods used to measure gut transit may be classified as radiological, calorimetric, 
particulate, chemical, and isotopic (Hinton et al., 1969). The first description of 
methodology, employing radiopaque polythene cylindrical pellets, was that of Hinton et al. 
(Hinton et al., 1969) who measured the disappearance of 20 such markers from the gut and 
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 their appearance in the stool by serial radiographs. They were able to establish that this 
marker was not absorbed, and was completely recoverable in the stool. Normal ranges for 
both men and women have subsequently been determined, with abnormal transit defined as 
retention of more than 20% of markers on a single plain radiograph at 5 days (Bassotti et al., 
1988)  
 
In patients in whom ‘constipation’ and incontinence coexist, transit studies provide objective 
confirmation of subjective complaints of infrequent defecation. Assessment of total and 
segmental colonic transit time using radio-opaque markers is a non-invasive method which 
provides information about colorectal motor function (Arhan et al., 1981, Chaussade et al., 
1989, Metcalf et al., 1987).  Furthermore, this technique has been used to localise a delayed 
transit in the colon and to evaluate the response to treatment (Benninga et al., 1996, 
Chaussade et al., 1989, Papadopoulou et al., 1994). It has been widely used in children with 
chronic constipation (Benninga et al., 1996, de Lorijn et al., 2004, van der Plas et al., 2000, 
Gutierrez et al., 2002).  Some investigators have shown a good relation between symptoms 
of constipation and colonic transit time in adults (Glia et al., 1999, Verduron et al., 1988). 
However, for accurate assessment of segmental colonic transit, radionuclide scintigraphy is 
required. 
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1.4 PSYCHOLOGY AND CHRONIC CONDITIONS 
 
1.4.1 Definition of Chronic Conditions 
 
Generally, definitions of chronicity vary because they are derived from different conditions, 
severities, causalities, treatment settings and psychosocial backgrounds. Thus, definitions of 
chronic conditions should remain flexible yet comprehensive to cater for a variety of 
conditions.  However common factors may pertain across different conditions; the most 
obvious being that the condition does not remit.  A universal definition will not necessarily 
cater to all conditions.  With this in mind, it is vital to specify definitions used by medical 
professionals and/or institutions and justify their use in particular situation.  This will 
minimize confusion and complexity when discussing and comparing between different 
chronic conditions.  The National Health Interview Survey conducted in Britain defined that 
chronic conditions included all problems lasting longer than three months (Pless, 2008). 
Although a complete or almost complete cure is now available for many children with ARA 
some children have to learn to adjust with some degree of ongoing illness.  Thus, this 
definition seems reasonable and useful when later discussing the long-term outcomes for 
children with ARA in this thesis.   
 
Conceptualisation of chronic illness has been generally based on categorical, non-categorical 
models and a mixture of the two.  The 'categorical' model concentrates on the adaptations for 
the child/parent/family with one specific chronic condition and its association with specific 
social or emotional functioning (World Health Organisation, 1982).  This approach 
characteristically groups chronic conditions in terms of specific conditions, such as asthma 
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 or haemophilia and/or body system impairment (such as metabolic, hearing, cardiac 
defects).  Pless and Perrin (1985) (Pless, 1985) and Davis (1993) (Davis, 1993) have each 
discussed the failure of categorical diagnostic approaches to consistently predict 
psychological outcomes in children with chronic conditions and their families.  The non-
categorical approach (Pless, 1975, Stein and Jessop, 1982) proposes that there are 
commonalities between different chronic conditions.  Furthermore, it recognizes that it is the 
natural history of the condition and its severity, and not its specific characteristics that is 
significant in the risk of psychological maladjustment.  This approach emphasizes:  
". . . that children face common life experiences and problems based on generic dimensions 
of their conditions rather than on idiosyncratic characteristics of any specific disease entity" 
(Stein and Jessop, 1982 p. 354) (Stein and Jessop, 1982). 
Yet, rather than accepting an either or approach to defining a chronic condition a 'mixed' or 
'partial' or 'modified' categorical approach has been suggested (Pless, 1985) (Perrin et al., 
1993) (Thompson, 1996).  This mixed approach involves a combination of the categorical 
and non-categorical models: 
". . . there are likely to be both illness-specific and generic approaches of importance to 
adaptation of children and families to chronic illness and that it is premature for the field to 
adopt solely a categorical or non categorical approach" (Thompson & Gustafson p. 5 
(Thompson, 1996).  
This thesis has adopted this frame of thinking when talking about a chronic condition 
because it recognizes variations between diagnostic categories yet continues to appreciate 
the commonalities across multiple conditions. 
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 1.4.2 Perspective of the chronic condition in paediatrics 
 
Chronic illness poses considerable stress for children and adolescents. Epidemiologic 
surveys show that children and adolescents with chronic disease are at a significantly greater 
risk than their healthy peers of developing major psychosocial problems (Cappelli et al., 
1989).  
 
One of the main areas this thesis will focus on will be the psychosocial functioning of the 
adolescent and adult living with ARA.  This involves accepting the physician/s, parent/s 
and/or childs’ perception on the impact of the condition. Analysis and comparisons between 
research studies becomes difficult when assessing psychosocial adjustment in children with 
chronic conditions.  This is because levels of adjustment vary depending on the informant.  
Research studies centred on parental responses generally reveal more maladjustment than 
those based on teacher or physician reports, or those indicated by objective measures 
(Kashani et al., 1988).  Generally, it is easy for adults to make assumptions what a child is 
thinking because they have passed the period of childhood.  Yet, this frame of thinking may 
lead adults to impose an adult view of the world instead of a childs’ (Waksler, 1986).   
 
Children’s’ views on illness are neglected or their perception of illness is understood within 
the context of stage developmental theories (Bibace and Walsh, 1980).  Piaget's (1929) 
general theory of cognitive development proposes a child’s developmental understanding of 
their body and illness as being within a systematic and predictable order of stages.  Concepts 
of illness are derived from a childs’ acquisition of informal reasoning (Burbach and 
Peterson, 1986).  Thus, the majority of children of a particular age will have grasped a level 
of understanding of illness.  Piagets’ stages propose that the young child (4 to 11years) is 
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 able to make sense of the world with limited knowledge acquired through direct 
experience and with concrete basis.  At this stage, children lack the ability to generalize to 
related experiences and to understand the variations that can exist in one situation.  Yet, with 
increasing age thinking becomes more mature and logical (i.e. with reason about real objects 
or events).  As children reach adulthood they are able to rationalize, think in abstract terms 
and explore problems systematically.  
 
The child may not hold specific knowledge about their condition; however they are often 
aware of their condition and make their own sense of it.  The staged development paradigm 
is useful for making sense of a childs’ growing awareness and understanding of their body 
and illness.  However, it is not a substitute for listening to a childs; own view and feelings 
about their experience with the condition.  It is therefore important to explore each childs’ 
unique understanding. For example, children who have experienced a significant illness in 
their life either establish less, equally, or more advanced illness concepts compared with 
children who have none/little experience of illness (Burbach and Peterson, 1986).  
 
This thesis will be focusing a great deal on adolescents with a chronic illness. In the care of 
adolescent patients, all aspects of clinical medicine are played out against a background of 
rapid physical, psychological and social developmental changes. For chronically ill 
adolescents, the development problems normally associated with adolescence are no doubt 
magnified (Boice, 1998). An overarching concern relates to social acceptance. An issue for 
all adolescents, this becomes more serious for those with chronic illnesses, who may spend a 
great amount of time isolated from other teenagers or in the company of adults.  
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1.4.3 Anorectal anomalies and psychosocial functioning 
 
“For a child, if you are labelled ‘difficult’, without those around having the knowledge as to why you 
are being ‘difficult’, it creates severe social problems for you. You may have been considered 
‘difficult’ before you developed the soiling problem, be that as it may be, but once you have a soiling 
problem, you are likely to be a whole lot more ‘difficult’. Being ‘difficult’ implies that it is somehow 
your fault” (Buchanan, 1992). 
 
The above quote, addresses the problems involved when dealing with such a taboo subject as 
ARA and the ongoing symptoms experienced. As one would expect, when surgical treatment 
is carried out on the paediatric patient, attention is focused on the immediate outcome.  More 
often than not the immediate outcome for ARA is satisfactory, with improvement of the 
symptoms, treatment of the anatomical defect, a quick return to a normal pattern of life and 
little, if any doubt concerning the ultimate prognosis.  Adolescents and adults with ARA 
who continue to have problems are particularly difficult group to treat.  They have 
undergone years of disruption to schooling and normal social interactions, as well as medical 
and surgical interventions which have failed them. They may understandably be unwilling to 
undergo further invasive evaluation and be sceptical about the efficacy of alternative or 
newer treatments.  Additionally, a patient with ARA there are no obvious disfiguring or 
physical signs (e.g. as you would with someone who has Down’s syndrome) to know they 
are ill. Although a discreditable condition allows an individual to appear to be without 
illness, it becomes necessary to decide how much to reveal to strangers or new 
acquaintances, which causes anxiety, especially when it comes to talking about issues such 
as FI and constipation.  In patients with ARA, often not much thought is given to the 
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 possibility that problems may develop in the long-term, and that consideration should be 
given to the question: ‘What happens to a paediatric surgical patient when adulthood is 
reached?’   
 
Several studies have found more psychosocial problems among children and adolescents 
with a chronic condition in comparison to children without a chronic condition (Eiser, 1990, 
Gortmaker, 1990, Lavigne, 1992, Varni et al., 1992, Wolman et al., 1994).  Other studies 
have found no difference (Orr et al., 1984, Kellerman et al., 1980, Cappelli et al., 1989, 
Logan et al., 1990).  Possible reasons for such psychosocial problems include physical 
limitations associated with the condition, severity of the condition, difficulties adhering to 
long-term medical treatments, high rates of school absence, limited opportunities for 
socialisation, feelings of helplessness, depression and increased dependency, and self-
consciousness (Bennett, 1994).   
 
Schlenk et al (Schlenk et al., 1998) found that patients with incontinence, chronic obstructive 
pulmonary diseases, acquired immunodeficiency syndrome and fibromyalgia have 
substantially lower quality of life. Faecal incontinence has had the greatest impact on the 
overall psychosocial functioning of children with ARA. This is because soiling is 
embarrassing and is considered shameful and socially unacceptable.  An accurate measure of 
continence is often difficult to obtain due to definitional variation and failure to make a clear 
distinction between occasional soiling and significant soiling.  Faecal incontinence, however 
defined has been found to be associated with poorer psychosocial functioning and parental 
criticism (Catto-Smith et al., 1995, Damon et al., 2004, Diseth, 1995).  This relationship 
between psychosocial function and severity of physical impairment is consistent with other 
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 studies of congenital malformations (Heller et al., 1985, Diseth, 1995, Spurkland et al., 
1993).  
 
Varying degrees of constipation and FI in patients with ARA have profound effects on 
quality of life as illustrated in our literature summary (Table 1.5) (Ditesheim and Templeton, 
1987, Ludman et al., 1994, Rintala et al., 1992, Diseth et al., 1998a, Diseth et al., 1998b).   
ARA has shown to have an impact on the patients’ day to day activities from school/work, 
family, participation in sport, ‘sleepovers’ and social life (Hassink et al., 1994, Hamid et al., 
2007, Poley et al., 2004). Hamid et al (Hamid et al., 2007) found issues such as, loss of body 
image, teasing from peers, offensive odour and pre-occupation with toileting some factors 
which affect patients with ARA. On the contrary, others have found that children with ARA 
have significantly worse bowel function than their peers, depending on the type of lesion, 
yet, despite this, their quality of life is not significantly impaired (Ludman and Spitz, 1996, 
Ludman et al., 1994, Goyal et al., 2006, Iwai et al., 2007, Bai et al., 2000).  Ludman and 
Spitz (1996) (Ludman and Spitz, 1996) found that the psychological problems, though high, 
were not related to the level of FI and that young incontinent girls tended to have statistically 
significant psychological maladjustment. Sexual issues also may produce anxiety, yet often 
ignored or denied when during a clinical consultation. It has been revealed that sexual 
problems such as erectile dysfunction and ejaculatory incompetence are common in male 
patients with high and intermediate type, ARA with sacral anomalies (Iwai et al., 2007, 
Konuma et al., 2006, Hamid et al., 2007). 
 
It may be expected that the more severe the condition is, the greater the probability of 
psychosocial difficulties.  Surprisingly no relationship between severity and problems with 
psychosocial adjustment has been found (MacLean et al., 1992) (McAnarney et al., 1974) 
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 (Perrin et al., 1989).  In fact more emphasis is placed on the presence of the condition 
rather than its level of severity.  However, it has been found in adolescence with ARA that 
had psychological morbidity tended to be more severe as the degree of FI worsened  
(Funakosi et al., 2005, Diseth et al., 1998b). While others found no association with severity 
of the condition or symptom to psychological functioning  (Ludman and Spitz, 1996) 
 
Morbidity has been found to coexist in patients with ARA even after surgical repair,
 
resulting in significant emotional and social difficulty for both the patients and their families 
(Table 1.5) (Ludman and Spitz, 1996, Hamid et al., 2007, Ditesheim and Templeton, 1987, 
Diseth and Emblem, 1996, Hassink et al., 1994, Ginn-Pease et al., 1991, Ludman and Spitz, 
1995) Children with chronic conditions or disabilities have psychosocial maladjustment, 
behavioural problems and more difficulties in everyday functioning than healthy children 
(Athanasakos et al., 2006).  Hamid et al (Hamid et al., 2007) found 80% of their patients 
with ARA to have one or more forms of psychological morbidity, including feedings of 
extreme anxiety and embarrassment, depression and low self esteem.  It has been suggested 
that bowel dysfunction is one of the most important factors that influences the level of 
depression of children with ARA (Table 1.5) (Amae et al., 2008, Hamid et al., 2007).  
Funakosi et al (Funakosi et al., 2005) found that in children with ARA, depression tended to 
be more severe as the degree of FI worsened as the child reaches adolescence, yet the 
association failed to reached statistical significance. Clayden (Clayden, 1992)
 
has suggested 
that a childs’ physical development may be disturbed by disordered bowel function and that 
faecal soiling has a critical effect on psychosocial factors such as self-esteem and confidence 
(Clayden, 1992). This is to our own data contrast (Athanasakos et al., 2006)
 
that children and 
young adults with Hirschsprung’s disease have minimal psychiatric morbidity, but 
experience condition-specific psychosocial problems (despite significant impairment of FI).   
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Hope has been defined as an expectation of positive events (Nunn, 1996b).  Nunn (Nunn, 
1996b) suggested that differences might exist between individuals in the need for perceived 
control in order to feel positively about the future.  Children at any age may have difficulties 
in perceiving their future.  This can have specific implications for children with a chronic 
condition when trying to cope with the condition and/or encourage adherence to treatment 
regimens.  From an adolescents’ outlook, there may be a greater comprehension of the long-
term of their condition – specifically the realisation that they will have if for the rest of their 
lives.  Existing limitations become more obvious and may place greater emphasis on future 
choices (such as career) and ambitions, such as living independently or having a family.  
Thinking about what one ‘can do’ and ‘can not do’ in the future, may cause the child to fear, 
resent or become perplexed about their purpose in life.  More so, adolescents will become 
aware of the sole responsibility for their condition as they reach adulthood (rather than 
parents or doctors) which could produce a deep sadness and despair, a sense of mourning for 
the loss of the perfect ‘picture’ or future. Cappelli et al. (Cappelli et al., 1989) suggested that 
adolescents with chronic illness (such as diabetes) are in fact not at greater risk of 
developing psychopathology, yet becoming more concerned about their health and future.  
There is currently limited literature investigating personal hopefulness in children with ARA 
to date. Despite the reported high level of psychosocial morbidity found in patients with 
ARA, Hamid et al (Hamid et al., 2007) found their level of hopefulness of the future to be 
positive (Table 1.5). Similar findings have been found in patients with Hirschsprung’s 
Disease (Athanasakos et al., 2006).  
 
Coping consists of both emotional and cognitive features (Holden, 1995). Discovering what 
children with chronic conditions find troublesome and recognising the strategies and support 
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 networks they use to cope with these stressors are vital for future clinical intervention.  
Studies have indicated that both environmental and biological factors facilitate effective 
coping (Compas and Boyer, 2001, Sinnema, 1991, Sharrer and Ryan-Wenger, 1995, Tyc et 
al., 1995) Factors which determine the way a child copes with a chronic condition includes 
their conceptualisation of the condition, characteristics of the condition (such as life 
threatening, ongoing treatments) and adjustment of others in their environment (i.e. parents, 
relatives, peers, medical professionals).  Ludman and Spitz (Ludman and Spitz, 1996) found 
that children with ARA will be able to adapt themselves to society.  However, other results 
indicate that intrinsic depression became more severe in adolescence and suggested that 
some patients may not be able to integrate themselves into society (Funakosi et al., 2005). 
Boekaerts and Roder (Boekaerts and Roder, 1999) found children with chronic conditions 
use coping strategies in relation to common stressors that appeared to be similar to those of 
healthy children.  Boyd and Hunsberger (Boyd and Hunsberger, 1998) proposed that 
chronically ill children who were frequently hospitalised became adept at recognising and 
implementing a repertoire of coping strategies.  Specifically, using family and friends as 
supportive resources and/or gaining knowledge of their condition from supportive health 
care professionals.   
 
Adolescents experience numerous changes; coping with a chronic condition adds yet another 
dimension to their lives. Adolescents with ARA have often adopted coping strategies to 
manage their chronic disability, which has nevertheless interrupted their social, emotional, 
physical and academic growth and development (Ludman and Spitz, 1996). Ludman and 
Spitz found that children aged 8 to 11 years with FI used denial as a coping strategy to 
handle difficult situations 
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 Table 1.5: Summary of the literature found in patients with anorectal anomalies investigating psychosocial and quality of life measures 
Author Year N Age range 
(years) 
Psychosocial Measures Who filled out questionnaire? Comparison 
groups 
Amae et al 2008 66 0-16  • Kovacs Children Depression Inventory – CDI:  6-
16 years. 
• Symptom scores  
Assessed mothers of patients: 
• Spielberger’s’ State-Trait Anxiety Index - STAI 
• Zung’s self-rating depression scale (SDS) 
Parent and child filled out 
questionnaire together 
None 
Iwai et al 2007 29 20-40 • Bowel function assessed by Japanese Study Group 
for ARA 
• Interview about social and sexual function 
Patient with ARA – 
questionnaire posted 
None 
Hamid et al 2007 84 3-27 • Athanasakos et al: The Hirschsprung's Disease 
Family Impact Questionnaire modified for ARA 
included: questions on continence, quality of life 
and level of hopefulness (Athanasakos et al., 
2006)  
Parent and child filled out 
questionnaire together – 
questionnaires posted 
None 
Goyal et al 2006 80 4-18 • Pediatric Quality of Life Inventory (PedsQL 4) 
• Functional outcome questionnaire - non 
standardised for assessment of continence. 
Child filled out questionnaire 
during outpatient visit with 
parent or posted. 
20 healthy 
controls (4.5-
14.8 years). 
Poley et al 
 
 
 
2005 286 1-51 (ARA) 
1-42 (CDH) 
• Health related quality of life (HRQol/TAIQOL) 
for children 1-4 years of age including symptom 
and quality of life subscales. 
• SF-36 ( > 16 years) 
Parent and child filled out 
questionnaire together where 
questionnaire was posted. 
Congenital 
diaphragmatic 
hernia (CDH) 
Funakosi et al 2005 50 0-16 • 7-16 years Children’s Depression Inventory (CDI) 
Assessed mothers of patients: 
• Zung’s self-rating depression scale (SDS) 
• Mothers had the Spielberger’s State Trait Anxiety 
Index (STAI) 
Parent and child filled out 
questionnaire together with a 
child psychiatrist. 
None 
Bai et al 2000 71 8-16  • Self-structured disease impact questionnaire  
• Child Behavior Check List (CBCL). 
Not known None 
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Author Year N Age range 
(years) 
Psychosocial Measures Who filled out questionnaire? Comparison 
groups 
Hassink et al  1998 109 1-18 • Nijmegen Questionnaire on Chidering Situations 
(NQCS) 
• Child Behaviour Checklist (CBCL).  
• Teachers Report Form (TRF) 
Parents were interviewed about 
day to day life with their child 
and questionnaires sent home. 
None 
Ludman et al 
(Same sample of 
patients were 
used for both 
papers). 
1996 
2000 
160 6-17 Semi-structured interviews carried out by clinical 
psychologist including :  
• Child Assessment Schedule (CAS)  
• DSM-III-R  
• Depression self-rating scale (DSRS)  
• Chid Behaviour Checklist (CBCL) 
• 30 item General Health Questionnaire 
• Kelly score (faecal continence) 
• Teachers Report Form (TRF) 
Child was separately 
interviewed (semi-structured) 
from parents.  
 
Parents were also interviewed 
(semi-structured).  
None 
Diseth et al 1998 17 12-20 Child interviewed (semi-structured) separate from parents: 
• Wingspread classification for continence scoring 
• Flatus continence assessed using analogue scale  
• Diagnostic and Statistical Manual of Mental 
Disorders (DSM-III-R)  
• Youth Self-Report (YSR)  
• Children’s Global Assessment Scale (CGAS) 
Parents interviewed (semi-structured) separate from child: 
• Child Behavior Checklist (CBCL)  
• Parental Account of Children’s Symptoms (PACS) 
• Chronic Family Difficulties (CFD) 
Child was separately 
interviewed (semi-structured) 
from parents.  
 
Parents were also interviewed 
(semi-structured). 
Hirschsprung’s 
Disease (n=19; 
10-20 years) 
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Author Year N Age range 
(years) 
Psychosocial Measures Who filled out questionnaire? Comparison 
groups 
Diseth et al  1996 33 12-20 • Clinical and anorectal manometry 
• Wingspread classification for 
continence  
• Flatus continence assessed using 
analogue scale  
• Child Assessment Schedule (CAS) 
• Child Behavior Checklist (CBCL) 
• Youth Self-Report (YSR) 
• Children’s Global Assessment Scale 
(CGAS) 
• DSM-III-R 
Adolescent assessed on their own 
in a semi-structured interview 
None 
Rintala et al 1992 83 Mean age 35 
years (range not 
mentioned) 
• Fecal incontinence – Holschneider 
Score 
• Interviewed patients about overall 
well being including social problems 
and difficulties in sexual life.  
Patient with ARA 
Healthy volunteer 
78 healthy controls  
(Mean age 33.4 
years) without 
history of anorectal 
surgery 
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1.5 KNOWLEDGE GAPS 
 
1.5.1 Summary and current limitations 
 
As discussed in great detail in this chapter, there is extensive literature on the bowel 
difficulties that patients with ARA experience (Zia-ul-Miraj and Brereton, 1997, 
Hettiarachchi et al., 2002, Rintala et al., 1992).  We know that despite surgical 
advances and advanced treatment modalities, voluntary bowel control is frequently 
poor following surgical care with high rates of FI, and also constipation after all 
grades of reconstructive surgery (Ong and Beasley, 1991, Rintala et al., 1993b, 
Rintala and Lindahl, 1995).  Furthermore, there remains conflicting views as to 
whether symptoms of constipation and FI in patients with ARA have profound effects 
on quality of life. Yet, despite various perspectives in the literature, morbidity has 
been found to coexist in patients with ARA even after surgical repair,
 
resulting in 
significant emotional and social difficulty for both the patients and their families.   
 
Currently, there are obvious limitations in the literature when it comes to discussing 
about quality of life and psychological morbidity in patients with ARA.  Firstly, the 
majority of questionnaires administered to access bowel and psychosocial 
functioning, included parental/familial influences.  Such influences will have an 
impact on how the child or adolescent views their condition and may alter their true 
perspective of their experience. The child or adolescent involved is the one who is 
living with it and is of a different age and developmental stage in comparison to their 
parents. Thus, questionnaires need to be administered in a way that encourages the 
child or adolescent to answer the questions in relation to their condition from their 
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 experience and make them feel comfortable that no one will judge their answers. 
Thus posting questionnaires or asking patients to fill out questionnaires with others 
will encourage input from others and possibly alter their answers. Secondly, in order 
to comprehend how poor patients with ARA are doing in terms of continence and 
psychosocial functioning, we need to use control groups to draw comparisons which 
few authors have done so far (Table 1.5).  
 
Lastly, our knowledge about the pathophysiological mechanisms involved in patients 
with ARA remains limited. Traditionally, sphincter dysfunction was considered as the 
sole contributory factor to FI. However, patients without a history of ARA and with 
an anatomically intact and normal functioning sphincter complex can also experience 
episodes of FI, indicating that there are other pathophysiological mechanisms 
contributing to their symptoms (Lunniss, 2007, Williams et al., 2001).  It is now 
clearly recognised that disturbances of ‘extra-sphincteric’ sensorimotor function are 
also crucial to the development of symptoms of FI (Bharucha et al., 2005, Williams et 
al., 2001, Lunniss, 2007, Salvioli et al., 2001) Yet, currently, our knowledge of the 
pathophysiology of FI relates almost exclusively to information gained in adults with 
acquired symptoms (i.e. usually post-obstetric or following anal surgery).  Thus, the 
pathophysiology of FI in congenital ARA, however, remains unclear and our 
understanding rudimentary. Notably, the importance of extra-sphincteric mechanisms 
has not been adequately addressed and is a current limitation.  
 
 122
 1.5.2 Aims and hypothesis 
 
The two main aims of this study were to determine the; 
• impact that FI and constipation has on psychosocial functioning in the context 
of ARA and  
• pathophysiological mechanisms that might contribute to poor bowel function 
in patients with ARA. 
 
Furthermore, two control groups were introduced to our study. These included:  
 
Group 1 (Positive disease controls): Idiopathic constipation (IC) refers to an 
incapacity to regularly pass stool, where the cause remains unknown. It is one of the 
most common bowel movement disorders among children and adolescents. This 
group shares similar symptoms of constipation and FI to our ARA group but are a 
functional disorder with no anatomical defect as in ARA.    
 
Group 2 (Negative disease controls): Patients who have been diagnosed with 
appendicitis and have had surgery (appendectomy). They have been treated for a 
condition entirely separate from the area that our patients ARA and IC individuals 
share in common.  
 
We hypothesized the following:  
• There would be a positive relationship with type of ARA (high, intermediate, 
low) with symptom scores  (i.e. FI, constipation) 
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• Symptom scores assessing constipation and FI would be major determinants 
for poor psychosocial functioning.  
• Patients with ARA would have poorer symptom and quality of life scores, 
mental state and coping strategies in comparison to the control groups which 
have normal anatomical anorectum with intact sphincters and associated 
structures. 
• Patients with ARA would represent higher levels of neuroticism and 
introversion in comparison to the control groups.  
• There would be a relationship between symptom scores and the 
structural/function integrity of the anal sphincter and supra-sphincteric 
anatomy. 
• The pathophysiology in ARA would involve extra-sphincteric mechanisms. 
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CHAPTER 2 
MATERIALS & 
METHODS 
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2.0 MATERIALS AND METHODS 
 
2.1 INTRODUCTION 
 
This chapter provides a detailed description of the methodologies undertaken to 
measure the impact of FI and constipation have on psychosocial functioning in the 
context of ARA and the pathophysiological mechanisms that might contribute to poor 
bowel function in patients with ARA. General methodology relating to the preparation 
of the thesis and recruitment and selection of patients for participation in this study 
will be included. Control and comparison subjects are described. The methodology of 
gastrointestinal physiological investigations is discussed in detail. Standardised 
psychiatric measures have been reviewed in this chapter in relation to its theoretical 
background, development and use in other research samples.  Each instrument used 
has been discussed in relation to its purpose, validity, reliability and why it was 
chosen for this research project.  
 
2.2 ETHICS APPROVAL 
 
Ethics relates to a set of rules or strict criteria as to whether or not the research study 
conforms to existing guidelines set out by government bodies, professional 
associations or local committees (Jackson, 2000). The research protocol was firstly 
peer reviewed prior (Appendix - A) to ethical approval (Appendix – B). The use of 
patients and healthy volunteers was approved by the East London and the City Health 
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 Authority (ELCHA) Research Ethics Committee. The following ethics 
committee references cover the body of work contained within this thesis. ELCHA 
no: 07/Q0605/2 (Appendix – B). 
 
2.3 ARA PATIENTS 
 
2.3.1 Recruitment 
 
Patients for study were recruited by written invitation from the author, or directly 
approached in person at times of clinical presentation to the Royal London Hospital 
(Barts & The London NHS Trust) and St Thomas’ Hospital (Guys, St Thomas’ and 
King’s NHS Trust). All clinicians in care of patients with ARA, were informed about 
our research project and criteria, and were asked to inform the author when a patient 
presented to the hospital.  In order to gain a representative of the ARA population as a 
whole, a request was made to medical records to both hospitals, to code for any 
patients who have been diagnosed with ‘anorectal malformation/anomalies’, 
‘imperforate anus’ and ‘ectopic anus’.  This allowed ‘all comers’ to become involved 
in our research project rather than selecting patients with poor bowel function. 
 
Since ARA is a rather rare congenital condition, we were unaware of how many 
possible patients could be recruited. Thus, an estimate number was calculated based 
on information provided from surgical colleagues, and from lists of patients used in 
previous research audit studies of this condition. Altogether, a number of 80 patients 
were found between the two institutions.  We consulted a statistician (Fiona 
Warburton) from Research and Development from Queen Mary University of 
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 London, who performed a power calculation in order to see how many patients 
were required for recruitment (was concluded to be 50 patients), which was based on 
the psychiatric tools we would be analysing and the availability of patients that could 
be attained. 
 
2.3.2 Selection 
 
Patients with ARA were initially contacted by a letter inviting the patient (Appendix – 
C) to our study which was either posted or given in person (i.e. during their clinic 
visit) along with a Patient Information Sheet (Appendix – D).  The letters included the 
purpose of the study, important aspects of their involvement and requesting their 
participation followed.  Patients and parents/carers (especially if the patient was under 
the age of 16 years) were able to call the medical researcher in charge to answer any 
enquires they had. They were assured anonymity at all times and were under no 
circumstances pressured to be part of the study.  Every effort was made to ensure the 
smooth and consecutive recruitment of eligible subjects which was succeeded with 
good rapport and patience. 
 
Written consent (Appendix – E) was received from patients.  Ten patients did not 
wish to participate in this research due to emotional burden, time constraints (due to 
work or school or travel commitments) or language barrier (however, interpreters 
were provided if needed.   
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2.3.2.1 Inclusion criteria 
Patients who have been diagnosed and/or surgically treated for ARA between 1963 -
1996 were included.  Patients will be divided into groups based on clinical (using 
symptomatic scores), physiological and psychosocial outcomes.  The original ARA 
sample (Figure 2.1) comprised 80 patients aged between eleven and forty-five years at 
the time of our research follow-up and resided in United Kingdom.  Eligibility criteria 
excluded patents with limited medical history, no contact details and who had died.  
Out of 80 patients with ARA, 18 (23%) patients could not be located, one who was 
deceased and died due to Hirschsprung’s disease and associated cardiac defect (Figure 
2.1).  
 
Figure 2.1: Selection of total population sample in anorectal anomalies 
 
Patients who have been diagnosed and/or surgically treated for ARA between 1963 -
1996 were included in this study.  Patients were included on the basis of: 
 
Original Sample 
N = 80 ARA Patients in total 
Noncontactable 
N = 18 patients uncontactable 
Refused 
N = 10 patients refused to participate 
Total Sample 
N = 52 ARA Patients in total 
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 i) ARA is defined as a range of congenital conditions ranging from a 
slight malposition of the anus to complex anomalies of the hindgut and 
urogenital organ reconstructed anorectal anomaly.  
ii) Patients were classified according to the Wingspread international 
classification (as mentioned in Chapter 1). 
iii) Patients who underwent reconstructive surgery for ARA. 
iv) Both symptomatic and asymptomatic patients were included in order to 
gain a representative population sample.  
v) Age range was between 11-45 years of age.  This age group will allow us 
to investigate a widespread of patients from all ages and thus gain a 
preview of how these patients cope after surgery in terms of their bowel 
function and everyday life.  
 
2.3.2.2 Exclusion criteria 
Patients were specifically excluded for the following: 
i. Downs/Autism or developmental delay: the main reason for this exclusion was 
due to the several questionnaires that need to be filled out by the patient 
themselves without parental/carer input. It was important to obtain patient’s 
perspective entirely.  
ii. Pregnancy: some physiological tests involved exposure to x-rays. 
iii. Patients who have had their rectum excised prior to participating in 
physiological investigations which needed the rectum to be intact.  
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2.4 DATA COLLECTION 
 
2.4.1 Methods of collection 
 
Clinical information was obtained by interview and review of records (patient hospital 
notes and computerised records using a number of software packages (patient 
administration system [PAS] or Electronic Patient Record [EPR]). Data were 
collected retrospectively. This assured consistency and accuracy in patient medical 
history.  When there was still missing information after viewing the patient’s record 
and on interview, the author consulted their clinician or simply entered ‘missing’ in 
the research database.  
 
2.4.2 Data storage 
 
All data, regardless of method of acquisition, were stored on a dedicated, password 
protected database, which was established at the start of the study, and modified 
subsequently as required. Data were stored on Microsoft ® Excel 97 for Windows 
(Microsoft Corporation, Santa Rosa, CA, USA) and statistical package SPSS Version 
16.0 for Windows (Coakes, Steed and Ong, 1999 John Wiley & Sons Australia)  and 
hard copies (if required) in a secure locked cabinet.  
 
2.4.3 Clinical data 
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 Medical history reviewed included general medical background of the patient 
with ARA from time of birth to present date of this research study.  A detailed patient 
history included gestation period (32-37 weeks), family medical history, other 
associated conditions, the nature of the patients presenting symptoms, mode of onset, 
personal past medical, treatment history, family history, and systematic enquiry was 
obtained, and included the variables listed in Table 2.1. 
 
2.4.4 Operative technique 
 
As discussed in Chapter 1, several operative techniques exist for the reconstruction of 
patients with ARA. As part of the learning process and appreciation in understanding 
the techniques, the author attended several operations during the research period in 
order to gain an insight of the techniques and for descriptive purpose for this thesis.   
 132
 
Table 2.1: Clinical data collected for patients with anorectal anomalies  
Basic details Date of birth 
 Sex 
 Gestation period 
 Ethnicity 
 Contact details and next of kin if patient < 16 
years old 
 Associated medical conditions (VACTREL) and 
other conditions 
Family history History of anorectal disorders in the family and 
other associated conditions 
History of ARA Obstetric history  
 Age of diagnosis  
 Type of anorectal anomaly 
 Type of reconstructive operation  
Investigations Physical examination 
Physiological assessment (if any) 
Psychological reports (if any) 
History of symptoms Type and onset of symptoms: constipation, faecal 
incontinence, abdominal pain.  
Treatment (excluding original 
reconstructive operation) 
Medication (such as laxatives): 
Type of medication  
Duration of medication 
Did the medication work? 
 Other treatments 
Botulinum toxin 
Sacral nerve stimulation 
Antegrade continence enema or other stomas 
Anal dilatation 
Myectomy 
Graciloplasty 
Other 
Psychosocial History Psychosocial difficulties 
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2.5 CONTROL GROUPS 
 
As discussed in Chapter 1, the current literature lacks a control groups when 
discussing bowel and psychosocial function in patients with ARA. The two control 
groups included in this research study are discussed below.  
 
2.5.1 Positive disease control group 
 
Idiopathic constipation (IC) refers to an incapacity to regularly pass stool, where the 
cause remains unknown. It is one of the most common bowel movement disorders 
among children and adolescents. This group shares similar symptoms of constipation 
and FI to our ARA group but are a functional disorder with no anatomical defect as in 
ARA.   Medical history reviewed included general medical background of the patient 
with ARA from time of birth to present date of this research study.  A detailed patient 
history included gestation period, family medical history, other associated conditions, 
the nature of the patients presenting symptoms, mode of onset, personal past medical, 
treatment history, family history, and systematic enquiry was obtained, and included 
the variables listed in Table 2.2 
 
2.5.2 Negative disease control group 
 
In this thesis, the negative disease control group included patients who have been 
diagnosed with appendicitis and have had surgery (appendectomy). They have been 
treated for a condition entirely separate from the area that our patients ARA and IC 
individuals share in common. Medical history included those listed in Table 2.3. 
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Table 2.2: Clinical data collected for patients with idiopathic constipation 
 
Basic details 
 
Date of birth 
 Sex 
 Gestation period  
 Ethnicity 
 Contact details and next of kin if patient < 16 
years old 
 Associated medical conditions (VACTREL) 
 Other medical conditions 
Family history History of constipation or other 
gastrointestinal disorders 
History of IC Age of diagnosis  
 Duration of constipation  
Investigations Physical examination 
Physiological assessment (if any) 
Psychological reports (if any) 
History of symptoms Onset of symptoms 
 Duration of symptoms 
Treatment (excluding original 
reconstructive operation) 
Medication (such as laxatives): 
Type of medication  
Duration of medication 
Did the medication work? 
 Other treatments 
botulinum toxin 
sacral nerve stimulation 
Antegrade continence enema 
Stomas 
Anal dilatation 
Myectomy 
Other 
Psychosocial History Psychosocial difficulties 
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Table 2.3: Clinical data collected for healthy controls 
 
Basic details 
 
Date of birth 
 Sex 
 Gestation period 
 Ethnicity 
 Contact details and next of kin if patient < 16 
years old 
 Other medical conditions 
History of gastrointestinal symptoms Examples include: constipation, faecal 
incontinence, piles etc.   
Appendicitis Age of onset and operation 
Psychosocial History Psychosocial difficulties 
 
2.6 SYMPTOM ASSESSMENT 
 
Symptom assessment was obtained in a short interview with the author, when the 
patient came to fill out other required questionnaires in a private room  
 
2.6.1 Constipation 
 
As mentioned in Chapter 1, constipation is a poorly defined clinical symptom, not a 
definitive diagnosis. Previous studies have investigated the symptoms associated with 
constipation, and scoring systems have been used in its diagnosis (Agachan et al., 
1996).  
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 The Knowles-Eccersley-Scott-Symptom (KESS) questionnaire (Appendix – F) is 
a modified version of that used in the Cleveland Clinic Score (Agachan et al., 1996). 
Changes in questions were based on clinical impression of those symptoms most 
likely to be discriminatory. Knowles et al (Knowles et al., 2000) questionnaire design 
involved a structured interviewer-led questionnaire consisting of eleven questions 
which was devised by incorporating internationally agreed-upon criteria (Whitehead, 
1991). This questionnaire was designed to be simple enough to be completed in less 
than five minutes. Each question had four or five possible linear integer scale to 
produce a range of between 0 and 3 or 0 to 4 points. Lower scores represented 
symptom free sates and higher scores, increased symptom severity. The total KESS 
score was the sum of all scores gained on individual questions with a maximum 
possible of 39 points. The answers to each question were worded such that any patient 
who fitted agreed criteria (Whitehead, 1991) for  constipation would be likely to score 
at least one point per question. KESS score for constipation:  includes items such as 
duration of constipation, laxative use, frequency of bowel movement, unsuccessful 
evacuatory attempts, feeling of incomplete evacuation, abdominal pain, bloating, 
enemas/digitations, difficulty in evacuating, time taken and stool consistency and use 
of laxatives and effectiveness.  
 
This structured symptom scoring questionnaire was completed by 71 chronically 
constipated patients and 20 asymptomatic controls. The symptom score correlated 
with a previously validated constipation score (Cleveland Clinic Score) (r = 0.90). 
Discriminant analysis using cross validation estimated that pathophysiology could be 
predicted correctly for 55% (95% confidence interval = 43-67%) of patients using just 
give symptoms (Knowles et al., 2000). This scoring system is a valid technique to 
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 assist in the diagnosis of constipation and is the first study using appropriate 
statistically methodology to demonstrate a discriminatory ability of multiple 
symptoms in constipation.  Further, validation of the classification performance of 
this method of symptom analysis in a prospective cohort of patients was undertaken 
(105 patients referred to their institution for specialist investigation of intractable 
constipation) (Knowles et al., 2002). 
 
2.6.2 Faecal Incontinence 
 
A scoring system for the assessment of severity of faecal incontinence (FI) is required 
to gain an objective comparison of outcomes of both conservative and surgical 
treatments. A number of scales have been published (Browning and Parks, 1983, 
Millar, 1988, Pescatori et al., 1992, Jorge and Wexner, 1993). The Wexner 
Continence Grading Scale has become a widely used for the assessment of severity of 
FI.  Vaizey et al (Vaizey et al., 1999a) felt that there were three areas in which this 
scale could be improved. Firstly, the scale does not take account of faecal urgency, 
which can be present without overt FI. Secondly, the need to wear a pad is given 
equal weighting to the occurrence of incontinence. However the use of a pad may not 
be fastidiousness. The use of a pad also often relates to the presence of coexistent 
urinary leakage. Finally, in the comparison of degree of incontinence preoperatively 
and postoperatively, the introduction of antidiarrhoeal drugs should be taken into 
account. These are often given as a part of the treatment package and a failure to 
recognise this could give a false impression of the surgical success rate. In developing 
a new scale, Vaizey (Vaizey et al., 1999a) felt that the Wexner scale formed an 
excellent basis, but with these modifications mentioned above. The new scale or 
 138
 called the ‘Vaizey Incontinence Questionnaire’ or ‘St Mark’s incontinence score’ 
(Appendix – G) has introduced an assessment of the ability to defer defecation and an 
additional score for the use of antidiarrhoeal, and reduced the emphasis on the need to 
wear a pad.  Vaizey et al (Vaizey et al., 1999a) found the ‘Vaizey Incontinence 
Questionnaire’ to correlate closely with a detailed clinical assessment by two 
independent observers, and has demonstrated the highest test-retest reliability, 
reproducibility and sensitivity to change produced by definitive treatment than 
Pescatori, Wexner and American Medical Systems.  Many studies have assessed FI 
along with physiological measurements using the new scale (Maeda et al., 2008, Terra 
et al., 2006b, Beddy et al., 2004, Kushwaha et al., 2003, Badvie and Andreyev, 2005, 
Olopade et al., 2005, Deutekom et al., 2005, Terra et al., 2006a, Dobben et al., 2007). 
 
The ‘Vaizey Incontinence Questionnaire’ consists of seven questions (Appendix – G). 
A score of 0 suggests no problems with bowel continence (complete continence), and 
a score of 24 suggests very severe problems with incontinence (complete 
incontinence). The scale consists of three items about the type (gas, liquid, solid) and 
frequency of incontinence (all scored from 0 to 4) and four additional items 
addressing social invalidation (0 to 4), the need to wear a pad or plug (0 to 2), the use 
of constipating medication (0 to 2) and the presence of urge incontinence (0 to 4). A 
Vaizey Incontinence score of at least 12 is considered poor (Felt-Bersma et al., 2007, 
Terra et al., 2006a, Terra et al., 2008, Terra et al., 2006b, Dobben et al., 2007, 
Deutekom et al., 2007, Deutekom et al., 2005). The Vaizey Incontinence score has 
gained wide acceptance and has found to correlate well with patients’ subjective 
perception (r = 0.55; P<0.001) and is reliable regardless of type of  incontinence, 
patient’s age, or gender (Maeda et al., 2008). It is also suitable for the severity 
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 assessment of FI and the evaluation of a treatment outcome (Maeda et al., 2008). 
For patients who are suffering from FI on a daily or regular basis, further questions 
were asked using the diary card (Appendix – G).  
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2.7 GASTROINTESTINAL PHYSIOLOGICAL TESTS 
 
A number of tests have been developed, principally in the last 30 years, to examine 
the physiological function of the colon and anorectum. Comprehensive clinical 
evaluation of the patient, along with clinical history, physical examination and 
investigations, allows the aetiology of their symptoms (such as FI) to be deduced, 
coexisting pathology to be excluded and the best suitable treatment to be offered.  An 
introduction to some of these physiological investigations in Chapter 1, have been 
discussed.  This section specifically describes the tests used routinely to assess 
patients presenting with symptoms of constipation and FI to the Gastrointestinal 
Physiology Unit (GIPU) and which have been used in assessing the pathophysiology 
of FI and constipation in patients with ARA. The study population includes 32 
consecutive patients comprised 15 females and 17 males.  Age range of the population 
sample included ranages bewteen 11-42 years of age and mean of 24 (+/- 9).  All 
patients included those who have underwent surgery for ARA as infants and were 
referred for investigation of their symptoms of faecal incontinence (FI) between 1998- 
2006.  The cohort of subjects who will undergo physiological testing are not all drawn 
from the ARA group for this part of the study. Only 14/32 patients were from the 
original ARA population group.  The data from the following tests are included in this 
thesis:  
 
1. Transit studies   Radio-opaque marker and / or radioisotope 
2. Anal manometry   Anal sphincter resting and squeeze pressures 
Rectoanal inhibitory reflex testing 
3. Rectal sensory testing  First constant sensation 
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 Defaecatory desire volume 
Maximum tolerated volume 
4. Evacuation proctography  Mechanical and functional outlet obstruction 
5. Pudendal Latency Test   Conduction time of pudendal nerve 
6. Endosonography   Integrity of anal sphincters  
 
The study population comprised of a small group of consecutive patients, who have 
undergone surgery for ARA as infants and were referred for investigation of their 
symptoms of FI between 1998-2006 to our GIPU. 
 
2.7.1 Transit Studies 
 
As discussed in Chapter 1, idiopathic constipation could be due to colonic motility 
disorder that is associated with a reduction in the rate of progress of colonic 
intraluminal contents (MacDonald et al., 1993).  Colonic transit studies allow 
patients’ subjective complaints to be objectively confirmed, and further allow the 
investigator to distinguish between those patients with a slow and normal colonic 
transit time.  This is achieved by a simple radio-opaque marker study which detects 
transit abnormalities in everyday clinical practice, involving the ingestion of non-
absorbable cylindrical pellets that are of similar density to food residue, and that have 
no effect on gut activity (Hinton et al., 1969) followed by a plain abdominal 
radiograph taken 3 to 5 days later (Arhan et al., 1981, Hinton et al., 1969, Roberts et 
al., 1993, Metcalf et al., 1987).   
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 For this thesis, patients presenting with infrequency of defaecation were assessed 
predominately by colonic transit studies, using radio-opaque marker studies (Figure 
2.2). For this thesis, laxative medication and opiate analgesics were stopped 24 h prior 
to the start of the study and avoided until its completion. Patients remained on their 
normal diet during the study period. Studies were carried out as previously described 
(Roberts et al., 1993), with a single plain abdominal radiograph performed at 100 h 
after administration of a gelatin capsule (broken down rapidly in the stomach) 
containing 50 radio-opaque markers, cut from a length of 2.5 mm (external diameter) 
diameter radio-opaque vinyl tubing (SIMS Portex Ltd., Hythe, UK). Delayed transit 
was defined as >20% of 50 administered markers remaining at 100h (Roberts et al., 
1993, Hinton et al., 1969). 
 
2.7.2 Anal manometry 
 
Measurements were undertaken of functional anal canal length, maximum resting and 
voluntary anal squeeze pressures using standard methodology (station pull-through 
manometry).   These measurements are performed with open-tipped or side-opening 
water perfused catheters, direct online solid-state transducers, or air-or water filled 
balloons of various sizes and configurations. Normal anal pressures vary according to 
sex, age and technique used (Diamant et al., 1999). It is found, that pressures are 
higher in men and younger people (Jameson et al., 1994).  
 
In this thesis, manometry was performed using a single channel side hole catheter 
linked to an Arndorfer-type pneumohydraulic water perfusion system: a pull back 
technique allowed assessment of functional anal canal length, maximum resting tone, 
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 and maximum voluntary squeeze pressures (Figure 2.3) (Read et al., 1984, Chan 
et al., 2005c). Anal resting tone and squeeze pressures were considered abnormal if 
they were below 50 cm H20, which are the lower limits of the normal for our unit. 
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Figure 2.2: Colonic transit studies, using radio-opaque markers.  This can be 
seen in the x-ray below with remaining markers in a patient (see arrow). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presence or absence of the recto-anal inhibitory reflex (RAIR) was also confirmed by 
positioning the manometry catheter in the high-pressure zone of the anal canal and 
distending the rectum with an air-filled balloon tied to a Foley-catheter (Farthing and 
Lennard-jones, 1978). Such values are comparable to those obtained from the 
literature for this technique (Read et al., 1979). 
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Figure 2.3: The apparatus required to perform anal manometry.  This is 
done at our GI Physiology Unit, Royal London Hospital (UK).  An intraluminal 
pressure- sensing water perfused catheter is connected to pressure transducers, and the 
analogue signals are amplified and digitalised by an interface converter and 
transmitted to a personal computer for display. 
 
 
2.7.3 Rectal sensory testing 
 
Rectal sensation was assessed by inflating a simple latex balloon (same rubber party 
balloon used before) with air at 1 ml/sec (Figure 2.4), positioned 10 cm from the anal 
verge and determining the threshold volumes for first constant sensation (FCS), 
defaecatory desire volume (DDV) and maximum tolerable volume (MTV) (Farthing 
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 and Lennard-jones, 1978). Values obtained for each sensory threshold were 
compared with normal ranges matched for age and sex (Jameson et al., 1994).  
Patients were considered to have rectal hyposensitivity if MTV was < 100 ml in 
females or < 80 mls in males (Chan et al., 2005a).   
 
Figure 2.4: Apparatus used to assess rectal sensory function during anorectal 
physiological investigation.  
 
 
2.7.4 Evacuation Proctography 
 
Additionally to colonic dysmotility, constipation could be due to secondary outlet 
obstruction (Martelli et al., 1978). Evacuation proctography (Figure 2.5.a) is a 
technique which involves imaging the rectum with instilled contrast material, which 
allows the observation of the process, rate and completeness of rectal evacuation 
using fluoroscopic techniques (Diamant et al., 1999).  The image (Figure 2.5.b) will 
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 also provide information about the anatomy of the rectum including any 
anatomical abnormalities (e.g. rectocoele, rectal prolapse/intussusception and others).  
 
Firstly, the semisolid contrast medium was prepared by mixing barium sulphate and 
scotch porridge oats at body temperature to make a thick paste. The test involved 
instilling barium paste (artificial stool) into the rectum to the previously determined 
maximum tolerable volume and allowing the patient to evacuate under fluoroscopy  
(Mahieu et al., 1984) (Womack et al., 1985). The contrast was injected into the 
rectum using a wide tipped syringe via a proctoscope. With the patient seated on a 
radiolucent commode (Figure 2.5.a), lateral fluoroscopy was performed using an 
image intensifier (Siemens Plc., Bracknell, UK). The amount of contrast voided, and 
the time taken to void were recorded. Any radiological abnormalities in the rectum 
were identified. 
 
In this thesis, normal evacuation proctography was classified when the patient had no 
difficulty expelling rectal contents (which included radiological abnormalities of the 
rectum that did not constitute a ‘physical obstruction’ to defaecation), and abnormal 
(outlet obstruction) when there was a clear difficulty expelling rectal contents.  
Patients with an abnormal proctogram were further subdivided into:  
 
i) ‘mechanical’ outlet obstruction – presence of anatomical 
abnormalities (e.g. rectocoele, rectal intussusception etc) that is due 
to a physical barrier to defaecation or 
ii) ‘functional’ outlet obstruction (Wald, 2001) – difficulty expelling 
rectal contents in the absence of radiological abnormalities (e.g. 
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 failure of pelvic floor muscle relaxation when the anorectal 
angle or anal canal remains closed despite adequate expulsive 
effort or slow prolonged evacuation – 180 seconds or early 
termination of evacuation despite normal opening of the anorectal 
angle and relaxation of the anal canal, with most of the neostool 
retained (>25%) and those with exaggerated rectal adaptation and 
loss of the sensation of rectal fullness (Chan et al., 2001). 
 
2.7.5 Pudendal Latency Test  
 
As mentioned in Chapter 1, branches of the pudendal nerve provide both efferent and 
afferent pathways to the pelvic floor, EAS and perineum. Thus, pathological 
processes affecting pudendal nerve conduction could impair the functioning of the 
anal sphincter and pelvic floor, and such neuropathy may be important in the 
aetiology of idiopathic or ‘neurogenic’ FI and other functional anorectal disorders 
(Hill et al., 2002). The pudendal nerve motor latency test (PNTML) is a measurement 
of the conduction time from stimulation of the pudendal nerve at the level of the 
ischial spines, to the evoked EAS contraction. Prolonged latencies are suggestive of 
pudendal neuropathy, and have been demonstrated in patients with idiopathic 
incontinence (Kiff et al., 1984), yet, with the advent of endosonography, many 
patients previously thought to have ‘idiopathic’ incontinence are now recognised as 
having identifiable muscle damage or degeneration (Vaizey et al., 1997, Kamm, 
1998).  
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Figure 2.5: Evacuation proctography.  This involves imaging the rectum with 
instilled contrast material radiolucent commode (a) as seen below at our GI (b) 
Physiology Unit (Royal London Hospital, UK) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
(b) 
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 For this thesis, PNTMLs were determined using a disposable glove-mounted 
stimulating and recording electrode (Figure 2.6) (St Mark’s pudendal stimulating 
electrode: Dantec Electronics Ltd, Bristol UK) (Kiff et al., 1984) connected to a 
recorder (Kiff et al., 1984).  The index finger bearing the electrode array was inserted 
into the rectum, and the ischial spine sought. Square wave stimuli of 01 ms duration 
and 50 V were applied at 1 s interval. PNTML are known to increase with age 
(Laurberg and Swash, 1989), patients were considered to have a pudendal neuropathy 
(either unilateral or bilateral) if PNTMLs exceed 2.3 ms in those <40 years or age, 
and exceeded 2.5 ms in those ≥ 40 years of age. These values represent the upper limit 
of normal for our unit (Chan et al., 2005a).  
 
2.7.6 Endosonography 
 
Endosonography or endoanal ultrasound is a technique used to accurately image the 
sphincter muscles. This has revolutionised our understanding of the pathogenesis of 
FI as mentioned above, showing that structural damage rather than pudendal nerve 
damage is the underlying cause in most patients (Nielsen et al., 1993, Burnett et al., 
1991, Law et al., 1991).  It now forms the cornerstone for the evaluation of sphincter 
integrity.  
 
In this thesis, we know that the cylindrical nature of the anal structures, imaging is 
best suited to a 360
0 
axial view obtained at right angles to the lumen. This achieved 
using 10MHz transducer attached to a mechanically rotating endoprobe (transrectal 
probe type 1850 and ultrasound machine, model 1846 and; B-K Medical Berkshire, 
UK) (Figure 2.7.a).  A hard plastic cone surrounding the transducer is filled with 
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 distilled water and protected with a condom, covering liberally inside and out 
with ultrasound gel to ensure good acoustic contact. During the evaluation, the probe 
was inserted into the rectum and slowly withdrawn through the anal canal with 
images Figure 2.7.b) being recorded from the upper, mid and lower levels.   Although 
operator dependent, sensitivity and specificity approach 100% for the identification of 
anatomical defects if carried out by an experienced practitioner (Sultan et al., 1994).  
Structural damage to either the internal or external anal sphincter was clearly 
identified, as well as degenerative changes in the smooth muscle (Vaizey et al., 1997).    
 
Figure 2.6: The St Mark’s pudendal nerve electrode.  This consists of a pair of 
stimulating electrodes mounted on a fixed array together with the recording electrode. 
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Figure 2.7: a) Endosonography machine.  Probe (see arrow) (a) and b) image 
produced showing sphincteric muscles and puborectalis. 
 
(a) 
(b) 
IAS 
EAS 
Puborectalis 
Probe 
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2.8 PSYCHIATRIC AND QUALITY OF LIFE 
INVESTIGATIONS 
 
Psychiatric tests included specific measures of depression, anxiety, personality, 
general health, gastrointestinal quality of life and level of hopefulness (Table 2.4).  
These questionnaires were done in a private room where the subject was entirely on 
their own with an identification number, in order to encourage anonymity and 
confidentiality.  As seen in Chapter 1 literature review table, most studies 
investigating quality of life and psychiatric measures in patients with ARA, the 
questionnaires were posted to the subject’s home address or done in clinic (i.e. in an 
interview format or with parent). The presence of other parties (e.g. parent/s, other 
family, researchers, and clinicians) could influence the subject’s answers to the 
questions and thus not encourage an honest answer. All subjects were given an 
envelope (with an ID number) which was provided at the beginning of the visit.  This 
allowed the subject to put all questionnaires in the envelope once completed, sealing it 
and avoiding the author in charge to become bias when analysing the results. If the 
subject was unable to attend the research unit or hospital, visits were made to the 
subject’s home/work place from the author, where the questionnaires were filled again 
in a private room.  One subject was in prison during the time of the research study, 
and since they fitted the inclusion criteria, they too were included in this research 
following the same format as above.  
 
2.8.1 Gastrointestinal Quality of Life 
 
Quality of life measurements have become increasingly important in surgical research 
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 and are nowadays often one of the endpoints of clinical trials, besides the more 
established outcome measures such as morbidity, mortality and survival rates (Okike 
et al., 1979, Andreollo and Earlam, 1987, Vantrappen and Hellemans, 1980).  
Measurement of quality of life in patients with various medical conditions is used to 
evaluate the nature and extent of functional and psychosocial impairment. 
Furthermore, it allows the monitoring of quality of care and comparison of different 
therapeutic approaches. Measuring quality of life necessitates use of instruments that 
are consistent, reproducible, sensitive and applicable. To date the gastrointestinal 
quality of life index (GIQLI) (Appendix - H) first published in the German version in 
1993, developed by Eypasch and colleagues to measure health related quality of life 
(HRQOL) in multiple chronic gastrointestinal disorders (Eypasch et al., 1995).  The 
 
Table 2.4: Psychiatric instruments for all subject groups 
Variables Ages Administered Instrument 
Quality of life ≥ 11 years The Gastrointestinal Quality of Life Index 
Depression 7-17 years  
≥ 18 years 
Children's Depression Inventory  
Beck Depression Inventory  
Mental health > 16 years General Health Questionnaire  
Anxiety 8-12 years  
≥ 13 years 
State-Trait Anxiety Inventory for Children  
State-Trait Anxiety Inventory (adults)  
Physical health ≥  11 years Pennebaker Inventory of Limbic Languidness 
Personality > 16 years 
< 16 years 
Big Five Inventory 
Big Five Inventory TTC (Transition to College)  
Hopefulness ≥ 11 years Hunter Opinions Personal Expectations Scale  
Lie Detector ≥  11 years Weinberger Adjustment Inventory 
Coping 
Mechanisms 
≥  11 years Cognitive Emotion Regulation Questionnaire 
(including Cognitive Emotion Regulation 
Questionnaire - kids) 
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 questionnaire contains up to 36 items, scored on a five point Likert scale (range 
0-144, higher score = better quality of life), in which additional modules specified by 
the particular gastrointestinal disease, supplement a set of core questions. It consists 
of five subscales: physical well being, gastrointestinal digestion, gastrointestinal 
defaecation, mental well being and other which is summarized in an overall score 
(Table 2.5).  
 
Table 2.5 Gastrointestinal Quality of Life Index (GIQOL) subgroups 
GIQOL Subgroups  
Physical well being  
Enjoyed eating 
Fatigue 
Feeling unwell 
Appearance 
Endurance 
Feeling unfit 
Daily activities 
Leisure activities 
Nausea  
Gastrointestinal digestion  
Pain in abdomen 
Fullness in abdomen 
Bloating 
Flatus 
Burping/belching 
Abdominal noises 
Regurgitation 
Eating speed 
Constipation 
Heartburn 
 Mental well being 
Coping with stress 
Sad about illness 
Nervous about illness 
Happy with life 
Frustrated by illness 
Gastrointestinal defaecation 
Bowel frequency 
Impaired sexual life 
Bowel urgency 
Diarrhoea 
Blood in stool 
Uncontrolled stools 
Other 
Restricted eating 
Wake up at night 
Bothered by treatment 
Worsened relations 
Dysphasia 
 
 
 
The GIQLI subscales have been found to have good internal reliability and the 
construct validity was supported by the pattern of correlations with the Rotterdam 
Symptom Check List and Medical Outcomes Studies (Nieveen Van Dijkum et al., 
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 2000). Construct validity was supported by demonstrating a reasonable 
correlation with the Spitzer quality of life index (r=0.53) and the Bradburn affect 
balance scale (r=0.42) in 204 German patients with a variety of gastrointestinal 
disorders (Borgaonkar and Irvine, 2000).  Other studies are in agreement with the 
GIQOL being a valuable instrument for measuring quality of life in patients with 
anorectal conditions (Vordermark et al., 1999, Sailer et al., 1998, Kasparek et al., 
2007) 
 
A Finish group examined adults with FI following surgical therapy for childhood with 
anorectal disorders. These included 26 subjects treated surgically for benign 
sacrococcygeal teratoma (Rintala et al., 1993a) and 83 who had surgery for low 
anorectal malformations (Rintala et al., 1992). Both groups had impaired bowel 
function with 27-39% of the respective cohorts reporting social problems due to 
impaired continence. In contrast, Moore et al found that 75% of 178 patients treated 
surgically for Hirschsprung’s disease described excellent function whereas only 6% 
described persistent incontinence and resultant psychosocial problems (Moore et al., 
1996). 
 
Patients with the most severe gastrointestinal disorder have shown to have a mean 
GIQLI score of 45 compared with healthy controls who had a mean score of 121 
(Weinryb et al., 1995) or 125.8 (Guillemin et al., 1993)  
 
2.8.2 Depression 
 
Depression or feelings of sadness experienced in children can have a negative 
influence on their daily life and level of hope.  Depressive symptoms have been 
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 generally related with poor academic achievement, peer friendship/relationship 
problems, behaviour problems, poor self-esteem and in severe cases, suicide (Kazdin, 
1990) (Worchel, 1987). As a result, medical professionals have come to appreciate 
how crucial it is to measure depressive symptoms in paediatrics.  This provides the 
opportunity to identify: 
1) children seriously in need of treatment 
2) those indicating milder depressive symptoms that may benefit from early 
intervention (Crowley, 1994). 
 
2.8.2.1 Children Depression Inventory (CDI) 
Depression in children between 7-17 years of age can be assessed by using the 
Children's Depression Inventory (CDI) (Appendix - I). The CDI is a self-report 
questionnaire, which is essentially a downward extension of the Beck Depression 
Inventory (BDI) (Beck et al., 1985). Modifications included additional items to 
evaluate areas of school and social/peer relations.  However, the CDI differs from the 
BDI mainly in its phraseology, which is more appropriate to the language of 8-13 year 
old children (Kovacs, 1977). The CDI comprises 27 self-rated symptom orientated 
scale.  Each item is divided into three statements that are graded in severity and are 
assigned numerical values from 0 to 2, providing a total score range of 0-54.  The CDI 
specifies a variety of depressive symptoms including (Kovacs, 1985): 
• Disturbed/negative mood 
• Anhedonia  
• Ineffectiveness (i.e. vegetative functions) 
• Self-evaluation (i.e. negative self-esteem) 
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• Interpersonal behaviours  
Approximately half of the items begin with the choice that reflects the greatest 
symptom severity; for the remainder, the sequence of options is reversed.  
 
The CDI will be chosen for this research study over similar instruments as it is 
commonly used and has been subjected to lengthy psychometric assessment in normal 
children and in the clinical setting.  It has also been modified in relation to its format 
and items in order to improve validity and comprehension.  The CDI has 
demonstrated to display: 
1) Good reliability with reasonable valid measure of depression among children 
(Hepperlin et al., 1990, Ghareeb, 1989, Ollendick and Yule, 1990, Smucker et al., 
1986)  
2) Acceptable internal consistency and test-retest reliability (Nelson, 1990, Kaslow 
et al., 1984, Kazdin, 1983, Meyer et al., 1989, Saylor et al., 1984, Finch, 1987, 
Wierzbicki, 1987, Weiss and Weisz, 1988)  
3) An index of the severity of depression (Garvin et al., 1991).   
4) Diagnostically effective using different cut-points between 10 and 30 (Doerfler et 
al., 1988, Garvin et al., 1991, Hodges, 1990, Kazdin, 1989, Kazdin et al., 1986, 
Smucker et al., 1986)  
5) Discriminate psychiatrically diagnosed school-aged depressed children and 
clinical cases whose disorders are not in the depressive domain (Hodges, 1990, 
Kazdin et al., 1986)  
 
Children who score high on the CDI generally tend to have a high level of anxiety and 
low self-esteem. Since these two phenomena are theoretically associated with 
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 depression and the data support the inventory/s validity (Eason et al., 1985) 
(Hammen and Zupan, 1984).   
 
Funakosi et al (Funakosi et al., 2005) demonstrated that the degree of depression in 
children with congenital ARA.  It was found that the CDI score was higher in children 
aged 12 to 16 years than in the children aged 7 to 11 years. During adolescence, when 
an individual’s self-image in a society is being established, the children tried to accept 
the faecal dysfunction and adapt themselves to society. However, problems such as FI 
may cause low self-evaluation and self-esteem, resulting in a high CDI score.  
Ludman and Spitz interviewed children with FI on a spontaneous basis and found that 
children aged 12 years or older were afraid of derision and prone to be repressed.  
 
CDI scores are reported as a T-score.  T-scores are standardized scores, which have 
the useful characteristics that each scale will have the same mean and standard 
deviation.  Thus, permitting the interpreter to directly compare the scores on one scale 
to the scores on another scale.  For this research study, a child who scored a T-score 
above 70 (i.e. > mean of 50, SD 10) was considered to be clinically depressed.  
 
2.8.2.2 Beck Depression Inventory 
Depression in young adults aged > 17 years was assessed using the 2
nd
 Edition Beck 
Depression Inventory (BDI-II) (Appendix - J) (Beck, 1996).  The BDI-II is a 21-item 
self-report instrument for screening the severity of depression in adults.  It is 
essentially an upward extension of the CDI (Kovacs, 1992).  BDI-II was developed 
for diagnosing depressive disorders listed in the American Psychiatric Association's 
Diagnostic and Statistical Manual of Mental Disorders- Fourth Edition (DSM-IV, 
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 1994).  For the modified version (BDI-II) four items (weight loss, body change, 
somatic preoccupation, and work difficulty) were replaced by four new items:  
1) Agitation 
2) Worthlessness 
3) Concentration difficulty  
4) Loss of energy.   
Such modifications were performed in order to index symptoms typical of severe 
depression or depression warranting hospitalisation.   
 
The BDI-II was chosen for this research study over other existing instruments for 
measuring depression because: 
1) it is commonly used 
2) it is an upward extension of the CDI 
3) it reports of good reliability.   
4) psychometric characteristics of the BDI-II used samples from four different 
psychiatric outpatient clinics and one college-student group.  [It has proven to be 
useful with a variety of populations  (Beck and Beamesderfer, 1974).   
5) it correlates well with several other psychological tests.  The BDI-II is positively 
related to both the Beck Hopelessness Scale (Beck, 1988); Scale for Suicide 
Ideation (SSI) (Beck et al., 1979) and Beck Anxiety Inventory (BAI) (Beck, 
1990); Hamilton Psychiatric Rating Scale for Depression (HRSD) (Hamilton, 
1960).  
6) it is sensitive to clinical change over time (Johnson and Heather, 1974) and has 
been used extensively as a pre-post-outcome measure in psychotherapy studies 
(Rush, 1977).  
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For this research study, a child who scored a BDI total score above 28 (i.e. range 
severe depression) was considered to be clinically depressed.  
 
2.8.3 General Health Questionnaire 
 
The General Health Questionnaire (GHQ) (Appendix - K) is designed to identify two 
main classes or problem: ‘inability to carry out one’s normal ‘healthy’ functions, and 
the appearance of new phenomena of a distressing nature’ (Goldberg 1979).  It 
focuses on breaks in normal functioning rather than on life-long traits; therefore it 
only covers personality disorders or patterns of adjustment where these are associated 
with distress.  
 
Psychological distress or dysfunction was measured in this research study using the 
General Health Questionnaire-28 (GHQ-28) (Goldberg, 1978) (Appendix - K).  The 
GHQ is a self-administered screening instrument revealing individuals with 
diagnosable psychiatric disorder. Different versions of the GHQ, including GHQ-12 
and GHQ-28 have been exposed to factor analysis in a variety of countries and 
settings.  The main focus of the GHQ-28 are the following:  
1) Inability to carry out one's normal 'healthy' functions 
2) Appearance of new phenomena of a distressing nature  
The GHQ-28 is made up of 28 items, which were originally derived from a factor 
analysis of the GHQ-60.  It consists of four subscales: 
1) Somatic symptoms  
2) Anxiety and insomnia 
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 3) Social dysfunction  
4) Severe depression.   
It is aimed at studies that require more information than a single severity score 
(Goldberg and Hillier, 1979).  Factor analysis within different settings including 
translation into different languages basically confirmed the original structure (Iwata 
and Saito, 1992, Nagata et al., 1993, Riaz and Reza, 1998, Weyerer et al., 1986)  
 
For this research purpose the GHQ-28 was chosen because:  
1) it is a commonly used self-report measure, which has been validated, in an 
Australian population, with correlations between clinical psychiatric ratings of 
severity and GHQ scores (Tennant, 1977).  
2) it functions well in terms of scale validity, with the four subscales contributing to 
48% of the total variance (Goldberg and Hillier, 1979, Kilic et al., 1997).  
3) it is valuable tool to assess general psychopathology and to screen for potential 
cases. 
4) both versions (GHQ-12; GHQ-28) have been shown to be reliable and to have 
stable factor structures across cultures and across time.  
 
The GHQ scoring method was used to assess psychiatric morbidity.  This method of 
scoring involves a dichotomous response (i.e. 0-0-1-1) scale where only pathological 
deviations (1 = ‘rather more than usual’ and ‘much more than usual’) signal 
possession of the item (‘less than usual’ and ‘no more than usual’ are scored 0).  
Therefore, cut-off scores less than five is indicated as a ‘probable non-case’ and all 
those more than or equal to five as ‘probable cases’.  
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2.8.4 Anxiety 
 
All individuals show signs of anxiety at some point during their life, with differences 
existing in relation to how often and how intensely it is shown.  Catell & Scheier 
(Cattell, 1961) suggested that anxiety has two dimensions:  
1) state anxiety: one tends to feel anxiety in a particular situation 
2) trait anxiety: this indicates the tendency to explain anxiety across a variety of 
situations.   
 
Spielberger (1973) notes that people who have high levels of trait anxiety are more 
likely to view a wider range of situations as threatening or dangerous.  Researchers 
have developed instruments to assess state and trait anxiety with different age ranges 
(Spielberger, 1970) (Spielberger, 1973). 
 
The State-Trait Anxiety Inventory for Children (STAIC) (Appendix - L)  
(Spielberger, 1973) (Appendix L) is one of many tests used to measure anxiety in 
children.  Primarily the STAIC was developed as a research tool for the study of 
anxiety in elementary school children.  The STAIC is similar to the State-Trait 
Anxiety Inventory (STAI) (Appendix M) (Spielberger, 1970) which measures anxiety 
in adolescents/adults.  Both the STAIC and STAI share similar items, but the format 
for responding to the STAIC has been simplified to cater for young children.  The 
STAIC measures anxiety in children who are in Grades 1 through 6 (i.e. 9 to 12 years) 
(Spielberger, 1973).  However, Spielberger et al., (Spielberger, 1973) suggested that it 
"may also be used with younger children who are average or above reading ability 
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 and with older children who are below average in ability" (Spielberger, 1973) 
p.5).  The STAIC is made up of two separate psychometric scales for measuring two 
distinct (yet related) anxiety concepts (as found in the STAI (Spielberger, 1973): 
1) STAIC State-Anxiety: consists of 20 statements, which ask children how they feel 
at a particular moment in time.  The purpose of State-Anxiety scale is to measure 
transitory emotional arousal or anxiety states.  This includes subjective 
consciously perceived feelings of apprehension, tension, and worry that vary in 
strength and fluctuate as a function of stressful situations that occur over time. 
2) STAIC Trait-Anxiety: consists of 20 item statements, yet subjects reply to these 
items in relation to how they generally feel.  The Trait-Anxiety assesses relatively 
constant individual differences in anxiety proneness.  This includes differences 
between children who are prone to experience anxiety states.   
 
Children with higher Trait-Anxiety patterns are more likely to show State-Anxiety 
characteristics due to their inclination to look at more situations as threatening or 
dangerous.  The STAIC was used in this research study because: 
1) it is most commonly used  
2) it provides reliable means to measure trait and state anxiety in children (Cross, 
1993) (Finch, 1987, Dorr, 1981).   
a) correlates with Children's Manifest Anxiety Scale (CMAS) (Castaneda et al., 
1956)) and (General Anxiety Scale for Children) (GASC) (Sarson, 1960). 
For this research study, scores at or above 35 (67
th
 percentile) were defined as high 
anxiety for this sample and scores at or below 30 (33
rd
 percentile) were defined as low 
anxiety for this sample (Emerson et al., 2005). 
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 The STAI has been mainly used in high school and college students, working 
adults, military personnel, and psychiatric, psychosomatic medical, surgical, and 
dental patients (Spielberger, 1973).  As in the STAIC, the STAI consists of 20 
statements that ask respondents to report how they feel at that particular moment by 
rating the intensity of their subjective feelings of anxiety (such as “I feel frightened”) 
on a four point scale:  
1) ‘not at all’ 
2) ‘somewhat’ 
3) 'moderately so'  
4) 'very much so' 
 
For this research the STAI was chosen because:  
1) it has investigated the role of anxiety in patients suffering from other chronic 
illnesses such asthma (Alexander, 1972, Kurata et al., 1976) colitis, dermatitis, 
duodenal ulcers, and infectious mononucleosis (Latimer, 1980, Rabavilas, 1980, 
Roark, 1971). 
2) Maternal mental distress was examined as possible predisposing factor for the 
child's disease and/or an effect of disease (Vandvik and Eckblad, 1991). 
 
The STAI is used to evaluate state and trait anxiety with a maximum score of 80. For 
this research study STAI (state anxiety), scores of 41 or less indicate normalcy, where 
scores of 42 to 50 imply a clinically significant state of anxiety. Furthermore, scores 
of higher than 50 indicate an extremely high level of anxiety (neurosis level) 
(Funakosi et al., 2005).  For STAI (trait anxiety) scores of 44 or less represent 
normalcy, whereas scores of 45 to 54 indicate clinically significant characteristic 
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 anxiety Scores higher than 55 or higher indicate extremely severe characteristic  
anxiety (neurosis level) (Funakosi et al., 2005). 
 
2.8.5 Pennebaker Inventory of Limbic Languidness  
 
The Pennebaker Inventory of Limbic Languidnes (PILL) (Appendix - N) is a 54 item 
scale that assesses the frequency of common physical symptoms and sensations 
(Pennebaker, 1993). Evidence of its validity was found in that high scores on this 
instrument were more likely to engage in health-related behaviours than those with 
lower scores (Carney et al., 2002). Previous research indicates that high scores on the 
PILL are significantly associated with a greater frequency of center visits, and greater 
number of days sick and/or work related absences.  Cronbach alphas range from 0.88 
to 0.91 and 2 months retest reliability ranges from 0.79 to 0.83 (Pennebaker, 1993, 
Carney et al., 2002).  
 
The overall score on the PILL is obtained by summing the total number of items for 
which the individual endorsed experiencing the symptom at least onece every month 
(Pennebaker, 1993).  Items include physical symptoms such as runny or congested 
nose, chills, headaches, fever and nausea.  Subjects are asked to indicate on a 5-point 
scal how they experience each symptom from 1 = ‘have never or almost never 
experienced the symptom to 5 = ‘more than once every week.  The PILL was included 
in this study because it is commonly used in studies of written disclosure and it is a 
sensitve measure of change in physical symptoms.   
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 2.8.6 Big Five Inventory 
 
The Big Five personality model has emerged as a widely accepted general framework 
for conceptualising personality traits (Digman, 1997, Digman, 1990).  The Big Five 
Inventory (BFI) (Appendix - O) consist of 44 questions desgined to separate each 
patients personality into five dimentions: extroversion, agreeableness, 
conscientiousness, neuroticism and openess (John, 1991). The BFI uses short and 
simple phrase to assess the most prototypical traits associated with each of the Big 
Five dimensions.  
 
Participants rate each BFI item on a 5-point scale ranging from 1 (disagree strongly) 
to 5 (strongly agree). Briefly, the personality dimensions encompass different traits. 
Extroversion describes persons who are talkaive, energetic, and assertive. 
Agreeableness characteristics include sympathy, kindnes and affection. Parents and 
teachers convey to young children that there are appropriate (good) and inappropriate 
(bad) ways to behave (Block et al., 2007). As articulated by Digman (Digman, 1997), 
in BFI terms, being a good child involves acting both agreeable (e.g. “don’t hit”, 
“share with your brother/sister”) and conscientiously (e.g. “do as you are told”, “pick 
up after yourself”). Conscientiousness describes persons who are organised, thorugh, 
and engage in planning. Tense, moody, and anxious persons score high in neuroticism 
dimensions. Finally, openness implies personality styles with wide interests, and are 
imaginative and insightful.  The BFI scales have shown substantial internal 
consistency, retest reliability, and clera factor structure, as well as considerable 
convergent and discrimiantnt validity with longer Big Five measures   
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 Scoring the BFI is usually done by an intuitive metric system known as 
percentage of maximum possible (POMP) scores (Cohen, 1999). A POMP score is a 
linear transformation of any raw metric into 0 to 100 scale, where 0 represents the 
minimum possible score and 100 represents the maximum possible score.  Srivastava 
(Srivastava, 2003) demonstrated in a sample of adults aged 21-60 who completed the 
BFI, that consicientiousness and agreeableness increased throughout early and middle 
adulthood at varying rates; neuroticism declined among women but did not change 
among men.  
 
Lounsbury et al (Lounsbury, 2003) uses the BFI - Transition to College (TTC) 
(Appendix - O) inventory for young adolescents, measuring normal personality 
characteristics in relation to students making the transition from high school to 
college.  It consists of 118 items measuring personality traits, preferences, and 
personal style. In this thesis, the BFI-TTC was administered to young adolescents (11-
16 years of age).  
 
The BFI-TTC encompasses the "Big Five" personality traits (Table 2.6):  Neuroticism 
(which we term here “Emotional Stability”), Extraversion, Openness, Agreeableness, 
and Conscientiousness.  There is an emerging consensus that the Big Five represents a 
“grand unified theory” for personality (Digman, 1990) that is replicable for a wide 
range of cultures, age groups, and settings, including school and work (Digman, 
1997).  Consistent with an emerging literature base demonstrating that predictive 
validity can often be enhanced by using “Narrow” personality traits in addition to the 
Big Five (Ashton, 1998, Paunonen, 1998),  the TTC includes the following 
personality dimensions  Aggression, Career Decidedness, Leadership, Optimism, 
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 Sense of Identity, Tough/Tender-Mindedness, Self-Directed Learning, and Work 
Drive.  
 
Table 2.6: “Big Five” Personality Traits Measured by the Transition to College 
(TTC) 
 
 
AGREEABLENESS 
Agreeableness refers to being agreeable, participative, helpful, 
cooperative, and inclined to interact with others in a harmonious 
manner. High scorers tend to interact smoothly with other people, 
especially peers, and to be easygoing and accepting in group 
settings.  Low scorers tend to be more outspoken, oppositional, 
contentious, argumentative, and divisive in group settings.   
 
CONSCIENTIOUSNESS 
Conscientiousness refers to being reliable, trustworthy, orderly, 
and rule-following.  High scorers tend to dependable, disciplined, 
and organized as well as to have better study and work habits. 
They function better in structured settings.  Low scorers tend to be 
more non-conforming and inclined to march to their own 
drummer, usually preferring spontaneity and a lack of structure.  
They function better in less structured settings. 
 
EMOTIONAL 
STABILITY / 
RESILIENCE 
Emotional Stability/Resilience (reverse of Neuroticism) reflects 
overall level of adjustment, resilience, and emotional stability.  
High scorers can function more effectively under conditions of 
stress and pressure, whereas low scorers are less stress-resistant, 
are frustrated more readily, and more subject to negative emotions. 
 
EXTRAVERSION 
Extraversion refers to being sociable, outgoing, lively, and 
warmhearted.  High scorers tend to talk and socialize more, and 
they are more likely to actively participate in clubs, groups, and 
discussions. They tend to have extensive friendships and 
acquaintanceships.  Low scorers tend to be introverted, quiet, 
focused, and reserved.  They tend to have fewer but more 
intensive friendships. 
OPENNESS TO NEW 
EXPERIENCE 
Openness refers to receptivity to new learning, change, and novel 
experience.  High scorers tend to be more willing to experiment 
and try new things, as well as to explore the world around them.  
Low scorers tend to prefer stability, convention, and tried-and-true 
ways of doing things 
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 2.8.7 Level of hopefulness 
 
Nunn et al (Nunn, 1996b) defines hope as the ‘that general tendency to construct and 
respond to the perceived future positively’. The hopeful person subjectively assesses 
what is desired for the future to be probable or so important as to constrain believe 
and behaviour to the grounded upon its possibility.  There are many reasons why hope 
should be considered to a greater degree than it has been in the past. First, the loss of 
hope has been shown to predict suicide as, or more powerfully, than depressive 
disorder (Beck et al., 1985, Wetzel et al., 1980). Second, the loss of hope and the 
generalisation of hopelessness has been implicated in the mediating pathway between 
social processes and the personal experience of depression (Nunn, 1996b).  Thirdly, 
hope and despair contribute to therapeutic efficacy as a study factor, an outcome 
factor, an intervening variable and a recovering factor (Brown et al., 1992, Greene, 
1989). Lastly, hope and the disorders of hope may be of central importance in mind-
body interactions. The role of hope and the loss of hope in the precipitation, 
perpetuation and emotional burden of physical illness have been considered indirectly 
and qualitatively (Buehler, 1975, Schmale and Iker, 1971) and more recently directly 
and quantitatively (Elliott et al., 1991, Snyder et al., 1991). Considering personal 
hopefulness in this study, will lead to a revaluation of the significance of concepts as 
depression and anxiety (Nunn, 1996b).   
 
The purpose of Hunter Opinions and Personal Expectations Scale (HO.P.E.S) 
(Appendix -P) was to measure personal hopefulness, focusing on essential 
components such as: 
• Wish or desire 
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• Expectation and future orientation  
 
H.O.P.E.S was the preferred instrument for this research study because: 
1) it has excellent psychometric qualities.  
2) Strong support for the H.O.P.E.S instrument's construct, concurrent and 
predictive validity (Nunn, 1996a, Nunn, 1996b, Nunn et al., 1996) 
3) Correlates with other psychometric measures (e.g. STAI, BDI) 
The overall score from the H.O.P.E.S measure (i.e. Hope subscale + 40 – Despair 
subscale) is best described as a measure of ‘global personal hopefulness’ (GPH) 
(Nunn, 1996a). Rather than defining this measure as clinical subgroups (i.e. like in the 
previous instruments of this chapter) it is probably more valuable to perceive this 
measure as a continuous index.  However, in order gain a general perception of how 
subjects view their future; the following scoring method was applied:  
• GPH score 0-36 = ‘very low’ or ‘well below average’ GPH 
• GPH score 37-49 = ‘low’ of ‘below average’ GPH 
• GPH score 50-62 = ‘average’ GPH 
• GPH score 63-80 = ‘high’ or ‘above average’ GPH 
 
Thus, a high total global personal hopefulness score indicated an excellent level of 
hopefulness for the future. 
 
2.8.8 Cognitive Emotion Regulation Questionnaire (CERQ) 
 
Cognitive emotion regulation can be understood as the cognitive way of managing the 
intake of emotionally arousing information (Garnefski, 2001, Garnefski, 2002, 
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 Garnefski, 2006, Thompson, 1991). The regulation of emotions through 
cognitions is inextricably associated with human life and helps to manage emotions 
after the experience of stressful events. In all stages of life, people have to deal with a 
wide range of stressors and challenges to adapt to the world. As children grow older, 
their emotion regulation repertoire increases and shifts from primarily external, 
behaviourally oriented emotion regulation strategies to more internal cognitively 
based ones (Harris et al., 1981, Fields and Prinz, 1997, McCarty et al., 1999). By the 
age of eight or nine, young children have learned to regulate their emotions by means 
of cognitions or thoughts about themselves, their feelings or others. For example, 
when experiencing a negative event, some children may have thoughts of blaming 
themselves, while others may rather blame someone else.  
 
The CERQ (Cognitive Emotion Regulation Questionnaire including CERQ-kids) 
(Appendix - Q) is a multidimenstional questionnaire constructed in order to identify 
the cognitive coping strategies someone uses after having experienced negative events 
or situations. Contrary to other coping questionnairs that do not explicity differentiate 
between an individual’s thoughts and his or her actual actions, the present 
questionnaire refers exclusively to an individual’s thoughts after having experienced a 
negative event.  The CERQ is a very easy to administer, self-report questionnaire 
consisting of 36 items. The questionnaire has been contructed both on a theoretcal and 
empirical basis and measures nine different cogitive coping strategies. The CERQ 
makes it possible to identify individual cognitive coping strategies and compare them 
to norm scores from various population groups. In addition, the opportunity to 
investigate relationships between the use of specific cognitive coping strategies, other 
personality variables, psychopathology and other problems. The CERQ can be 
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 administered in normal populations and clinical populations, both with adults and 
adolescents aged 12 years and over. Cognitions or cognitive processes help people 
regulate their emotions or feelings and not get overwhelmed by the intensity of these 
emotions, for example during or after experiencing a negative or stressful life event.  
The CERQ is a self-report questionaire measuring cognitive coping strategies of 
adults and adolescents.  In other words, with the help of this questionnaire it can be 
assessed what people ‘think’ after having experienced a negative or traumatic event. 
Cognitive coping strategies are defined here at strategies for cognitive emotion 
regulation, that is, regulating in a cognitive way the emotional responses to events 
causing the individual emotional aggravation (Thompson, 1991).  Cognitive coping 
strategies are assumed to refer essentially to rather stable styles of dealing with 
negative life events, however not to such an extent that they can be compared to 
personality traits. It is assumed that in certain situations people may use specific 
cognitive strategies, which may divert from the strategies they would use in other 
situations. It may also be assumed that potentially cogitive  coping strategies can be 
influenced, changed, learned and unlearned, for example through psychotherapy, 
intervention programmes or one’s own experiences. The CERQ distinguishes nine 
different cognitive coping strategies, each consisting of four items measured on a 5-
point Likert scale and each referring to what someone thinks after the experience of a 
stresssful life event. These are: 
1. Self-blame - referring to thoughts of blaming yourself for what you have 
experienced  
2. Acceptance – referring to thoughts of resigning to what has happened 
3. Rumination – referring to thinking all the time about the feelings and thoughts 
associated with the negative event  
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 4. Positive refocusing – which refers to thinking of other, pleasant matters 
instead of the actual event.  
5. Refocus on planning – or thinking about what steps to take in order to deal 
with the event.  
6. Positive reappraisal  - or thinking of attaching a positive meaning to the event 
in terms of personal growth.  
7. Putting into perspective or thoughts of playing down the seriousness of the 
event when compared to tother events.  
8. Catastrophizing – referring to explicity emphasizing the terror of the 
experience.  
9. Other-blame – referring to thoughts of putting the blame for what you have 
experienced on others. 
 
The CERQ is suitable for use in different populations such as adolescents, adults, 
elderly people, students and psychiatric patients. Besides, experience has been gained 
in administering the questionnaire to groups of varoius educational backgronds.  It has 
also turned out that the CERQ can be very well administered in a number of specific 
populations, such as chronically ill adolescents, individuals with fear of flying, groups 
of  people characterised by having experienced similar types of traumatic events.  
 
The psychometric properties of the CERQ have been proven to be good (Kraaij, 2006) 
(Garnefski, 2006). A number of previous studies have  reported positively on the 
internal consistencies, factorial validity, construct validity and criterion-related (or 
predictive) validity of the CERQ scales (Garnefski, 2002) while strong relationships 
were found between the use of specific cognitive emotion regulation strategies of 
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 rumination, catastrophizing and self-blame and the reporting  of symptoms of 
depression. This might imply that by usign these strategies, people may be more 
vulnerable to developing symptoms of psychopathology in response to negative life 
events than others (Garnefski, 2002). Other outcomes suggested that people may more 
easily tolerate or master negative life experiences by using other cognitive styles, such 
as Positive Reappraisal.  Internal consistency of the CERQ of the various subscales 
were assessed across the diverse populations which were good to very good (in most 
cases well over .70 and in many cases even over .80)  (Garnefski, 2002).  Research 
has shown that the subscales have good internal consistencies, with alaphas ranging 
from 0.67 to 081 (Garnefski, 2001, Garnefski, 2002)  
 
2.8.9 Weinberger  Adjustment Inventory  
 
In order to demonstrate how self defning memory characteristics may reflect aspects 
of personality adjustment, defensiveness and distress, we selected the Weinberger 
Adjustment Inventory (WAI) (Appendix – R) (Weinberger, 1991). The WAI was 
designed to operationalize distress and self-restraint as dimension of social-emotional 
adjustment. It also includes scales of response and can be used as a ‘lie detector’ 
which will be use in this thesis. The two primary dimensions of self-restraint and 
subjective express of distress are measured in the WAI. The self-restraint includes 
intrapersonal (impulse control), interpersonal (suppression of aggression and 
consideration for others) and communal (responsability) aspects of socialisation. Low 
restraint is a characteristic in young children  or individuals who do not regulate their 
impulses and affects succcessfully and is associated with problem behaviour such as 
durg use, delinquency and aggression (Farrell and Sullivan, 2000, Weinberger, 1998) .  
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 Overcontrol is the result of soicalisation and can be more adaptive; however, 
individuals who are best socially and emotionallly adapted should show moderate 
self-restraint as they manage affect skillfully and do not become rigid or overly 
intellectualised (Asendorpf and van Aken, 1999, Hart et al., 1997) (Weinberger and 
Schwartz, 1990). The subjective experience to distress dimension has the subscales of 
trait anxiety, depression, low well being, and low self-esteem and it captures the self’s 
own appraisal of its status in relation to personal goals as well as to external sources 
of threat .  
 
Subjects are asked to complete the inventory based on ;what they are usually like’ 
using a 5-point scale. The composite distress and restraint scale had internal 
consistencies of at least 0.91 and 0.85, respectively, across subsamples adolescents 
(Weinberger, 1991).  In this thesis, the 37-item short form was used and subjects were 
classified as being repressors or nonrepression using the cutoff suggested by 
Weinberger (Weinberger, 1991). 
 
2.9 DATA ANALYSIS 
 
2.9.1 Software 
 
Following database entry, data were generally exported following appropriate 
execution of ‘queries’ into a spreadsheet application (Microsoft ® Excel 97, SR-1, 
Microsoft Corporation, Santa Rosa, CA, USA). After manipulation within this format, 
further statistical analysis and graphic presentation of data were performed using a 
combination of computerised statistical packages including Package for the Social  
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 Sciences (SPSS
®
 Version 16, Chicago Illinois USA) and GraphPad Prism
®
 5.02 
Inc (GraphPad Software 1992-2009 La Jolla, CA 92037  
USA). 
 
2.9.2 Statistical analysis 
 
Specific statistical analyses are described within the chapters to which they refer. 
Deviations from a Gaussian distribution were tested using the Kolmogorov-Smirnov 
test.  In general, most data comparison was performed with non-parametric analyses 
based on the distribution of data points.  The Mann-Whitney U-test was used for 
comparison of 2 independent populations of non-parametric numeric data, and the 
Wilcoxon rank-sum test for paired sets of data.  Contingency analyses were 
performed using Fisher’s exact (2 rows and columns in contingency table) or chi-
square tests (more than 2 rows or 2 columns in contingency table). A two-tail p value 
was calculated in all cases (p< 0.05 was considered significant).  
 
Linear correlation or regression was used to compare the covariation of 2 numeric 
variables. In simple terms, regression was chosen when X values were controlled e.g. 
age. When linear regression analysis was used, 95% confidence intervals (CI), 
goodness of fit (r2), and residuals were calculated. When correlation was applied, 
parametric (Pearson correlation) or non-parametric (Spearman correlation) methods 
were used as appropriate. For all tests, p < 0.05 was considered to show a significant 
difference. 
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CHAPTER 3 
RESULTS (Part I) 
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3.0 RESULTS - Part I 
3.1 DEMOGRAPHICS FOR ALL SUBJECTS  
 
3.1.1 Age and sex 
 
The study population comprised 149 subjects with 91/149 males (61.1%) and 58/149 
females (38.9%) (Table 3.1).  There was a male predominance found overall (p<0.01) 
with higher frequency of males than females in the anorectal anomalies (ARA) and 
idiopathic constipation (IC) groups (Table 3.1).  In each group there are 52/149 
(34.9%) patients with ARA and the control groups consists of 46/149 (30.9%) patients 
with IC and 51/149 (34.2%) subjects who have undergone an appendectomy (healthy 
controls). 
 
Table 3.1: Distribution of sex in all groups  
Group Male Female Total 
Anorectal Anomalies  33 (63.5%) 19 (36.5%) 52 
Idiopathic Constipation 33 (71.7%) 13 (28.3%) 46 
Healthy controls 25 (49.0%) 26 (51.1%) 51 
Total 91 58 149 
χ2 = 5.44; df 2; p = 0.066 
 
Age groups for the entire sample consisted of two groups i) 103/149 subjects between 
the ages of 11-18 (69.1%) and ii) 46 subjects > 18 years of age (30.9%) (Table 3.2, 
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 Figure 3.1).  There was significantly a higher number of the second age group 
(>18 years) in the healthy controls (p<0.0001) in comparison to ARA and IC groups 
(Table 3.2).  There was a significance between age and gender (p = 0.009) with a 
higher frequency of males between the ages 11-18 years (70 males; 33 females) than 
subjects > 18 years of age (21 males; 25 females).  
 
Table 3.2: Distribution of age groups in all groups  
Groups 11-18 years > 18 years Total Mean (+/- SD) 
Anorectal Anomalies  43 (82.7%) 9 (17.3%) 52 16.04 (+/- 7.37) 
Idiopathic 
Constipation 
39 (84.8%) 7 (15.2%) 46 15.76 (+/-4.89) 
Healthy controls 21 (41.2%) 30 (58.8%) 51 23.63 (+/-8.66) 
Total 103 46 149 18.55(+/-8.05) 
χ2 = 28.44; df 2; p <0.0001 
Figure 3.1: Age Distribution of all  Groups
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 3.1.2 Ethnicity 
 
Ethnicity was divided into the following groups: Caucasian, Asian, African-Caribbean 
or those who did not wish to state their ethnicity (‘not stated’). Overall, the majority 
of our population were Caucasian in the total study population (73/149) (49.0%) 
(Table 3.3).  There was significantly a higher distribution of Asian ethnicity (16/23) 
(69.6%) in healthy controls, in comparison to IC (1/23) (4.31%) and ARA (6/23) 
(2.61%) (p = 0.005) (Table 3.3). 
 
Table 3.3: Distribution of ethnicity in all groups  
Group Caucasian Asian African-
Caribbean 
Not-stated Total 
Anorectal 
Anomalies  
28 (53.8%) 6 (11.5%) 3 (5.8%) 15 (28.8%) 52 
Idiopathic 
Constipation 
23 (50.0%) 1 (2.2%) 3 (6.5%) 19 (41.3%) 46 
Healthy controls 22 (43.1%) 16 (31.4%) 1 (2.0%) 12 (23.5%) 51 
Total 73 23 7 46 149 
χ2 = 18.61; df 6; p < 0.005 
 
3.1.3 Gestation  
 
The gestation period ranged from 27 to 43 weeks gestation (Mean 37.3 +/- 2.81) 
(Figure 3.2).  There was a significantly longer gestation period found in ARA than IC 
(p<0.0001, Mann Whitney test) in the study population.  
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3.2 ANORECTAL ANOMALY GROUP 
 
As discussed in Chapter 1, in this thesis we will be using the Wingspread 
International Classification in order to analyse the results.  In the ARA sample, there 
were 7 patients with a low defect, 13 with intermediate and 23 with a high defect and 
9 patients unknown (Table 3.4).  Classifying them in terms of type of anorectal 
anomalies can be difficult due to the lack of documentation, however in our 
population 29/52 were specified: 4 cloaca, 6 anorectal agenesis, 4 rectovesical fistula, 
3 rectourethral fistula, 2 rectovulvar fistula, 1 sacral agenesis, 1 anal stenosis, 1 
rectovaginal, 4 rectovestibular fistula and 3 no fistula.  There was a male 
predominance found in each classification which was significant (p<0.03) (Figure 
3.3). 
Figure 3.2: Distribution of  Gestation  Period
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Table 3.4: Wingspread international classification for anorectal anomalies 
Group Male Female Total 
High  17 (73.9%) 6 (26.1%) 23 
Intermediate 5 (38.5%) 8 (61.5%) 13 
Low 5 (71.4%) 2 (28.6%) 7 
Unknown 6 (66.7%) 3 (33.3%) 9 
Total 33 19 52 
χ2 = 4.82; df 3; p = 0.19 
 
 
 
 
 
 
Figure 3.3 Distribution of Wingspread Classification and Sex in 
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 3.2.1 Type of Reconstructive Surgery 
The most common type of reconstructive surgical approach used in our ARA 
population sample was the posterior sagittal anorectoplasty (PSARP) including the 
modified version (Table 3.5).  
 
Table 3.5: Type of Reconstructive Surgery for anorectal anomalies 
Type of reconstructive surgery Number (%) 
Posterior sagittal anorectoplasty (PSARP) 32 (62) 
Abdominal perineal pull through (ABpt) 2 (4) 
Combination of PSARP and ABpt 3 (6) 
* Other 7 (14 
Unknown 8 (15) 
* These included: anal transposition and other perineal pull through 
 
3.2.2 Associated conditions 
 
As mentioned in Chapter 1, ARA occur commonly in multi-anomaly sequences, such 
as the VACTERL (vertebral, anorectal, cardiac, trachea-oesophageal, renal and limb 
(radius).  In our population sample, 24/52 (46%) of patients with ARA had associated 
VACTERL conditions. Other conditions not associated with the VACTERL list were 
found in 8 patients such as: asthma, eczema, ophthalmologic problems, deafness, 
epilepsy, spina bifida and diabetes.  There is a higher incidence of VACTERL in 
patients with a high defect (13/24) (54.2%) in comparison to low (1/24) (4.2%).  One 
patient in our ARA population sample had a history of child physical abuse (Table 
3.6).  
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Table 3.6: Distribution of VACTERL/Other conditions with anorectal 
anomalies classification  
Anorectal Anomalies High Intermediate Low Unknown 
VACTERL 13 8 1 2 
Other Conditions 5 1 1 1 
Total 18 9 2 3 
 
3.3 REPRESENTATION OF OUR CONTROL GROUPS 
 
3.3.1 Idiopathic Constipation 
 
The study sample comprised 46 subjects with IC with 33 males (72%) and 13 females 
(28%) (Table 3.1) diagnosed ≥ 5 years of age.  As discussed in Chapter 1, there is a 
subgroup of patients with functional constipation which have persistent dilation of the 
rectum and/or colon, termed idiopathic megarectum (Holdstock et al., 1970) 
(Gladman et al., 2007).  In our patients with IC, 13/46 (28%) were diagnosed soley 
with a megarectum, 13/46 (28%) with a slow transit and 11/46 (24%) with both a 
megarectum and slow transit.   
 
In our IC population sample, 8/46 (17%) had VACTERL conditions (i.e. not related to 
bowel habit). Other conditions not associated with the VACTERL list were also found 
which included: asthma, eczema, dyslexia, diabetes, obesity, hearing difficulties, 
hypothyroidism, autism, Perthes disease, dysprexia and Ehlers-Danlos syndrome. 
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 3.3.2 Appendectomy (Healthy Controls) 
 
In this thesis, the negative disease control group included patients who have been 
diagnosed with appendicitis and have had surgery (appendectomy).  Thus they are 
categorised as our ‘healthy control’ group. They have been treated for a condition 
entirely separate from the area that our patients ARA and IC individuals share in 
common. The study sample comprised 51 subjects who have had an appendectomy 
with 25 males (49%) and 26 females (51%) (Table 3.1). All subjects had their 
appendectomy more than 1 year ago (1980-2006), prior to taking part in this research.   
Other conditions noted in this group included a variety of symptoms/diseases such as: 
hard of hearing (temporary deafness), asthma, insomnia and three patients had a 
history of haemorrhoids.  As discussed in Chapter 2, all groups filled out the 
Pennebaker Inventory of Limbic Languidnes (PILL) which is a 54 item scale that 
assesses the frequency of common physical symptoms and sensations. This will be 
discussed in Chapter 4 (Part II). 
 
3.4 OTHER TREATMENT MODALITIES  
 
 
3.4.1 Antegrade Continence Enema  
 
As discussed in Chapter 1, a surgical treatment offered to children suffering from 
chronic constipation and FI is the antegrade continence enema (ACE), also known as 
the Malone antegrade continence enema. In our population sample, 40/98 (40.8%) 
patients had an ACE stoma comprising 25 males and 15 females (Table 3.7) with a 
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 mean age of 14 years old (age range 11-19 years old).  In the ACE population, 
21/40 (41%) were ARA (Table 3.7) including 12 with a high, 4 with an intermediate 
and 1 with a low defect anomaly. Additionally, 19/40 (48%) patients with IC have had 
the ACE stoma (Table 3.7), 11 of which have a megarectum.  
 
Table 3.7: Wingspread International Classification in ACE population 
Group Male Female Total 
Anorectal anomalies 12 (57.1%) 9 (42.9%) 21 
Idiopathic Constipation 13 (68.4%) 6 (31.6%) 19 
Total 25 15 40 
Fisher's exact test p = 0.527 
 
In this ACE population, 10/40 (25%) of patients had their ACE stoma closed (Table 
3.8). Reasons for closing the ACE stoma were due to i) success of treatment 
(improved symptoms); ii) non-compliance; iii) no improvement to the patient’s 
symptoms and opted for other treatment modalities; iv) didn’t like the ACE 
(physically and psychologically) and/or v) time consuming to fit in their daily 
lifestyle.  
 
Table 3.8: ACE distribution in patients with anorectal anomalies and idiopathic 
constipation 
Patient Groups Open ACE Closed ACE Total 
Anorectal anomalies 15 (71.4%) 6 (28.6%) 21 
Idiopathic constipation 15 (78.9%) 4 (21.1%) 19 
Total 30 10 40 
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 3.4.2 Medication  
 
As discussed in Chapter 1, patients use a variety of medications to resolve their 
ongoing symptoms such as FI and constipation (Table 3.9). Both stimulant and 
osmotic laxative are the most common type of medication used in our population. In 
our population sample, 33/52 (63.5%) patients with ARA and 41/46 (89.1%) in IC 
have used or are using more than one type of medication to resolve their symptoms. 
There are 6 in ARA and 3 in IC, who currently don’t use any form of medication.  
 
Table 3.9: Use of medication in anorectal anomalies and idiopathic constipation 
Medication Anorectal 
Anomalies 
Idiopathic 
Constipation 
Total 
Bulk forming laxatives 4 (28.6%) 10 (71.4%) 14 
Stimulant laxatives 39 (48.8%) 41 (51.3%) 80 
Faecal softeners 4 (44.4%) 5 (55.6%) 9 
Osmotic laxatives 33 (47.1%) 37 (52.9%) 70 
Bowel cleansing solutions 6 (25.0%) 18 (75.0%) 24 
Pearson χ2 = 5.88; df 4; p = 0.208 
3.5 SYMPTOM SCORES 
 
3.5.1 Knowles-Eccersley-Scott-Symptom (KESS) - Constipation 
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 The Knowles-Eccersley-Scott-Symptom (KESS) questionnaire (Appendix) was 
used to assess for ongoing symptoms of constipation. The total KESS score is the sum 
of all scores gained on individual questions with a maximum possible of 39 points. 
The answers to each question were worded such that any patient who fitted agreed 
criteria (Whitehead, 1991) for  constipation would be likely to score at least one point 
per question.  A score of ≥ 5 points was considered abnormal in this thesis and a score 
of >12 were considered severe ongoing symptoms of constipation.  The highest mean 
score was found in the IC group (15.48 +/-8.43) in comparison to ARA and healthy 
controls (Table 3.10, Figure 3.4).  Statistical analysis included a 1-way ANOVA, with 
a significantly higher KESS score found in patients with IC (<0.0001) compared to 
ARA and healthy controls (Adjusted r
2
 0.2874). Overall a total of 53/149 (36%) had 
severe constipation according to the KESS score (Table 3.10), with IC having the 
highest number (32/149) (21.5%) (Table 3.10).    
 
 
 
Table 3.10: Summary of KESS scores in all groups 
Groups Score < 5 Score 5-12 Score > 12 Mean (+/-SD) 
*
 CI of mean 
Anorectal anomalies 20 (37.0%) 16 (38.1%) 16 (30.2%) 8.48 (+/-6.317) 
(6.722-10.24) 
Idiopathic 
constipation 
7 (13.0%) 7 (16.7%) 32 (60.4%) 15.48 (+/-8.427) 
(12.98-17.98) 
Healthy controls 27 (50.0%) 19 (45.2%) 5 (9.4%) 5.176 (+/-4.573) 
(3.890-6.463) 
Total 54  42 53  
* CI of mean (Lower - Upper 95%)  
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There was no significant relationship between age of subject and KESS score (Figure 
3.5).  Linear regression analysis can be demonstrated in Figure 3.5 (r² = 0.028). 
Figure 3.4: The KESS Score (Constipation) in all groups
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Figure 3.5: Linear regression of age and  KESS scores in all groups
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 3.5.2 Vaizey Incontinence Score 
 
The ‘Vaizey Incontinence Questionnaire’ consists of seven questions. A score of 0 
suggests no problems with bowel continence (complete continence), and a score of 24 
suggests very severe problems with incontinence (complete incontinence). A Vaizey 
Incontinence score of at least 12 is considered poor (Deutekom et al., 2007, Deutekom 
et al., 2005) (Dobben et al., 2007) (Terra et al., 2006a, Terra et al., 2006b) (Terra et 
al., 2008) (Felt-Bersma et al., 2007).  The IC had a higher mean Vaizey Incontinence 
score (7.26 SD +/- 7.01) in comparison to ARA and healthy controls (Table 3.11, 
Figure 3.6).   Partial to full incontinence was evident in 11/13 and 12/13 patients with 
a megarectum and slow transit respectively (Table 3.12) 
 
Statistical analysis included a 1-way ANOVA (Kruskal Wallis), with a significantly 
higher Vaizey score found in patients with ARA (<0.0001) and IC (0.0002) compared 
healthy controls (Adjusted r
2
 0.1989).  
 
Table 3.11: Summary of Vaizey Incontinence scores in all groups 
Groups Perfect 
Continence 
Partial 
Incontinence 
Full Incontinence Mean (+/-SD) 
N
 CI of mean 
Anorectal 
anomalies 
20 (27.0%) 21 (58.3%) 11 (44.0%) 5.87 (+/-6.639) 
(4.017-7.714) 
Idiopathic 
constipation 
14 (18.9%) 16 (44.4%) 16 (64.0%) 7.26 (+/-7.006) 
5.180-9.341) 
Healthy 
controls 
41 (55.4%) 10 (27.8%) 0 (0.0%) 0.63 (+/1.496) 
(0.2067-1.048) 
Total 74 36 25  
N CI of mean (Lower - Upper 95%) 
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Table 3.12: Vaizey incontinence score in patients with IC and megarectum  
 Perfect 
Continence 
Partial 
continence 
Full 
incontinence 
TOTAL 
Megarectum 2 4 7 13 
Slow transit 1 6 6 13 
Megarectum & 
slow transit 
7 3 1 11 
* 
Unknown 4 3 2 9 
* 
Absence of information within medical notes 
Figure 3.6: Vaizey Incontinence scores for patient groups
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There was no significant relationship between age of subject and KESS score (Figure 
3.7).  Linear regression analysis can be demonstrated in Figure 3.7 (r² = 0.076). 
 
3.5.3 Symptom scores and ACE  
 
On the KESS score, IC had significantly a higher KESS mean score of 18.79 (+/-8.08) 
compared to ARA 10.19 (+/-8.08) (p<0.001 Mann Whitney t test) (Table 3.13).  A 
score of >12 is considered severe constipation, which was found mostly in the IC 
group (16/19) (84.2%) compared to ARA (8/21) (38.1%).  
 
On the Vaizey Incontinence Score, IC had a higher total mean score 9.74 (+/-6.95) 
compared to ARA 5.86 (+/-5.42), yet there was no statistical significance (Table 
3.14).  In IC, there are a higher number of patients who are fully incontinent (10/19) 
Figure 3.7: Linear regression of age and Vaizey Incontinence  score in all groups
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 (52.6%) compared to perfectly clean (3/19) (15.8%) compared to ARA group 
(5/21, 3/21 respectively) (Table 3.13).  
 
Table 3.13: Distribution of KESS Score in the ACE population 
Groups Score < 5 
  
Score > 5 Mean (+/-SD) 
(Range) 
*
 CI of mean 
Anorectal anomalies 6 (75.0%) 15 (46.9%) 10.19 (+/-18.79) 
(1-25) 
7.15-13.24 
Idiopathic constipation 2 (25.0%) 17 (53.1%) 18.79 (+/-8.08) 
(3-30) 
14.90-22.68 
Total 8 32  
* CI of mean (Lower - Upper 95%)  
Fisher's exact test p = 0.241 
 
 
Table 3.14: Distribution of Vaizey Incontinence scores in the ACE population 
Groups Perfect 
Continence 
Partial 
Incontinence 
Full 
Incontinence 
Mean (+/-SD) 
(Range) 
* 
CI of mean 
Anorectal 
anomalies 
5 (62.5%) 13 (68.4%) 3 (23.1%)  5.86 (+/-5.42) 
(0-20) 
3.39-8.32 
Idiopathic 
constipation 
3 (37.5%) 6 (31.6%) 10 (90.9%)  9.74 (+/-6.95) 
(0-22) 
6.39-13.09 
Total 8 19 13  
*
 
CI of mean (Lower - Upper 95%)  
 
 195
 
 
 
 
 
 
 
 
 
CHAPTER 4 
RESULTS (Part II) 
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4.0 RESULTS Part II 
 
4.1 PSYCHOSOCIAL AND QOL MEASURES 
As discussed in Chapter 2, psychosocial measures for this thesis included specific 
measures of quality of life (specific to gastrointestinal symptoms), coping 
mechanisms, depression, anxiety, personality, general health and level of hopefulness 
(Table 2.4).  This chapter will provide a detailed analysis for each psychosocial 
measure, correlating it with symptom scores as discussed in Chapter 3.  Lastly, an 
overview of the psychosocial measures in the ACE population will be presented 
separately. 
 
4.1.1 The Gastrointestinal Quality of Life Index Questionnaire (GIQOL) 
 
As discussed in Chapter 2, the gastrointestinal quality of life index (GIQLI) contains 
up to 36 items, scored on a five point Likert scale (range 0-144, higher score = better 
quality of life), in which additional modules specified by the particular 
gastrointestinal disease, supplement a set of core questions. It consists of five 
subscales: physical well being, gastrointestinal digestion, gastrointestinal defecation, 
mental well being and other which is summarized in an overall score. The lowest total 
GIQOL mean score was found in the IC group (101.4 SD+/-20.69) in comparison to 
ARA and healthy controls (Table 4.1, Figure 4.1).  In addition to the total GIQOL 
score, IC had the lowest mean score in the majority of the GIQOL subgroups in 
comparison to ARA and healthy controls (Table 4.1)  
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Statistical analysis included a 1-way ANOVA (Krushkal-Wallis test, Dunn’s Multiple 
Comparison test), indicating significance between the three groups (Adjusted r
2
 = 
0.152). There is a significantly poorer total GIQOL score found in patients with IC 
compared to healthy controls (p<0.001) and ARA compared to healthy controls 
(p<0.01) (Figure 4.1).  There was no significant difference found between ARA and 
IC (p>0.05).  The poorest GIQOL scores for physical well being was significantly 
poorer in patients with IC compared to ARA (p<0.01) and IC compared to healthy 
controls (p<0.001) (Table 4.1) (Figure 4.2 A).  Additionally, ARA had significantly 
poorer GIQOL scores for physical well being compared to healthy controls (p<0.01).  
IC had significantly poorer GIQOL scores for gastrointestinal digestion symptoms 
compared to healthy controls (p<0.01) (Table 4.1) (Figure 4.2 B).  ARA had 
significantly poorer GIQOL life scores for gastrointestinal defaecation symptoms 
compared to healthy controls (p<0.001) and IC also had poorer GIOQL scores for 
gastrointestinal symptoms compared to healthy controls (p<0.01) (Table 4.1) (Figure 
Figure 4.1: Gastrointestinal Quality of  Life (GIQOL) Scores
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 4.2 C).  In terms of mental state, ARA had significantly poorer GIOQL score to 
healthy controls (<0.05) and IC had significantly poorer mental state to healthy 
controls (p<0.001).  Items not included in a subscale (‘other’) included questions on 
restricted eating, wake up at night, bothered by treatment, worsened relations and 
dysphasia.  ARA had poorer GIQOL ‘other’ scores, compared to healthy controls 
(p<0.01) and IC had also poorer GIQOL scores for ‘other’ compared to healthy 
controls (p<0.01).  
Table: 4.1: Statistical Analysis for GIQOL scores for all Groups 
Subject Groups 
 
 
 
(Score range) 
Anorectal 
Anomalies 
Mean (+/-SD) 
(Range) 
* CI of mean 
Idiopathic 
Constipation 
Mean (+/-SD) 
Range 
CI of mean 
Healthy controls 
Mean (+/-SD) 
Range 
CI of mean 
GIQOL Total   
(0-144) 
110.2 (+/-24.05) 
(49-144) 
103.5-116.9 
101.4 (+/-3.05) 
(35-141) 
95.29-107.6 
123.5 (+/-5.58) 
(77-144) 
119.0-127.9 
Subgroups     
Physical well being  
(0-40) 
30.44 (+/-7.14) 
(10-40) 
28.46-32.43 
26.04 (+/-6.68) 
(7-40) 
24.06-28.03 
34.12 (+/-5.58) 
(13-40) 
32.55-35.69 
Gastrointestinal 
digestion  
(0-40) 
30.60 (+/-7.02) 
(11-40) 
28.64-32.55 
28.17 (+/-7.01) 
(15-40) 
26.09-30.26 
33.08 (+/-5.43) 
(20-40) 
31.55-34.61 
Gastrointestinal 
defaecation  
(0-24) 
19.31 (+/-4.27) 
(6-24) 
18.12-20.50 
19.54 (+/4.34) 
(6-24) 
18.25-20.83 
21.92 (+/-3.3) 
(7-24) 
20.99-22.86 
Mental well being  
(0-20) 
14.13(+/-4.77) 
(3-20) 
12.81-15.46 
13.35 (+/-4.25) 
(4-20) 
12.08-14.61 
16.41 (+/-3.52) 
(6-20) 
15.42-17.40 
Other  
(0-20) 
15.50 (+/-4.02) 
(4-20) 
14.38-16.62 
15.24 (+/-4.13) 
(1-20) 
14.01-16.47 
17.75 (+/-2.73) 
(10-20) 
16.98-18/51 
* Lower –Upper 95% CI of mean 
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 Figure 4.2 GIQOL Subgroup Scores for all groups (A: Physical well being; B: Gastrointestinal digestion; C: Gastrointestinal defaecation; D: 
Mental well being) 
 
Figure 4.2  (A) Physical well being
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Figure 4.2 (B) Gastrointestinal Digestion
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Figure 4.2 (C) Gastrointestinal Defaecation
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Figure 4.2 (D) Mental well being
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4.1.1.1 Relationship with GIQOL and Symptoms Scores 
 
Statistical analysis included a Fisher's exact test to evaluate the relationship between 
GIQOL and symptoms scores.  Subjects who had a higher KESS score, significantly 
had poorer GIQOL scores (65/81) compared to those with normal KESS scores 
(16/81) (p<0.0001) (Table 4.2, 4.4, Figure 4.3).  There was a significant difference 
with GIQOL and Vaizey Incontinence Scores, whereby subjects with full 
incontinence significantly had poorer GIQOL compared to good GIQOL (p<0.0001 
χ2
 
22.16, df 2) (Table 4.3, 4.4, Figure 4.4) 
 
Table 4.2: Relationship between GIQOL and KESS scores 
GIQOL Poor GIQOL Good GIQOL Total 
* KESS <5 16 (29.1%) 39 (40.1%) 55 
KESS ≥ 5 65 (69.1%) 29 (30.9%) 94 
Total 81 68 149 
* KESS < 5 (normal); ≥ 5 (abnormal); Fisher's exact test p<0.0001 
 
Table 4.3: Relationship between GIQOL and Vaizey Incontinence scores 
GIQOL Poor GIQOL Good GIQOL Total 
Full continence 30 (40.0%) 45 (60.0%) 75 
Partial Incontinence 26 (55.3%) 21 (44.7%) 47 
Full Incontinence 25 (92.6%) 2 (7.4%) 27 
Total 81 68 149 
χ2 = 22.16; df 2; p < 0.0001 
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Additionally, there was a significant relationship between poor quality of life and high 
KESS score (p < 0.003) and high Vaizey incontinence score (p<0.02) in patients with 
ARA (Table 4.4).  There was no significant relationship between type of anorectal 
defect and GIQOL score.  Healthy controls who had abnormal KESS scores (24/51) 
(47.1%), had significantly poorer GIQOL scores (12/24) (50.0%) than those with 
normal KESS score with poor GIQOL score 3/27) (11.1%) (p<0.005) (Table 4.4).  
 
Figure 4.4: Relationsihp between GIQOL and Vaizey Score
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Figure 4.3: Relationship between GIQOL and KESS
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Table 4.4: GIQOL with symptoms scores 
GIQOL  Good GIQOL Poor GIQOL 
 ARA (%/Total) IC (%/Total) HC (%/Total) ARA (%/Total) IC (%/Total) HC (%/Total) Total 
Symptom Scores        
KESS 
< 5 (normal) 
> 5 (abnormal) 
 
15 (65%) 
8  (35%) 
 
0 
9  (100%) 
 
24  (67%) 
12  (33%) 
 
6  (21%) 
23 (79%) 
 
7  (19%) 
30 (81%) 
 
3  (20%) 
12 (80%) 
 
Total 23 9 36 29 37 15 149 
VAIZEY 
Full continence 
Partial Incontinence 
Full Incontinence 
 
12 (52%) 
10 (43%) 
1  (4%) 
 
2  (2%) 
6  (66%) 
1  (1%) 
 
31 (86%) 
5  14%) 
0 
 
8  (28%) 
11 (38%) 
10 (34%) 
 
12 (32%) 
10 ((27%) 
15 (41%) 
 
10 (67%) 
5  (33%) 
0 
 
Total 23 9 36 29 37 15 149 
Legend: ARA (anorectal anomalies); IC (idiopathic constipation); HC (healthy controls)
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4.1.2 Hunter Opinions and Personal Expectations Scale (HO.P.E.S)  
 
The purpose of Hunter Opinions and Personal Expectations Scale (HO.P.E.S) was to 
measure personal hopefulness, focusing on essential components such as wish or 
desire and/or expectation and future orientation.  As discussed in Chapter 2, the 
overall score from the H.O.P.E.S measure (i.e. Hope subscale + 40 – Despair 
subscale) is best described as a measure of ‘global personal hopefulness’ (GPH) 
(Nunn, 1996a).  
 
The highest GPH score was found in healthy controls compared to ARA and IC 
(Table 4.2, Figure 4.5), however there was no significance relationship between these 
groups (p> 0.05; Adjusted r
2
 = 0.002).  Additionally, there was no significant 
differences between the three groups for the hopes and despair subgroups (p>0/05) 
(Table 4.5) 
 
Table 4.5: Mean scores for Global Personal Hopefulness in all groups 
Groups Anorectal 
Anomalies 
Idiopathic 
constipation 
Healthy controls 
GPH  
 (Mean (+/-SD) 
 
56.85 (+/-14.67) 
 
54.46 (+/-15.36) 
 
59.49 (+/-10.75) 
* CI of mean 52.8-60.9 49.9-59.0 56.5-62.5 
Hopes Subgroup 27.1 (+/-9.26) 25.13 (+/-8.60) 29.3(+/-6.53) 
Despair subgroup 10.3 (+/-9.32) 9.28 (+/-8.28) 9.82 (+/-6.12) 
* Lower –Upper 95% CI of mean
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Statistical analysis included Fisher's exact test to evaluate the relationship between 
GPH and GIQOL measure. Subjects with good GIQOL score correlated significantly 
with normal GPH (p<0.005) (Table 4.6).  Additionally, there was no significant 
relationship between GPH score and symptom scores in the population sample. 
 
Table 4.6: Relationship between GIQOL and Global Personal Hopefulness 
 Poor GIQOL Good GIQOL Total 
Normal GPH 52 (47.3%) 58 (52.7%) 110 
Low GPH 29 (74.4%) 10 (25.6%) 39 
Total 81 68 149 
Fisher's exact test p<0.005 
4.1.3 Pennebaker Inventory of Limbic Languidness (PILL) 
 
The Pennebaker Inventory of Limbic Languidnes (PILL) (Appendix) is a 54 item 
scale that assesses the frequency of common physical symptoms and sensations 
(Pennebaker, 1993).   
Figure 4.5: Global Personal Hopefulness (GPH) in all groups
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 Table 4.7: Mean scores for PILL in all groups 
Groups Anorectal 
Anomalies 
Idiopathic 
constipation 
Healthy controls 
Mean (+/-SD) 45.35 (31.1+/-) 12.72 (12.26+/-) 40.55 (26.96+/-) 
* CI of mean 36.6-54.1 9.08-16.36 33.0-48.1 
 
Idiopathic constipation had the lowest mean PILL score compared to ARA and 
healthy controls (Table 4.7, Figure 4.6). Statistical analysis included a 1-way 
ANOVA (Krushkal-Wallis test), indicating a significance between the three groups 
(Adjusted r
2
 = 0.2341). There was significantly lower PILL score in the IC group 
compared to healthy controls (p<0.0001) and ARA (p<0.001). There was no 
significant relationship between PILL and GIQOL and symptom scores.  
 
4.1.4 Cognitive Emotion Regulation Questionnaire (CERQ) 
 
The CERQ distinguishes nine different cognitive coping strategies, each consisting of 
four items measured on a 5-point Likert scale and each referring to what someone 
thinks after the experience of a stresssful life event (Refer to Chapter 2).  
 
Means, standard deviations and confidence intervals for the total CERQ score and 
subgroups are presented in Table  4.8.  Statistical analysis included a 1-way ANOVA 
(Krushkal-Wallis test, Dunn’s Multiple Comparison test), indicating a significance 
difference in overall coping mechanisms between ARA and healthy controls (p<0.05) 
(Figure 4.7).  Reasons for this comparison can be shown by observing the different 
coping mechanisms used mostly by that group (Table 4.8). ARA significantly used 
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significantly more positive reappraisal (p<0.05) and putting into perspective (p<0.01) 
as a way of coping under stressful situations in comparison to healthy controls (Table 
4.8).   
Figure 4.7: Cognitive Emotion Regulation Questionnaire (CERQ) scores in all
groups
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Figure 4.6: Pennebaker Inventory of Limbic Languidnes (PILL)  scores in all
groups
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Table 4.8: The Cognitive Emotion Regulation Questionnaire (CERQ) scores for all groups 
Groups Anorectal Anomalies Idiopathic Constipation Healthy controls 
 Mean (+/-SD) * CI of mean Mean (+/-SD)  CI of mean (Mean (+/-SD) * CI of mean 
Total  CERQ Score 92.45 (+/-19.49) 86.5-98.4 95.17 (+/-20.15) 89.2-101.2 101.4 (+/-17.63) 96.4-106.3 
Subgroups       
Self-blame 9.09 (+/-3.46) 8.0-10.1 9.17 (+/-3.68) 8.0-10.3 9.37 (+/-3.39) 8.2-10.3 
Acceptance 11.30 (+/-3.88) 10.1-12.5 11.87 (+/-4.26) 10.6-13.1 12.43 (+/-3.18) 11.5-13.3 
Rumination 9.71 (+/-3.81) 8.5-10.9 11.30 (+/-3.86) 10.2-12.5 11.25 (+/-3.85) 10.2-12.3 
Positive Refocusing 10.5 (+/-3.63) 9.4-11.6 11.2 (+/-4.37) 9.9-12.5 10.75 (+/-4.02) 9.6-11.9 
Planning 11.25 (+/-3.55) 10.2-12.3 11.50 (+/-3.45) 10.5-12.5 13.61 (+/-3.05) 12.8-14.5 
Positive Reappraisal 11.05 (+/-3.33) 10.0-12.1 12.04 (+/-4.20) 10.8-13.3 13.06 (+/-3.36) 12.1-14.0 
Putting into Perspective 11.20 (+/-3.53) 10.1-12.3 11.93 (+/-3.97) 10.8-13.1 13.55 (+/-3.21) 12.7-14.5 
Catastrophising 8.80 (+/-3.57) 7.7-9.9 9.20 (+/-3.36) 8.2-10.2 8.71 (+/-2.94) 7.9-9.5 
* Lower –Upper 95% CI of mean 
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4.1.5 Depression 
 
Depression in children between 7-17 years of age was assessed by using the 
Children's Depression Inventory (CDI) and the Beck Depression Inventory (BDI-II) 
instrument was used for screening the severity of depression in adults (Refer to 
Chapter 2).  Means and standard deviations for both CDI and BDI scores are 
presented in Table  4.9. 
 
Table 4.9: Mean and standard deviation scores for CDI and BDI  
Depression Scores CDI 
Mean (+/-SD)  
BDI 
Mean (+/-SD) 
Anorectal Anomalies 7.36 (+/-8.22) 26.0 (+/-22.63) 
Idiopathic Constipation 10.12 (+/-9.56) 23.0 (+/-14.14) 
Healthy controls 9.14 (+/-7.26) 25.5 (+/-30.41)  
 
Table 4.10: Distribution of depression in all Groups 
Depression Scores Depressed  Normal Total 
Anorectal Anomalies  10 (19.2%) 42 (80.8%) 52 
Idiopathic Constipation  13 (28.3%) 33 (71.7%) 46 
Healthy controls  4 (7.8%) 47 (92.2%) 51 
Total 27 122 149 
χ2 = 6.86; df 2; p < 0.03 
 
Overall, 27/149 (18%) of our population sample were diagnosed to have clinical 
depression.  Statistical analysis using χ2
 
indicated a higher number of depressed 
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subjects in groups ARA (10/52) (19.2%) and IC (13/46) (28.3%) (p<0.03 χ2
 
= 6.86; df 
2) in comparison to healthy controls (4/51) (7.8%) (Table 4.10).  There was no 
significant relationship with symptom scores and depression measures. Subjects who 
are depressed significantly had poorer GIQOL scores in comparison to those not 
depressed using Fisher's exact test (p<0.0005) (Table 4.11).  
 
Table 4.11: Relationship between GIQOL and depression 
 Normal Depressed Total 
Poor GIQOL 58 (71.6%) 23 (28.4%) 81 
Good GIQOL 64 (94.1%) 4 (5.9%) 68 
Total 122 27 149 
Fisher's exact test p < 0.0005 
 
Subjects who score normal on the global personal hopefulness (GPH) are significantly 
less likely to be depressed in comparison to those who have a low GPH (p<0.0001) 
(Table 4.12).  
 
Table 4.12: Relationship between depression and Global Personal Hopefulness 
 Normal Depressed Total 
Normal GPH* 100 (90.9%) 10 (9.1%) 110 
Low GPH 22 (56.4%) 17 (43.6%) 39 
Total 122 27 149 
* GPH (global personal hopefulness) Fisher's exact test p < 0.0001 
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4.1.6 Anxiety 
 
The State-Trait Anxiety Inventory for Children (STAIC) and the State-Trait Anxiety 
Inventory (STAI) (Spielberger, 1970) (Appendix) which measures anxiety in 
adolescents/adults were used in this thesis (Refer to Chapter 2).  Means and standard 
deviations for both STAIC and STAI scores are presented in Table 4.13. 
 
Table 4.13: Mean and standard deviation scores for STAIC and STAI  
Anxiety 
Scores 
STAIC 
Mean (+/-SD)  
STAI 
Mean (+/-SD) 
 State  Trait State Trait 
Anorectal 
Anomalies 
28.95 (+/-4.35) 34.18 (+/-8.89) 34.23 (+/-11.35) 40.97 (+/-14.21) 
Idiopathic 
Constipation 
34.80 (+/-9.20) 34.20 (+/-6.83) 40.78 (+/-13.01) 43.05 (+/-13.24) 
Healthy 
controls 
32.67 (+/-11.72) 37.00 (+/-3.61) 35.29 (+/-11.26) 38.54 (+/-10.38) 
 
Table 4.14: Distribution of High State/Trait anxiety in all groups 
Anxiety scores High Trait Anxiety High State Anxiety 
Anorectal Anomalies  22 (35.5%) 10 (19.6%) 
Idiopathic Constipation  23 (37.1%) 24 (47.1%) 
Healthy controls  17 (27.4%) 17 (33.3%) 
Total 62 51 
χ2 = 3.48; df 2; p = 0.175 
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Overall, 62/149 (42%) of our population sample were diagnosed to have high trait 
anxiety and 51/149 (34%) with high state anxiety.  Statistical analysis using χ2 
indicated no significance difference between the three groups (Table 4.14). Subjects 
with perfect continence significantly indicate normal ‘state’ anxiety levels in 
comparison to those with partial and full incontinence (p<0.0005 χ2 = 15.11; df 2) 
(Table 4.15). There was no significant association with ‘trait’ anxiety and Vaizey 
Incontinence scores (Table 4.15).  There was no significant association between 
anxiety scores and KESS scores.  
 
Table 4.15: Relationship between Vaizey Incontinence scores and anxiety 
Anxiety scores State Anxiety Trait Anxiety 
 Normal High Normal High 
Perfect continence 57 (55.9%) 18 (38.3%) 47 (54.0%) 28 (45.2%) 
Partial incontinence 35 (34.3%) 12 (25.5%) 30 (34.5%) 17 (27.4%) 
Full incontinence 10 (9.8%) 17 (36.2%) 10 (11.5%) 17 (27.4%) 
Total 102 47 87 62 
State anxiety: χ2 = 15.11; df 2; p < 0.0005; Trait anxiety: χ2 = 6.20; df 2; p = 0.05 
 
Subjects with poor GIQOL score significantly have higher state (p<0.001) and trait 
(p<0.0001) anxiety compared to subjects with good GIQOL scores (Fisher's exact 
test) (Table 4.16).  
 
Table 4.16: Relationship between GIQOL and anxiety  
Anxiety scores State Anxiety Trait Anxiety 
 Normal High Normal High 
Poor GIQOL 46 (45.1%) 35 (74.5%) 35 (40.2%) 46 (74.2%) 
Good GIQOL 56 (54.9%) 12 (25.5%) 52 (59.8%) 16 (25.8%) 
Total 102 47 87 62 
State anxiety: Fisher's exact test p< 0.001 Trait anxiety: Fisher's exact test p< 0.0001 
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Subjects with poor global personal hopefulness (GPH) scores significantly have 
higher state (p<0.0002) and trait (p<0.0001) anxiety compared to subjects with good 
GPH scores (Fisher's exact test) (Table 4.17).  
 
Table 4.17: Relationship between Global Personal Hopefulness and anxiety  
Anxiety scores State Anxiety Trait Anxiety 
 Normal High Normal High 
Normal GPH* 85 (83.3%) 25 (53.2%) 73 (83.9%) 37 (59.7%) 
Low GPH 17 (16.7%) 22 (46.8%) 14 (16.1%) 25 (40.3%) 
Total 102 47 87 62 
* GPH (global personal hopefulness); State anxiety: Fisher's exact test p< 0.0002 
Trait anxiety: Fisher's exact test p< 0.0001 
 
Subjects who are depressed, significantly have higher state (p<0.0001) and trait 
(p<0.0001) anxiety compared to subjects who are not depressed (Fisher's exact test) 
(Table 4.18).  
 
Table 4.18: Relationship between depression and anxiety  
Anxiety scores State Anxiety Trait Anxiety 
 Normal High Normal High 
Normal 97 (95.1%) 25 (53.2%) 86 (98.9%) 36 (58.1%) 
Depressed 5 (4.9%) 22 (46.8%) 1 (1.15%) 26 (41.9%) 
Total 102 47 87 62 
State anxiety: Fisher's exact test p< 0.0001 Trait anxiety: Fisher's exact test p< 0.0001 
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4.1.7 Big Five Inventory 
 
The Big Five Inventory (BFI) consist of 44 questions desgined to separate each 
patients personality into five dimentions: extroversion, agreeableness, 
conscientiousness, neuroticism and openess as discussed in Chapter 2 (John, 1991). 
The BFI - Transition to College (BFI-TTC) was administered to young adolescents 
(11-16 years of age). Means and standard deviations for both BFI and BFI-TTC 
scores are presented in Table  4.20.  Overall, in our population sample 83/142 (58%) 
are extroverts, 84/142 (59%) agreeable, 88/142 (62%) conscientious, 79/142 (56%) 
neurotic and 90/142 (63%) openness (Table 4.19).  Figure 4.8 demonstrates the 
distribution of personality traits within in each group.   Statistical analysis using χ2 
indicated no significant difference between the three groups.   
 
Table 4.19: Distribution of Personality traits in all groups 
Groups Anorectal 
Anomalies 
Idiopathic 
constipation 
Healthy 
controls 
Total 
Extroversion 25 (30.1%) 26 (31.3%) 32 (38.6%) 83 
Agreeableness 27 (32.1%) 19 (22.6%) 38 (45.2%) 84 
Conscientiousness 29 (33.0%) 24 (27.6%) 35 (39.8%) 88 
Neuroticism 25 (31.6%) 29 (36.7%) 25 (31.6%) 79 
Openess 29 (32.2%) 24 (26.7%) 37 (41.1%) 90 
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Table 4.20: The Big Five Inventory scores for all groups  
Groups Anorectal Anomalies 
Mean (+/-SD) 
Idiopathic Constipation 
Mean (+/-SD) 
Healthy controls 
Mean (+/-SD) 
 BFI  BFI-TTC BFI  BFI-TTC BFI  BFI-TTC 
Extroversion 3.28 (+/-1.00) 3.57 (+/-0.64) 3.48 (+/-1.06) 3.71 (+/-0.56) 3.58 (+/-0.77) 3.83 (+/-0.55) 
Agreeableness 4.01 (+/-0.61) 3.31 (+/-0.72) 3.71 (+/-0.91)  3.15 (+/-0.59) 3.96 (+/-0.55)  3.60 (+/-0.714) 
Conscientiousness 3.49 (+/-0.822) 3.16 (+/-0.77) 3.42 (+/-1.05) 3.35 (+/-0.70) 3.78 (+/-0.59) 3.28 (+/-0.91) 
Neuroticism 3.14 (+/-1.16) 3.37 (+/-0.58) 3.30 (+/-1.49) 3.36 (+/-0.66) 2.72 (+/-0.78) 3.51 (+/-0.54) 
Openness 3.69 (+/-0.75) 3.54 (+/-0.80) 3.70 (+/-0.78) 3.36 (+/-0.72) 3.56 (+/-0.67) 3.70 (+/-0.614) 
 
Figure 4.8 Distribution of Personality traits in all groups
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Extroversion significantly correlated to lower global personal hopefulness (GPH) 
scores (24/38)  (63.2%) in comparison to introversion (14/38) (36.9%) (Fisher's exact 
test p<0.002).  Higher PILL scores significantly correlated with extroversion (27/32) 
compared to introversion (5/32) (15.6%) (p<0.0001).  Neuroticism significantly 
correlated with lower GPH scores (28/38) (73.7%) compared to normal GPH scores 
(10/38) (26.3%) (p<0.01). Additionally, neuroticism significantly correlated with high 
state (33/46) (71.8%) and high trait anxiety (42/62) (67.7%) compared to subjects 
who were not identified to have neurotic personality traits (p<0.01).  
 
4.1.8 General Health Questionnaire-28 (GHQ-28) 
 
General Health Questionnaire-28 (GHQ-28) (Goldberg, 1978) is a self-administered 
screening instrument revealing individuals with diagnosable psychiatric disorder. As 
discussed in Chapter 2, a cut-off scores less than five is indicated as a ‘probable non-
case’ and all those more than or equal to five as ‘probable cases’.  Means and standard 
deviations for GHQ scores are presented in Table  4.21.  Overall, 21/91 (23%) of our 
population sample, have a probable case of a psychiatric illness. Statistical analysis 
using χ2 indicated no significance difference between the three groups (Table 4.22).   
 
Subjects with probable case of psychiatric illness significantly correlated with poorer 
GIQOL scores (p<0.001), lower global personal hopefulness (p<0.0007), depression 
(p<0.001), high state and trait anxiety (p<0.0002), neuroticism (p<0.0001) and place 
more emphasis on their physical health (p<0.006) compared to subjects who are not a 
probable case.  
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Table 4.21: Mean and standard deviation scores for GHQ-28 
 GHQ-28 
Mean (+/-SD)  
Anorectal Anomalies 4.59 (+/-6.49) 
Idiopathic Constipation 8.47 (+/-9.13) 
Healthy controls 3.47 (+/-5.70) 
 
Table 4.22: Distribution of probable psychiatric cases in all groups 
GHQ-28 Probable case Non Probable case Total 
Anorectal Anomalies  4 (19.0%) 17 (81.0%) 21 
Idiopathic Constipation  7 (29.2%) 17 (70.8%) 24 
Healthy controls  10 (21.7%) 36 (78.3%) 46 
Total 21 70 91 
χ2 = 0.74; df 2; p = 0.691 
 
4.1.9 Weinberger Adjustment Inventory (WAI) 
 
The Weinberger Adjustment Inventory (WAI) (Weinberger, 1991) was designed to 
perationalize distress and self-restraint as dimension of social-emotional adjustment. 
It also includes scales of response and can be used as a ‘lie detector’ which will be use 
in this thesis. Means and standard deviations for WAI scores are presented in Table  
4.23.  Statistical analysis using χ2 indicated no significance difference between the 
three groups.  Lie detection was included to see how truthfully our subjects were 
answering the questions. There were 140/149 (94%) who completed the WAI 
questionnaire, with 14/140 (10%) detected of lying (Table 4.23).  
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Table 4.23: Mean scores for Weinberger Adjustment Inventory (WAI) in all 
groups  
Groups Anorectal 
Anomalies 
(Mean (+/-SD) 
Idiopathic 
constipation 
(Mean (+/-SD) 
Healthy controls 
 
(Mean (+/-SD) 
Restraint 3.64 (+/-0.73) 3.47 (+/-0.75) 3.79 (+/-0.68) 
Distress 2.58 (+/- 0.89) 2.77 (+/-1.34) 2.39 (+/-0.70) 
Defensive 2.60 (+/-0.92) 2.74 (+/-0.80) 2.81 (+/-0.69) 
Lie Detector 3 detected 7 detected 4 detected 
 
4.2 ACE POPULATION AND QUALITY OF LIFE AND 
PSYCHIATRIC MEASURES 
 
4.2.1 Gastrointestinal Quality of Life   
 
In the ACE population, the GIQOL mean score for ARA was 100.5 (+/-27.07) and 
99.79 (+/-19.02) in IC (Figure 4.9, Table 4.24).  There was no significant difference 
between ARA and IC in terms of GIQOL total and subgroup means (Table 4.23).  
 
 
 
 
 
 
 
 
Figure 4.9: Gastrointestinal Quality of Life (GIQOL) in ACE patients
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Table 4.24: Statistical Analysis for GIQOL scores in ACE population 
Subject Groups 
 
(Score range) 
Anorectal 
Anomalies 
Mean (+/-SD) 
 
(Range) 
* CI of mean  
Idiopathic 
Constipation 
Mean (+/-SD) 
 
(Range) 
* CI of mean 
* Significance 
between ARA and 
IC (p value) 
 
GIQOL Total   
(0-144) 
100.5 (+/-27.07) 
 
(29-144) 
(88.20-112.8) 
99.79 (+/-19.02) 
 
(65-141) 
(90.62-109.0) 
ns 
Subgroups     
Physical well being  
(0-40) 
27.00 (+/-7.24) 
 
(16-40) 
23.70-30.30 
24.05 (+/-6.61) 
 
(13-40) 
20.87-27.24 
ns 
Gastrointestinal 
digestion  
(0-40) 
28.19 (+/-28.32) 
 
(18-39) 
23.94-31.44 
28.32 (+/-6.86) 
 
(15-40) 
25.01-31.62 
ns 
Gastrointestinal 
defaecation  
(0-24) 
18.90 (+/-4.92) 
 
(6-24) 
16.67-21.14 
20.00 (+/-4.37) 
 
(6-24) 
17.89-22.11 
ns 
Mental well being  
(0-20) 
11.90 (+/-5.59) 
 
(3-20) 
9.36-14.45 
13.37 (+/-4.11) 
 
(5-20) 
11.39-15.35 
ns 
Other  
(0-20) 
13.33 (+/-4.31) 
 
(4-20) 
(11.37-15.29) 
14.05 (+/-3.95) 
 
(7-20) 
(12.15-15.96) 
ns 
* Mann Whitney t test (ns = not significant) 
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The majority of patients with poor GIQOL score, also have a high KESS score 
(27/40) (67.5%) compared to those with good GIQOL score 5/40 (12.5%) (Table 
4.24), however, the sample is too small to have any statistical significance.  In the 
ACE population 32/40 (80.0%) had a poor GIQOL score, 7/40 (17.5%) of which were 
fully clean and 25/40 (62.5%) partially to fully incontinent (Table 4.25).  Being 
partially or fully incontinent significantly correlates with poor GIQOL score (Fisher's 
exact test p<0.05).  
 
Table 4.25: Relationship between GIQOL and KESS scores in ACE population 
GIQOL Poor GIQOL Good GIQOL Total 
* KESS <5 5 (62.5%) 3 (37.5%) 8 
KESS > 5 27 (84.3%) 5 (15.6%) 32 
Total 32 8 40 
* KESS < 5 (normal); > 5 (abnormal); Fisher's exact test p= 0.320 
 
Table 4.26: Relationship between GIQOL and Vaizey Incontinence scores in 
ACE population 
GIQOL Poor GIQOL Good GIQOL Total 
Full continence 7 (87.5%) 1 (12.5%) 8 
Partial Incontinence 13 (68.4%) 6 (31.6%) 19 
Full Incontinence 12 (92.3%) 1 (7.7%) 13 
Total 32 8 40 
χ2 3.10; df 2; p = 0.212 
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4.2.2 Other Psychosocial Measures in the ACE population 
 
Global personal hopefulness (GPH) mean scores were similar between ARA (51.10 
+/-17.25) and IC (54.63 +/- 18.46) (Table 4.27) with no significant differences.  
Overall, ARA had higher number of patients with low GPH (8/21) (38.1%) compared 
to IC (3/19) (15.8%). Table 4.27 demonstrates mean and standard deviations for hope 
and despair subgroups, with no significant differences found between ARA and IC, 
yet a higher mean despair mean score in ARA compared to IC is evident (Table 4.27).  
There was no significant relationship between global personal hopefulness (GPH) and 
GIQOL scores in the ACE population.   
 
Table 4.27: Mean scores for Global Personal Hopefulness in ACE population 
Groups Anorectal Anomalies Idiopathic constipation 
GPH (Mean (+/-SD) 
(Range) 
51.10 +/-17.25 
(16-79) 
54.63 +/- 18.46 
(0-77) 
* CI of mean 43.24-58.95 45.74-63.53 
Hopes Subgroup 22.43 (+/-10.66) 25.47 (+/-10.28) 
Despair subgroup 11.33 (+/-9.68) 8.74 (+/-8.09) 
* Lower –Upper 95% CI of mean 
 
In terms of the Pennebaker Inventory of Limbic Languidnes (PILL), the total mean 
score in ARA was 54.00 (+/- 32.66) and 52.00 (+/-43.34) in IC, with no significant 
differences between the groups.   General Health Questionnaire-28 (GHQ-28) was 
filled out by patients > 16 years of age, thus 13/40 patients with an ACE completed 
this questionnaire. Overall, 6/13 had probable case of psychiatric diagnosis, 4 in ARA 
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and 2 in IC respectively.  In the ACE population, there was no significant differences 
evident between ARA and IC in terms of personality traits (Table 4.28).   
 
Table 4.28: Distribution of Personality traits in ACE Population 
Groups Anorectal Anomalies Idiopathic constipation Total 
Extroversion 12 (52.2%) 11 (47.8%) 23 
Agreeableness 11 (64.7%) 6 (35.3%) 17 
Conscientiousness 13 (61.9%) 8 (38.1%) 21 
Neuroticism 12 (52.2%) 11 (47.8%) 23 
Openess 14 (60.9%) 9 (39.1%) 23 
  χ2 1.16; df 4; p = 0.884 
Means, standard deviations and confidence intervals for the total CERQ score and 
subgroups are presented in Table  4.29.  There was no significant difference, between 
ARA and IC in the ACE population for CERQ total and subgroups.  
 
As indicated in Table 4.30, there is no significant difference between ARA and IC in 
our population sample in terms of distribution of patients who are clinically 
depressed. Overall, 14/40 (35.0%) patients are clinically depressed, with 8 patients in 
ARA and 6 in IC respectively (Table 4.30). As indicated in Table 4.30, there is no 
significant difference between ARA and IC in our population sample in terms of 
distribution of patients who are clinically anxious. Overall, 17/40 (42.5%) patients 
have high trait anxiety and 26/40 (65.0%) high state anxiety (Table 4.30).  
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Table 4.29: The Cognitive Emotion Regulation Questionnaire (CERQ) scores in 
ACE population 
Groups Anorectal Anomalies Idiopathic Constipation 
 Mean (+/-SD) * CI of 
mean 
Mean (+/-SD)  CI of mean 
Total  CERQ Score 
(Range) 
93.85 (+/-22.15) 
(43-140) 
83.48-104.2 99.00 (+/-18.26) 
(72-128) 
90.20-107.8 
Subgroups     
Self-blame 9.05 (+/-3.63) 7.30-10.80 9.11 (+/-3.30) 7.52-10.69 
Acceptance 10.42 (+/-3.72) 8.63-12.21 12.00 (+/-4.11) 10.02-13.98 
Rumination 9.90 (+/-4.25) 7.84-11.95 10.95 (+/-3.70) 9.16-12.73 
Positive Refocusing 11.16 (+/-3.15) 9.64-12.68 12.84 (+/-4.54) 10.66-15.03 
Planning 11.37 (+/-3.32) 9.77-12.97 11.89 (+/-3.89) 10.02-13.77 
Positive Reappraisal 11.16 (+/-3.27) 9.58-12.73 13.53 (+/-4.39) 11.41-15.64 
Putting into 
Perspective 
11.26 (+/-4.23) 9.23-13.30 12.68  (+/-4.20) 10.66-14.71 
Catastrophising 8.63 (+/-3.44) 6.98-10.29 9.32 (+/-3.61) 7.58-11.05 
 
Table 4.30: Distribution of depression in ACE population 
Depression Scores Depressed  Normal Total 
Anorectal Anomalies  8 (38.1%) 13 (61.9%) 21 
Idiopathic Constipation  6 (31.6%) 13 (68.4%) 19 
Total 14 26 40 
Fisher's exact test p = 0.746 
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Table 4.31: Distribution of State/Trait anxiety in ACE population 
Anxiety scores High Trait Anxiety High State Anxiety 
Anorectal Anomalies  8 (47.1%) 16 (61.5%) 
Idiopathic Constipation  9 (52.9%) 10 (38.5%) 
Total 17 26 
Fisher's exact test p = 0.531 
 
Means and standard deviations for Weinberger Adjustment Inventory (WAI) scores 
are presented in Table 4.32.  There was no significance difference between ARA and 
IC.  Lie detection was included to see how truthfully our subjects were answering the 
questions with 6/40 (15.0%) subjects detected of lying in the ACE population (Table 
4.32).  
 
Table 4.32: Mean scores for Weinberger Adjustment Inventory (WAI) in ACE 
population. 
Groups Anorectal Anomalies 
(Mean (+/-SD) 
Idiopathic constipation 
(Mean (+/-SD) 
Restraint 3.76 (+/-0.63) 3.59 (+/-0.82) 
Distress 2.61 (+/-0.86) 2.40 (+/-0.93) 
Defensive 2.63 (+/-1.21) 2.73 (+/-0.87) 
Lie Detector 2 detected 4 detected 
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5.0 RESULTS Part III 
 
5.1 PATHOPHYSIOLOGY OF ANORECTAL ANOMALIES 
 
5.1.1 Introduction 
 
As discussed in Chapter 1, currently, our knowledge of the pathophysiology of FI 
relates almost exclusively to information gained in adults with acquired symptoms 
(i.e. usually post-obstetric or following anal surgery) (Lunniss, 2007). The 
pathophysiology of incontinence in congenital anorectal anomalies (ARA), however, 
remains unclear and our understanding rudimentary. Notably, the importance of extra-
sphincteric mechanisms has not been adequately addressed.  
 
The aim of this chapter is to present the results of a retrospective study of adults with 
anorectal anomalies (ARA), presenting to our tertiary GIPU (Barts and The London, 
The Royal London Hospital NHS Trust) with a history of previous surgery for ARA.  
This will be achieved by comprehensive evaluation of those measurable components 
contributing to continence (as discussed in Chapter 2) and the pathophysiological 
mechanisms which might contribute to poor bowel function.  
 
Preliminary results to this chapter have been published (Athanasakos EP et al.  
(2008).  British Journal of Surgery 95 (11): 1394-400). 
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5.1.2 Demographics and General Background of the population sample 
 
 
The study population comprised 32 consecutive patients comprised 15 females and 17 
males.  Age range of the population sample was 11-42 years of age and mean of 24 
(+/- 9).  All patients who have all underwent surgery for ARA as infants and were 
referred for investigation of their symptoms of FI between 1998- 2006.  All patients 
had a detailed clinical history taken and underwent anorectal physiological 
assessment. All patients reported life long FI; the nature of which was urge in 16, 
passive in 6 and combined urge and passive FI 10. Eighteen patients had associated 
symptoms of intractable constipation that met with the Rome III diagnostic criteria. 
 
Using the Wingspread Classification Score, ARA were classified as: high in 16 
(females: cloacal; males: rectoprostatic); intermediate in 8 (females: rectovestibular; 
males: rectourethral); and low in 7 (perineal in both females and males); in one 
patient, the abnormality was unknown (Table 5.1). One patient also had Klippel-Fiel 
syndrome and another neuropathic bladder.  Surgery included a variety of techniques 
including 8 posterior sagittal anorectoplasty (PSARP), 8 anal transposition, 5 
abdominal perineal pull through, 2 combined PSARP and abdominal perineal pull 
through and 7 others (Stephens, cut-back and anoplasty) (Table 5.1). 
 
Out of 32 patients, 7 had an Antegrade Continence Enema (ACE), 2 of which were 
intermediate and 5 high ARA. Patients with an ACE presented with 5/7 with urge FI, 
1 passive FI and 1 with a combination of urge and passive FI.  
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5.1.3 Summary of Physiological Measures 
 
As discussed in detail in Chapter 2, subjects underwent station pull through 
manometry of the anal canal, assessment of pudendal nerve terminal motor latencies 
and endoanal ultrasonography.  Rectal sensory thresholds were determined using a 
volumetric-based balloon distension technique. In patients with symptoms of 
constipation and incontinence, colonic transit studies using radio-opaque markers, 
were performed to distinguish between normal and slow colonic transit.  Evacuation 
proctography was performed where indicated in those patients with symptoms of 
obstructed defaecation. 
 
Table 5.1: Summary of classification and surgery in anorectal anomalies 
Grade of Anorectal Anomaly 
(Frequency)  
Surgical Technique Male Female 
Low (7)  Unknown 
Cut-back procedure 
Anorectoplasty 
Anoplasty  
Anal Transposition 
Abdominal perineal + revised 
PSARP 
 
1 
 
1 
 
 
1 
1 
1 
1 
 
1 
 
 
Intermediate (8) Posterior sagittal anorectoplasty  
Unknown 
Abdominal perineal pull through  
Anal Transposition 
 
 
1 
2 
1 
 
4 
High (16) Posterior sagittal anorectoplasty  
Anal Transposition 
Stephens sacro-perineal 
Abdominal perineal pull through 
Abdominal perineal pull through + 
PSARP 
6 
 
3 
3 
1 
 
3 
 
 
* Unknown (1) Abdominal perineal pull through  1 
* Unknown information was due to destroyed medical records 
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5.1.4 Statistical Analysis 
Statistical analysis was performed using the Statistical Package for the Social 
Sciences (SPSS Version 12.0.01, Chicago, USA). Fisher’s exact test was used to 
analyse contingency tables. For this test, p<0.050 was considered to show a 
significant difference 
 
5.2 RESULTS 
 
5.2.1 Anorectal physiology 
 
All tests could not be performed in all patients due to subject preference or 
intolerance.  However, anorectal physiology was demonstrated to be abnormal in all 
subjects, which involved multiple mechanisms in every individual (Table 5.2). 
  
5.2.1.1 Sphincter function and morphology 
Anal resting tone and squeeze increments were attenuated in 23/32 and 17/32 patients 
respectively (4 of which could not be elicited) (Figure 5.1).  The mean for maximum 
resting pressure (MRP) was 30.9 (+/- 21.4) ranging from 10.0-88.0 cm H2O and the 
mean for maximum squeeze increment (MSI) was 43.2 (+/-30.7) ranging from 10.0 to 
118.0 cm H2O.  
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Note (Figure 5.1):  The dotted line shows the lower limit of normal; bars represent means. 
 
 
 
 
 
 
 
 
 
 
 
 
Endosonography was performed in 29/32 patients, with only three patients having at 
least one anal sphincter completely present including 2 low and 1 high ARA (Table 
5.2). Eight patients had almost incomplete or ‘absent’ sphincters in both IAS and 
EAS, all had abnormal MRP and MSI and all presented with urge FI and 3 having a 
combination of both urge and passive FI.  In Figure 5.2a demonstrates a healthy 
control without ARA compared to 5.2b with an ARA (Figure 5.2).   
 
Evidence of pudendal neuropathy was found in 11/13 patients studied; this was 
unilateral in 5 and bilateral in 6 (Table 5.2). Patients with neuropathy presented with 
urge FI, either in isolation (n = 4) or passive FI (n =2) or in combination of urge and 
passive (n = 5) and all patients had fragmented to incomplete sphincters. 
Figure 5.1: Anal manometry in anorectal anomalies
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Figure 5.2: Endosonography of (a) normal and (b) abnormal sphincteric 
mechanism ( IAS, internal anal sphincter; EAS, external anal sphincter).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a  Normal 
b  Abnormal 
IAS 
EAS 
IAS remnant 
Deficient EAS 
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5.2.1.1 Extra-sphincteric function 
 
Abnormal rectal sensation was demonstrated in 18/22 (82%) patients, with 10/22 
(45%) being hypersensitive, 4/22 (18%) hyposensitive and normal in 4/22 (18%) 
(Table 5.2). In the 8 patients tested with a high anorectal anomaly, 5 had sensory 
dysfunction, all of whom were hypersensate and 3 normal rectal sensation (Table 5.2). 
There was a mixed picture in the other two groups: in low anomalies, all 5 patients 
tested had sensory dysfunction, 3 of whom were hypersensate and 2 were 
hyposensate; in the intermediate anomaly group, of the 5 patients tested, 2 were 
hyposensate, 2 were hypersensate and 1 had normal rectal sensation (Table 5.2). The 
patient in whom the anomaly was unknown was hypersensitive. Six of ten patients 
with rectal hypersensitivity presented with symptoms of urge FI, followed by 1 
passive FI and 3 a combination of urge and passive FI (Table 5.2). All patients found 
to have rectal hyposensitivity had delayed colonic transit and concomitant symptoms 
of constipation (Table 5.2). 
 
The recto-anal inhibitory reflex (RAIR) was absent in 4/22 patients tested, all of 
whom had a pudendal neuropathy (unilateral in 1 and bilateral in 3); 3 of these 4 had 
co-existent constipation. The RAIR was absent in 2 patients with an intermediate 
anomaly, 1 with a low anorectal anomaly and the patient in whom anomaly grade was 
unknown (Table 5.2).  
 
Overall rectal emptying was abnormal in 9/14 patients tested, which was secondary to 
‘outlet dysfunction’ (poor defecation dynamics pelvic floor dyssynergia) in the 
majority (7), mechanical obstruction in 1, and a combined functional / mechanical 
problem in 1. Patients with a ‘functional’ problem included those with all grades of 
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anomaly: 2 of 3 low anomalies tested, 3 of 5 intermediate and 3 of 6 high anorectal 
anomalies. In the 18 patients with co-existent constipation, 5 had abnormal 
parameters of evacuation and 8 had delayed colonic transit. Only 1 patient with 
combined FI and constipation had normal rectal emptying on proctography and 
normal colonic transit. In those patients with combined symptoms of incontinence and 
constipation, colonic transit was delayed in 5/18 (28%). All 4 hyposensate patients 
were within this group, and the other was hypersensitive (Table 5.2). Patients with 
delayed colonic transit had either a low (n = 2) or intermediate anorectal anomaly (n = 
4) or high (n = 2). There were no statistical relationship with the type of anorectal 
defect and type of reconstructive surgery and physiological outcomes in this selected 
population group.   
 
5. 3 PSYCHOSOCIAL MEASURES  
 
Chapters 3 and 4 were studies completed independently from the pathophysiology 
component study. However, 14/32 (43.8%) patients were involved in all studies.  In 
these 14 patients, 10/14 (71.4%) had a KESS score > 5 and 9/14 (64.3%) had partial 
to full FI (5 of whom denied FI in their questionnaire), 11/14 (78.6%) had poor 
GIQOL scores, 5/14 (35.7%) had low level of global personal hopefulness, 3/14 
(21.4%) clinically depressed, 8/14 (57.1%) clinically anxious in which was mainly 
trait anxiety (n = 5) and both trait and state in the remaining, 3/14 (21.4%) probable 
cases of psychiatric diagnosis and 2/14 (14.3%) with high PILL scores. In terms of 
personality traits, 9/14 (64.3%) extroverts, 9/14 (64.3%) agreeable, 7/14 (50.0%) 
concientious, 6/14 (42.9%) neurotic and 7/14 (50.0%) open minded.   
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Table 5.2: History and test results of 32 patients with faecal incontinence after surgery for congenital anorectal anomalies 
 
Anorectal 
Anomaly 
Grade 
Surgical 
Procedure 
Type of 
FI 
Constipation Anal Pressures PNTML Endosonography RAIR Rectal 
Sensation 
Colonic 
Transit 
Proctography 
    MRP MSP  IAS EAS     
Low Unknown Urge NO N A Unilateral Fragmented Absent Present Hypersensitive - - 
Low Cut-back Both YES A N Bilateral Fragmented Fragmented Absent Hyposensitive Delayed Mechanical 
Low Cut-back Urge NO A A - Absent Absent Present Hypersensitive - Functional 
Low Anorectoplasty Passive YES N A Bilateral - - Present Hyposensitive Delayed Functional 
Low Anoplasty Urge NO A N - N Fragmented Present Hypersensitive - - 
Low Anal 
Transposition 
Urge NO - - - N Scarred - - - - 
Key to Table:  
PSARP (posterior sagittal anorectoplasty); -  : test not performed; Type of FI: both = passive & urge; Anal Pressures: N = normal; A = abnormal; PNTML (pudendal nerve terminal motor latencies): N 
= normal; neuropathic = unilateral or bilateral; Endosonography: N = normal; Rectal sensation: N = normal; Colonic transit: N = normal; Proctography: Both = mechanical & functional; N = normal 
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Anorectal 
Anomaly 
Grade 
Surgical 
Procedure 
Type of 
FI 
Constipation Anal 
Pressures 
PNTML Endosonography RAIR Rectal 
Sensation 
Colonic 
Transit 
Proctography 
    MRP MSP  IAS EAS     
Low Abdominoperi
neal with 
PSARP 
Passive YES A A - Absent Absent Present - N - 
Intermediate PSARP Urge NO A A - Absent Absent Present Hypersensitive - Functional 
Intermediate PSARP Urge YES A - - Fragmented Fragmented - - - - 
Intermediate Unknown Both YES A A Bilateral Absent Absent Absent Hypersensitive Delayed N 
Intermediate Abdominal 
Perineal 
Urge YES N N Bilateral Fragmented Scarred Absent N N Functional 
Intermediate Anal 
Transposition 
Both YES A A N Absent Absent - Hyposensitive Delayed Both 
Intermediate Anal 
Transposition 
Urge YES A A Unilateral Absent Absent Present Hyposensitive Delayed N 
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Anorectal 
Anomaly 
Grade 
Surgical 
Procedure 
Type 
of FI 
Constipation Anal Pressures PNTML Endosonography RAIR Rectal 
Sensation 
Colonic 
Transit 
Proctography 
    MRP MSP  IAS EAS     
Intermediate Anal 
Transposition 
Both YES N N - Fragmented Fragmented Present - N - 
Intermediate Anal 
Transposition 
Both YES A N - Fragmented Fragmented Present - Delayed - 
High PSARP Urge NO A A - Absent Fragmented - N - N 
High PSARP Passive YES A A - Fragmented Fragmented Present - N - 
High PSARP Passive YES A N - Fragmented Fragmented Present - - - 
High PSARP Urge NO A - - Absent Scarred - - Normal - 
High PSARP Urge NO A N - Fragmented Fragmented Present - Normal - 
High PSARP Urge YES A A - Scarred Scarred Present - Normal - 
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Anorectal 
Anomaly 
Grade 
Surgical 
Procedure 
Type of 
FI 
Constipation Anal 
Pressures 
PNTML Endosonography RAIR Rectal 
Sensation 
Colonic 
Transit 
Proctography 
    MRP MSP  IAS EAS     
High Anal 
Transposition 
Both YES A A - Absent Absent Present Hypersensitive N N 
High Anal 
Transposition 
Both NO A A Bilateral Absent Absent - N - N 
High Anal 
Transposition 
+ 
anorectoplasty 
Urge YES A - - Fragmented Absent Present - - - 
High Stephens 
sacro-perineal 
Passive NO A A Unilateral Absent Fragmented Present Hypersensitive - Functional 
High Stephens 
sacro-perineal 
Both NO A A Unilateral Fragmented Absent - Hypersensitive - Functional 
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Anorectal 
Anomaly 
Grade 
Surgical 
Procedure 
Type of 
FI 
Constipation Anal 
Pressures 
PNTML Endosonography RAIR Rectal 
Sensation 
Colonic 
Transit 
Proctography 
    MRP MSP  IAS EAS     
High Stephens sacro-
perineal 
Both NO A A N Fragmented N Present N - - 
High Abdominoperineal 
+ PSARP 
Urge YES A - - Fragmented Fragmented - - Delayed - 
High Abdominal 
Perineal 
Urge NO N N - Fragmented Fragmented - Hypersensitive - - 
High Abdominal 
Perineal 
Both YES N A - - - Present - Delayed - 
High Abdominal 
Perineal 
Both YES A A Bilateral Fragmented Fragmented - - N Functional 
Unknown Abdominal 
Perineal 
Urge NO A A Unilateral - - Absent Hypersensitive - - 
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6.0 DISCUSSION 
6. 1  INTROUDCTION 
 
This chapter is structured in a way that aims to guide the reader through some of the 
questions we addressed in Chapter 1, by attempting to provide a clearer understanding 
of the determinants behind the emotional strain and debilitating symptoms which 
patients with ARA experience.   
 
6.1.1. Aims and Hypothesis  
 
As discussed in Chapter 1, the two main aims of this thesis were to determine the: 
i) impact of FI and constipation has on psychosocial functioning in the context of 
ARA compared to two control groups.  
ii) pathophysiological mechanisms that might contribute to poor bowel function in 
patients with ARA. 
We hypothesized the following:  
i) Symptom scores assessing constipation and faecal continence will be major 
determinants for poor psychosocial functioning.  
ii) Patients with ARA will have poorer symptom and quality of life scores in 
comparison to the controls groups.  
iii) Patients with ARA will have poorer level of hopefulness, mental state 
(depression and anxiety) and different coping strategies in comparison to the 
control groups. 
iv) Psychopathology in patients with ARA will have specific personality traits 
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compared to the control groups.  
v) Patients with the more severe anatomical defect in ARA will have poorer 
symptom and quality of life scores.  
vi) The pathophysiology in ARA will involve extra-sphincteric mechanisms. 
vii) There will be a relationship between poor quality of life and poor 
pathophysiological outcomes in patients with ARA.  
 
6. 2  DISCUSSION 
 
6.2.1 Representation of study groups 
 
The study population comprised 149 subjects with 91 males (61.1%) and 58 females 
(38.9%).  There was a male predominance found overall (p<0.01) with higher 
frequency of males than females in the anorectal anomalies (ARA) and idiopathic 
constipation (IC) group. This has been confirmed by previous authors, who also found 
in Western communities, with 55-70 per cent of patients in larger series have being 
males (Pena, 2000, Rintala, 2005).  This has also been confirmed in patients with IC 
with a 2-3 to 1 male to female ratio, yet with adults there is marked female 
predominance (Clayden, 1992).  However, other authors have found the male-female 
ratio associated with ARA almost equal, with 56:44 male: female ratio (Smith, 1988, 
Endo et al., 1999).   
 
Overall, the majority of our population were Caucasian in the total study population 
(73/149). It has been noted in the literature, that ARA appears to have worldwide 
incidence and have been reported from most countries, but there is great paucity of 
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information as to the relative incidence of ARA between ethnic groups. Smith (Smith, 
1988) reviewed the reported incidence and suggested that factors such as definition 
and inclusion may account for many of the variations observed.  
 
There was significantly a higher number of the second age group (>18 years) in the 
healthy controls (p<0.0001) in comparison to ARA and IC groups.  This can be 
explained by the fact that the diagnosis of appendicitis is more commonly found in 
adolescents/adults compared to the paediatric population (Lee, 1962). 
 
In the ARA sample, there were 7 patients with a low defect, 13 with intermediate and 
23 with a high defect and 9 patients unknown.  There was a male predominance found 
in each classification which was significant (p<0.03).  Generally it has been noted in 
the literature, that low defects are more common in females than males, whereas > 
50% of affected males have high lesions (Rintala, 2005, Cook, 1990, Endo et al., 
1999, Cuschieri, 2001, Cuschieri, 2002).  As mentioned in Chapter 1, ARA occur 
commonly in multi-anomaly sequences, such as the VACTERL association (vertebral, 
anorectal, cardiac, trachea-oesophageal, renal and limb (radius) (Davies et al., 2004, 
Czeizel and Ludanyi, 1985).  In our population sample, 24/52 (46%) of patients with 
ARA had associated VACTERL conditions.  This can be confirmed by other authors 
who have found similar associations with VACTERL conditions (Endo et al., 1999, 
Cuschieri, 2002).  In patients with IC, 13/46 (28%) were diagnosed soley with a 
megarectum, 13/46 (28%) with a slow transit and 11/46 (24%) with both a 
megarectum and slow transit.  It is important to note here, that slow transit studies 
were not performed in all patients or were missing from their medical records.  This 
can be confirmed by other authors who have reported prevalence for megarectum in 
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constipated patients (van der Plas et al., 2000, Meunier et al., 1984, Loening-Baucke, 
1984a). 
 
6.2.2 What is the impact of faecal incontinence and constipation has on psychosocial 
functioning in the context of ARA compared to two control groups? 
 
6.2.2.1. Patients with ARA will have poorer symptom scores in comparison to 
the controls groups. 
 
In our research study, IC had the poorest KESS and Vaizey scores in comparison to 
ARA and healthy controls.  However, both ARA and IC had a KESS total mean score 
>7 which is considered above the normal range of healthy controls (Knowles et al., 
2000).  Additionally, there was evidence of a significantly higher Vaizey scores found 
in patients with ARA (<0.0001) and IC (0.0002) compared to healthy controls.  The 
Vaizey mean score found in our ARA and IC patients can be confirmed similar to 
other patient population groups with symptoms of FI (Vaizey et al., 1999a, Deutekom 
et al., 2005).  Despite surgical advances, it is clear from our findings above, that 
voluntary bowel control is frequently poor following surgical care for ARA 
(Heikenen et al., 1999) with high rates of faecal incontinence (FI), and also 
constipation after all grades of reconstructive surgery (Rintala and Lindahl, 1995, Ong 
and Beasley, 1991, Rintala et al., 1993b).   
 
Our hypothesis was partly met, in that ARA did have poorer symptom scores 
compared to healthy volunteers, but were similar to the IC group.  In can be said, that 
both ARA and IC appear to have similar bowel characteristics despite the fact that IC 
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patients do not have a known anatomical defect and have intact sphincters compared 
to ARA.     
 
6.2.2.2. Symptom scores assessing constipation and faecal continence will be 
major determinants for poor psychosocial functioning. 
 
Overall, in our population study, IC had significantly poorer total GIQOL scores 
compared to healthy controls (p<0.001) and ARA compared to healthy controls 
(p<0.01).  There was no significant difference found between ARA and IC (p>0.05), 
indicating similar gastrointestinal health related quality of life characteristics exists 
between these two groups.   Varying degrees of constipation and FI in patients with 
ARA have profound effects on quality of life (Rintala et al., 1992) (Ludman et al., 
1994, Diseth et al., 1998a, Diseth et al., 1998b, Ditesheim and Templeton, 1987), 
which has been confirmed in our study.   
 
Studying the subgroups in the GIQOL, this study can clearly state that symptoms in 
patients with ARA and IC have a potential impact on the patient’s lifestyle.  Physical 
well being includes factors as general physical health and fitness and the ability to 
enjoy eating and leisure activities. Both ARA and IC significantly had poorer physical 
well being compared to healthy controls, however IC was found to be worse than 
ARA.   IC had significantly poorer GIQOL scores for gastrointestinal digestion 
symptoms (such as abdominal pain, bloating, flatus, regurgitation, constipation, 
heartburn) compared to healthy controls (p<0.01) illustrating a more global 
dysfunction in comparison to ARA patients.  Both ARA and IC had significantly 
poorer GIQOL life scores for gastrointestinal defaecation symptoms (such as bowel 
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frequency/urgency, uncontrolled stools, impaired sexual life, diarrhoea, blood in 
stools) and mental state (such as coping with stress, sad/nervous about illness, happy 
with life and frustrated by illness) compared to healthy controls.  Items not included 
in a subscale (‘other’) included questions on restricted eating, wake up at night, 
bothered by treatment, worsened relations and dysphasia.  Both ARA and IC had 
poorer GIQOL ‘other’ scores, compared to healthy controls.  
 
Our hypothesis was partly met, in that ARA did have poorer quality of life compared 
to healthy volunteers, but were similar to the IC group. Thus, both ARA and IC 
appear to have similar psychosocial functioning.  Our findings have also confirmed 
that FI and constipation are both major determinants for psychosocial functioning in 
patients with ARA and IC.  Since patients with ARA are born with an anatomical 
defect, we expected poorer symptom scores which will have an impact on their 
quality of life. However, we did not expect the IC group to share such strong 
similarities to ARA, since they have normal anatomy of the anorectum with intact 
sphincters.  This finding raises the question: Is childhood constipation a physical or 
behavioural problem in childhood?   There are two ways of conceptualising these 
findings based on these results so far.   
 
A possible suggestion to this question could be that the patient has a familial 
predisposition to delayed defecation by having a rectum of a larger capacity than the 
average individual.  In our study population, the majority of our patients with IC had 
been diagnosed in their medical history to have a megarectum (with/without slow 
transit) .  This suggest that these patients have a rectal evactory disorder which entails 
an increase rectal capacity and reduced sensation.  In such cases, the patient has the 
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tendency to hold their stool rather than being forced to pass it (Clayden and Keshtgar, 
2003).  Therefore, if the patient has a larger capacity, it will need higher volume of 
stool to cause complete inhibition of their IAS. Eventually, the rectal volumes reaches 
the stage where the IAS is fully relaxed and the stool descends, which usually causes 
anal pain due to the difficulty in passing the stool.  The patient then responds, by 
straining to withhold the stool in order to avoid the pain by contracting their EAS and 
pelvic floor muscles.  However, the situation worsens by the fact that withholding 
eventually leads to episodes of overflow FI which in turn prevents intestinal 
obstruction (Clayden and Keshtgar, 2003).  It has been found that withholding is a 
common behavioural factor of constipation in young children which can be due to 
psychological stressors (Mason et al., 2004, de Lorijn et al., 2004) or fear of using the 
toilet or potty (Clayden, 2004, Cladyen, 2005) or episodes of painful defaecation, 
often due to constipation.  Thus, psychosocial stressors could be causing withholding 
which further leads on to ignoring the urge to defecate, and eventually the stool 
retained in the rectum becomes impacted leading to constipation (Rogers, 2003) 
(Clayden and Keshtgar, 2003).  There remains continuous debate over the association 
between constipation and psychosocial problems, and whether constipation causes 
psychosocial problems or vice versa (Benninga et al., 2004).  Studies have found that 
psychosocial and behavioural problems are the main cause of chronic idiopathic 
constipation (Coughlin, 2003, Southwell et al., 2005, Gabel et al., 1986, Friman et al., 
1988). Whichever theory chosen, both could be responsible for our patient’s poor 
symptoms and quality of life and no doubt, needs to be further investigated in order to 
solve the underlying problem.   
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Secondly, in our IC population group, all patients developed their symptoms in 
childhood with continuation of inadequately treated faecal retention.  It has been 
suggested by authors that there is a tendency for increasing denial and dissociation 
from their problematic condition that limits the effectiveness of psychological input 
and any medical or surgical intervention (Keshtgar et al., 2004a, Ludman et al., 1994). 
For the treatment to be successful, a joint physical and psychological approach is 
important to encourage the patient to deal with their condition. Thus, it is vital to 
promote early effective treatment of constipation and the withholding habit in early 
childhood, which might reduce the incidence of chronic IC with faecal soiling and 
overflow later in adulthood.   
 
6.2.2.3. Patients with ARA will have poorer level of hopefulness, mental state 
(depression and anxiety) and different coping strategies in comparison to the 
control groups. 
 
Our findings indicated that ARA were, not significantly more depressed or anxious 
individuals compared to the control groups.  However, in the literature, psychiatric 
morbidity has been found to coexist in patients with ARA,
 
resulting in significant 
emotional and social difficulty for both the patients and their families (Hamid et al., 
2007, Ludman and Spitz, 1996, Ditesheim and Templeton, 1987, Diseth and Emblem, 
1996, Hassink et al., 1994, Ginn-Pease et al., 1991, Ludman and Spitz, 1995). It has 
been suggested that bowel dysfunction is one of the most important factors that 
influences the level of depression of children and adolescents with ARA (Amae et al., 
2008, Hamid et al., 2007, Funakosi et al., 2005).  In our research study, it was shown 
that patients who were clinically depressed and/or anxious, significantly had poorer 
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quality of life related to their symptoms, in comparison to those who were not.  
Additionally, patients with partial and full incontinence significantly had higher 
incidence of state anxiety compared to those who were fully clean.  Similarly, 
Funakosi et al (2005) found in children with ARA, that the depression tended to be 
more severe as the degree of FI worsened and as the child reached adolescence, yet 
the association failed to reach statistical significance.  Our findings imply that 
symptoms of gastrointestinal nature such as FI and constipation could influence the 
patient’s psychiatric well being, despite not reaching statistical significance.  Similar 
findings have been found in children and adolescents with Hirschsprung’s disease 
(Athanasakos et al., 2006). Based on our findings so far, it appears that patients with 
ARA and IC have minimal psychiatric morbidity, but experience condition-specific 
psychosocial problems as demonstrated in our first two hypotheses above.   
 
There was no significant difference between the three groups in terms of level of 
hopefulness in our population groups.  If the subject had a good quality of life 
(according to the GIQOL measure), they were significantly more hopeful about their 
future in comparison to those with poor quality of life scores. Symptoms scores had 
no impact with level of hopefulness in this research study. Cappelli et al (1989) 
(Cappelli et al., 1989) found similar findings in adolescents with chronic illness which 
are in fact not at greater risk of developing psychopathology, yet they appeared to 
become more concerned about their health and future.  There is currently limited 
literature investigating personal hopefulness in children with ARA to date, with one 
author having investigated this area (Hamid et al., 2007). Despite the reported high 
level of psychosocial morbidity found in patients with ARA, Hamid et al (Hamid et 
al., 2007) also found their level of hopefulness of the future to be positive.  Similar 
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results have been found in patients with similar symptoms to ARA and IC, in patients 
with Hirschsprung’s disease (Athanasakos et al., 2006). This raises the question as to 
how our patients with ARA and IC remain hopeful individuals, despite their disabling 
symptoms and distress.   
The above question can be possibly explained by investigating the individual’s coping 
strategies. Boekaerts and Roder (Boekaerts and Roder, 1999) found children with 
chronic conditions to use coping strategies in relation to common stressors that 
appeared to be similar to those of healthy children.  As expected, we found a 
significance difference in overall coping mechanisms between ARA and healthy 
controls (p<0.05).  ARA significantly used more ‘positive reappraisal’ which involves 
thinking of attaching a positive meaning in the event in terms of personal growth  and 
also ‘putting into perspective’ by referring to thoughts of playing down the 
seriousness of the event or emphasizing the relativity when comparing it to other 
events (Garnefski, 2006).   
 
In our study, patients with ARA and IC could be holding unrealistic positive beliefs 
about their condition and future as demonstrated in their level of hopefulness scores, 
however, this could assist the patients to cope with the stress of their condition 
(Scheier et al., 1989).  Thus, being unrealistically positive may be a coping 
mechanism that helps people feel better and is related with positive social 
relationships and motivation to work. Thus, despite the unrealistic positive illusions 
the individual may have, it could assists them to approaching the situation 
realistically, once they have coped with the intense emotions associated with the 
condition first. Some authors describe the above coping mechanisms as a form of 
denial in such patients (Ludman and Spitz, 1996, Ludman et al., 1994).  Freud (1961) 
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first used the concept of denial within the language of defence mechanism in 
psychoanalytical theory (Freud, 1961). Such defence mechanisms can be used by the 
ego to avoid the anxiety of a threatening or stressful situation. Freud described denial 
as the refusal to acknowledge the existence of an unbearable situation or the feelings 
associated with it, and saw it as one of the defence mechanisms use to protect the ego 
from anxiety. Through its use, painful or distressing thoughts and emotions were 
prevented from entering the consciousness, and this provided time for the ego to 
become strong enough to deal with a changed situation, but only up to point. If denial 
were prolonged, it would lead to pathology.   
 
In summary, it is clear from our findings that patients with ARA and IC have poor 
quality of life specifically due to their disabling symptoms however this has not 
necessarily increased their psychiatric morbidity.  These findings clearly show that 
symptoms (such as FI and constipation), drives an emotional response to the 
individual which can be further understood by how the individual copes with the 
stressor. For example, anything that induces fear or anger causes the heart to beat 
faster, increases the tension in our back and neck muscles, enhances the sensitivity of 
the bladder, the colon contracts vigorously and so on (Rang, 2003, Read, 2006).  
These natural physiological responses, indicates that changes in bodily function are 
brought about largely through both sympathetic (flight or fight response) and 
parasympathetic (conservation, restoration and recovery) responses to change.  In the 
sympathetic state, there is an increase of blood pressure, respiration, heart rate and 
shuts down areas such as the gut, liver and kidneys.  In the parasympathetic state, this 
induces a state of rest and calm, promotes sleep, stimulates the digestion and supports 
tissue growth and repair (Rang, 2003, Read, 2006). Unlike the sympathetic system, it 
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slows the heart, steadies the respiration and promotes the function of the gut, liver and 
kidneys.  Furthermore, sympathetic and parasympathetic responses to change are 
often supported by the release of the stress hormone cortisol. If such emotions to the 
situation can’t be resolved either sympathetic or parasympathetic withdrawal, then 
prolonged activation of these strategies will inevitable result in exhaustion, 
demoralisation and illness (Read, 2006). This could suggest that patients who are 
suffering ongoing symptoms of bowel function which leads to poor quality of life 
causing distress (as found in our patients) chronically as shown from our results, then 
their symptoms are even more amplified by their mental state.  It is beyond the scope 
of this thesis to explore such brain-gut axis relationship, but it is important to note that 
illness is not all in the body nor all in the mind, but rather a dual relationship which is 
needed to resolve the patient’s illness.  This may explain why ARA and IC share 
similar psychological characteristics, no matter if one has a pathogenic cause and the 
other doesn’t, because their ongoing distressing symptoms is causing them to behave 
the way they do.   
 
6.2.2.4. Psychopathology in patients with ARA will have specific personality 
traits compared to the control groups. 
 
Some authors believe that adolescents with a chronic illness could be at risk of 
developing psychopathology (Eiser, 1990, Gortmaker, 1990, Lavigne, 1992, Varni et 
al., 1992, Wolman et al., 1994).  We aimed to investigate the association between 
psychopathology and specific personality traits that could be associated with patients 
with ARA. Based on the current situation in the literature, this is the first research 
study to include personality measures in patients with ARA.  Overall, in our 
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population sample, there was no significant difference between the three subject 
groups, thus no specific personality trait was associated with patients with ARA.  A 
study which looked at epilepsy in children and adolescents also found no specific 
personality traits that could be linked to their patients (Otero, 2009).  Emotional states 
and personality traits may affect the physiology of the gut (Wood et al., 1999), and 
play a role in how symptoms are experienced and interpreted, and can thus influence 
treatment. Neuroticism and aggression are reported to be higher in patients with 
functional gastrointestinal disease without psychiatric comorbidity, and personality 
traits are believed to influence pain reporting (Tanum and Malt, 2001).  In our study 
extroversion significantly was found to be associated with lower level of personal 
hopefulness and higher PILL score (i.e. more emphasis on physical health) and 
neuroticism significantly correlated with lower level of personal hopefulness, high 
state and trait anxiety. These findings do not indicate specific personality traits within 
the population group, but it does imply that traits such as extroversion and 
neuroticism do influence the patient’s level of hopefulness about their future.  This 
area needs to be further explored in future research.   
 
6.2.2.5. Patients with the more severe anatomical defect in ARA will have 
poorer symptom and quality of life scores.  
 
It may be expected that the more severe the condition is, the greater the probability of 
psychosocial difficulties.  In our study, there was no relationship between severity of 
the anorectal defect with psychosocial adjustment and symptom scores, found in 
patients with ARA.  This finding implies that it isn’t the type or severity of the 
anatomical defect in patients ARA that influences the severity of the symptom or 
  
 
252
psychopathology.  There remains confusion within the literature about this area.  It 
has been found in adolescence with ARA that had psychological morbidity tended to 
be more severe as the degree of FI worsened  (Funakosi et al., 2005) (Diseth et al., 
1998a). While others found no association with severity of the condition or symptom 
to psychological functioning  (Ludman and Spitz, 1996). In fact more emphasis is 
apparently placed on the presence of the condition rather than its level of severity.  In 
our study, we investigated the amount of emphasis an individual puts on their general 
health, by using the Pennebaker Inventory of Limbic Languidnes (PILL).  In our 
study, IC significantly placed less emphasis on their general health, compared to ARA 
and healthy controls.  Reasoning for this finding, could be that IC place their 
emphasis on the symptom that is most troublesome for them based on their poor 
symptom and quality of life scores and place less focus on other bodily sensations.     
 
6.2.2.6. The ACE stoma is an effective treatment with good symptom and 
quality of life scores for both ARA and IC.   
 
The ACE stoma is a treatment offered to patients when other forms of medication 
have failed for the patient suffering from FI and constipation.  In our research study, 
patients with IC had significantly poorer KESS score compared to ARA and poorer 
continence scores when compared to ARA in the ACE population, which did not 
reach statistical significance.  There was no significant difference between ARA and 
IC in terms of GIQOL in the ACE population.  However, patients with an ACE had 
below the normal mean for GIQOL score compared to healthy volunteers and 80% of 
the ACE population had poor GIQOL which is the majority of the sample.  Thus, we 
did not find that the ACE stoma significantly improves the quality of life for the 
  
 
253
patient with symptoms of FI and constipation.  There has been mixed perceptions 
about the success of the ACE.  Some studies have found that the ACE stoma is an 
effective treatment for constipation and soiling (Yerkes et al., 2003, Searles et al., 
2000, Herndon et al., 2004, Hutson et al., 2001, Clayden, 2004), while other studies, 
has not rated the ACE as highly (Rubin and Dale, 2006) due to the instances of 
repeated treatment failures, and they also identify that complications are common 
(stomal stenosis and pain with the enemas) (Dey et al., 2003).  Studies (King et al., 
2005) have found that the ACE stoma significantly improves the quality of life of 
children with chronic idiopathic constipation.   
 
The above findings could imply that patients, who generally dislike having the ACE 
due its appearance or time consuming treatment, lead to non compliance and therefore 
unsuccessful outcomes.  Non compliance is a characteristic that is often associated 
with being in denial (Anderson, 1991).  People living with an ongoing condition often 
learn that their response to illness do not follow the patterns described by healthcare 
professionals as in the case in patients with an ACE.  Thus, they begin to find their 
own self-care practices that fit within the context of their lives, even if it means not 
complying with the treatment they have been advised to pursue.  Instead, patients may 
assert themselves by refusing to take medication, opposing treatments or giving 
healthcare professionals as little information as possible.  Thus, patients are often 
labelled as problematic or in denial, but in fact, these actions could be explained as a 
way of asserting self-agency through realising personal needs and wishes in the life 
context.  Thus individuals prioritise their own needs and wishes over the demands of 
medication instruction, even at the risk of poorer health outcomes.  It is important to 
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note that the health professional needs to take into account the wider social context of 
the individual’s setting (e.g. home, school, work, relationships etc).      
 
6.2.3 What are the pathophysiological mechanisms that might contribute to poor bowel 
function in patients with ARA? 
 
6.2.3.1. The pathophysiology in ARA will involve extra-sphincteric 
mechanisms 
 
This study has demonstrated that in a cohort of symptomatic adult patients whose 
problems with FI have persisted since surgery for their ARA, pathophysiology was 
multifactorial in all. This supports contemporary thinking that anal sphincteric 
dysfunction is not solely responsible for FI, and that extra-sphincteric mechanisms 
may be equally important (Davies et al., 2004). The pathophysiologies encountered, 
namely attenuated anal sphincter function (structural neuropathic or both), altered 
rectal sensation, disordered rectal evacuation, and delayed colonic transit, occurred 
with all grades of anomaly following different procedures. Although there was a 
tendency for both clinical and pathophysiological differences to occur between 
subgroups (e.g. more high anomalies appeared to be hypersensate, and a greater 
proportion of intermediate anomalies had co-existent constipation) it is impossible, to 
draw firm conclusions. Appropriate statistical analyses could not be performed on the 
relationship between the types of anorectal anomalies, their surgical correction and 
the pathophysiology found, due to limited numbers. Furthermore, analysis was 
complicated by a lack of comprehensive information concerning the initial surgery 
and, the variety of procedures used. 
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With regard to surgical correction of ARA, some procedures involve division of the 
sphincter complex (Pena and Devries, 1982, deVries and Cox, 1985, Smith, 1987, 
Engel et al., 1995, Lunniss et al., 2004), as opposed to pull through techniques which 
also aim to conserve the IAS (Smith, 1987). It is notable and disappointing that most 
patients in this study who underwent posterior sagittal anorectoplasty, a popular 
technique, currently, demonstrated poor sphincter quality. Previously, in patients with 
acquired FI (usually due to obstetric or iatrogenic trauma), symptoms of passive 
incontinence have been shown to correlate with low anal resting tone and symptoms 
of urge FI often correlate with low squeeze pressures (Lunniss, 2007, Engel et al., 
1995, Lunniss et al., 2004). The IAS plays a major role in continence, particularly in 
patients in whom EAS function is also deficient. The necessity to preserve the IAS at 
operations for anorectal and cloacal anomalies, which has been recommended by 
some authors, has either not been achieved in the majority of these patients or the 
sphincter was deficient from the start (deSouza et al., 1999).  
 
Integrity of anal sphincter morphology and function are of fundamental importance to 
normal continence, but the contribution of extra-sphincteric components (both colonic 
and rectal) is increasingly recognised (Chan et al., 2005a, Lunniss, 2007, Williams et 
al., 2001, Bharucha et al., 2005, Bharucha, 2004, Salvioli et al., 2001, Chan et al., 
2005c, Gladman et al., 2005).  Pudendal neuropathy may underlie EAS weakness in 
patients with symptoms of FI. In addition, the frequent association of neuropathy with 
ARA, which may be either congenital or acquired as a result of surgery, may result in 
altered anorectal sensation, contributing to both constipation and incontinence 
(Hettiarachchi et al., 2002).  
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With regard to demonstration of rectal sensory dysfunction, it was found that patients 
with rectal hypersensitivity presented with symptoms of urge FI, and patients who 
were hyposensitive, presented with concomitant constipation and were found to have 
delayed colonic transit. The relationship between hypersensitivity and faecal urgency 
or urge incontinence has been reported previously (Lunniss, 2007, Williams et al., 
2001, Bharucha et al., 2005, Chan et al., 2005c, Sun et al., 1990, Felt-Bersma et al., 
2000). In those with significant blunting of the ability to sense distension (rectal 
hyposensitivity), all were in the low or intermediate category and had coexistent 
constipation comparable with previous findings (Gladman et al., 2006). Three of the 
four had incomplete evacuation on proctography. Whether the delay in transit was 
primary or secondary to disordered defecation is unknown.  However FI occurring 
secondary to blunted rectal sensation and disordered defaecation is well established 
(Lunniss, 2007, Farthing and Lennard-jones, 1978, Rao et al., 2004, Lubowski and 
Nicholls, 1988, Di Lorenzo and Benninga, 2004). 
 
6. 3  STRENGTHS AND LIMITATIONS 
 
There are some limitations present in this research study.   When recruiting patients 
with a rare condition such as ARA, sample size is always a potential problem. A large 
sample size is needed to ensure the generalisability and the accuracy of the results, but 
small enough so that the study question can be answered within the research resources 
that are available and time frame. As seen in Table 1.5 (Chapter 1), sample size for 
similar research studies, ranged from 17-286 patients with ARA.  Despite the fact that 
our research patient population group (n = 52) was not as high as some authors (Poley 
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et al., 2004, Hamid et al., 2007, Amae et al., 2008, Bai et al., 2000, Hassink et al., 
1994, Ludman and Spitz, 1996), control groups were absent (especially healthy 
subjects) and psychosocial measures were limited in their studies.  Despite the 
presence of healthy control group (appendectomy subjects), there was significantly a 
higher number of the second age group (>18 years) in the healthy controls (p<0.0001) 
in comparison to ARA and IC groups which makes age matching not accurate when 
comparing between all groups.  However, as discussed above, this can be explained 
by the fact that the diagnosis of appendicitis is more commonly found in 
adolescents/adults compared to the paediatric population (Lee, 1962). 
 
Despite various perspectives in the literature, morbidity has been found to coexist in 
patients with ARA even after surgical repair,
 
resulting in significant emotional and 
social difficulty for both the patients and their families.  In our research study, we 
failed to include perspectives from the family members involved in the care of the 
child and adolescent with ARA.  This information could be beneficial when talking 
about coping mechanisms, treatment compliance issues and generally trait 
characteristics which the parent and child have in common.  Most studies have 
included a joint perspective of both the parent and patient involved when answering 
questions about their bowel and psychosocial functioning making it difficult to derive 
the patient’s sole perspective of they are thinking rather than the parent/carer involved 
(Amae et al., 2008, Hamid et al., 2007, Iwai et al., 2007, Goyal et al., 2006, Poley et 
al., 2004, Funakosi et al., 2005, Hassink et al., 1994).    
 
Limitations are also evident in the pathophysiology study of this thesis.  All patients 
with ARA in this study were self selected with poor bowel function and were thus not 
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representative of the population as a whole. Therefore, the expected pattern of better 
outcomes in low and intermediate anomalies as opposed to high is not clearly 
apparent. It may be that patients with isolated deficiencies in function of either 
sphincteric or suprasphincteric components achieve better levels of continence. 
Additionally, patients included were symptomatic patients which attended our GI 
Physiology Unit with FI. This research failed to explore a more homogenous cohort of 
patients with equivalent anorectal anomaly and surgery, irrespective of whether the 
patient is symptomatic or not. Despite the considerable variability in this population 
sample and the investigations performed, it is important to appreciate the difficulties 
regarding recruitment and reproducibility. Nevertheless this study is unique despite 
these aforementioned limitations, as it considers other mechanistic processes involved 
in continence in addition to sphincteric factors in isolation.   
 
However, this study does not have the limitations of similar studies which have shown 
to lack control groups, specific psychosocial measures (e.g. assessing level of 
hopefulness, personality, coping mechanisms) and symptoms scores which will be 
discussed.  This research study was well designed in that groups were divided on the 
basis of major age groups such as high school (adolescence) and adulthood (work 
force/university/college etc).  Few studies have looked at such a wide age range as our 
research project (age range: 11-45 years) (Hamid et al., 2007, Goyal et al., 2006, 
Poley et al., 2004, Hassink et al., 1994).  Having a wide age group allows a better 
representation of the patient group and an insight to how patients are doing at 
different age groups (and development stage).  It may also highlight certain bowel or 
psychosocial characteristics evident at certain age periods.  There are several 
symptom scores available in the literature however authors fail to investigate the 
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relationship between bowel function using validated and well recognised symptoms 
scores with health-related quality of life measure and psychiatric measures in patients 
with ARA.  The major strength to our study is the inclusion of control groups which 
has been discussed in Chapter 2. This thesis has age and sex matched control groups 
including patients with similar symptoms yet no anatomical defect compared to our 
patients with ARA and healthy volunteers without a chronic gastrointestinal 
condition.  Finally, this is the first study to include personality and coping validated 
questionnaires in patients with ARA.       
 
6. 4  IMPLICATIONS 
 
There are several implications that can be derived from our research study.  This 
study has clearly shown that symptoms of constipation and FI are ongoing and 
distressing for patients with ARA and IC.  Despite, the fact that IC has an unknown 
underlying aetiology, they share similar bowel function to ARA and are equally 
challenging group of patients to treat.    
 
Both FI and constipation are determinants of poor psychosocial functioning in 
patients with ARA and IC and thus, provision for adequate psychosocial support for 
these patients, should be an integral part of outpatient services.  Regular follow-ups 
are crucial in order to become aware of any changes in stooling and behavioural 
patterns over time for the child with ARA and IC.  From the very beginning the child 
is diagnosed with ARA and IC, patients and the family, should be informed of the 
potential risks, long term outcomes, general understanding of bowel functioning and 
treatment available.  From the time child starts toilet training, the health professional 
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involved must begin to explain the importance of going to the toilet and along with 
explaining why soiling or constipation is happening and ways to deal with the 
situation.    This needs to be further reinforced by the parent/carer involved to the 
child in order to create better communication and the best possible bowel outcome for 
the patient. Regular follow-ups may minimise and improve issues of withholding, 
behavioural problems and issues or fear of using the toilet or potty or episodes of 
painful defaecation.   
 
Every institution varies in which operative technique is used, age at which the child is 
followed up, regularity of follow-ups, definitions of symptoms (such as FI) and many 
other factors.  Thus it is important as healthcare professionals to become aware of 
such variability and to use caution when making generalisation and conclusions about 
patients with ARA and IC.  A national standardised questionnaire or assessment tool 
would be of value for healthcare professionals to use when evaluating patients on a 
regular and long-term basis.  Particular focus should be placed on definitions for 
constipation and FI to avoid discrepancies and severity confusion.  Having the same 
questionnaire used by all institutions will provide: 
• Clarity of the child's bowel functioning over time and at different ages.   
• The opportunity to draw comparisons between groups 
• Clearer understanding of potential risk target groups 
• Improvement in clinical management  
• Increase data quality and research. 
 
General knowledge about the condition (e.g. CD, handbook) or additional facilities or 
aids within educational institutions (e.g. shower facilities if the child has had 
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explosive amounts of faecal soiling in underpants) are examples of ways to improve 
everyday functioning for the patient and family involved.  Since ARA and IC are 
hidden conditions (i.e. it is not obvious like Haemophilia or Downs Syndrome), it is 
easy for education professionals to ignore or fail to appreciate the importance when a 
child needs to go to the toilet urgently or having ‘smelly’ underpants.   Thus, regular 
contact with the school should be maintained since alterations in performance or 
behaviour may be sensitive predictors of future difficulties.  
 
Special efforts will be required to break through defences to insure that anxieties, 
conflicts and concerns about the future are identified early. Ideally psychosocial 
screening procedures should be developed and used routinely in the outpatient care of 
all adolescents with chronic disorders such as ARA and IC so that potential problems 
may be identified promptly and action taken to prevent their development. It is of 
equal importance to develop a program to insure that the child with ARA and IC is 
revaluated psychologically at regular intervals in the same way they are medically for 
bowel function. It is by identifying psychological and social adaptation problems 
early, that possible intervention to help the child successfully adjust to their illness 
becomes inevitable. The fact that children with ARA and IC have persisting bowel 
functioning problems after surgical correction, it is vital to counsel parents from the 
very beginning (i.e. at diagnosis) regarding realistic expectations of the child’s long-
term outcomes.  Counselling should be offered for both the child with ARA and 
family.  This will allow parents (and for older children) to become comfortable 
talking about ‘that’ region of the body (such as the buttocks) and grasp an 
understanding of why it is so difficult to do certain things (such as going to the toilet, 
stop soiling).  Failure to address psychosocial problems from an early age could 
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increase the development of psychosocial morbidity in these patients.   This can be 
accomplished by close cooperation of all professionals working locally (i.e. surgeons 
and psychiatrist working closer together), annual seminars or workshops within the 
medical field and for families, to keep updated with advanced treatments, concerns 
and other medical science advancements.    
 
There is no doubt, that ARA forms a significant load on the surgical services 
worldwide, not only in the emergency situations but also in terms of long term 
corrective procedures and management of symptoms such as FI and constipation. As 
discussed in Chapter 1, there have been major advances in the surgical management 
of these children, but these patients still represent a continuing challenge as a result of 
the significant reconstructive problems involved, as well as the fact that a significant 
number suffer from ongoing symptoms in later life.  This needs to be implemented 
when discussing the financial burden it has on the patient, family and medical system 
involved.  
 
As seen by the complexity and multifactorial nature found in patients with ARA in 
respect to pathophysiology, it is clear that implementation of any treatment targeted 
on one area of dysfunction may fail and two or more treatment modalities may be 
necessary to achieve continence, i.e. rectoplasty and antegrade continence enema 
stoma, or sphincteroplasty or anal plug (Keshtgar et al., 2007b, Keshtgar et al., 
2007a).  Other more advanced surgical techniques may also be considered (Malouf et 
al., 2000, Saunders et al., 2004).  Alternatively, colostomy may offer a solution. 
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6. 5  FUTURE DIRECTIONS 
 
This research study opens doors for further research for patients with ARA. These 
include:  
 
1) This study focused on how the patient is functioning at this moment of time.  It 
may be that this time period was insufficient to capture all aspects of ARA and its 
impact on the individual.   Ideally, a large multi-centred and longitudinal study in 
patients with ARA would be conducted and young people would be followed up 
into their 30s and 40s to evaluate the impact of ARA later in adult life.   
2) This thesis purely gained the patient’s perspective about their bowel and 
psychosocial functioning. In order to grasp how the family influences the patient’s 
perspective and coping mechanism living with this condition, parental and sibling 
perspectives could be included.  
3) To gain a better understanding of the brain-gut relationship in patients with ARA 
and IC, brain imaging and cortical evoked potential research could enhance our 
knowledge further.  
4) Future pathophysiological research needs to explore a homogenous cohort of 
patients with equivalent anorectal anomaly and surgery, irrespective of whether 
the patient is symptomatic or not.  It is only then that we will be able to 
confidently comment on the pathophysiologies observed in this study and if these 
are associated with symptom development or not.  The importance of the 
psychological impact and coping mechanisms in such a group of patients needs 
also to be studied concurrently. 
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6. 6  CONCLUSION  
 
Patients with anorectal anomalies (ARA) have a complex, structural developmental 
abnormality. Whilst surgical treatment aims to correct the anatomical defect, 
functional issues remain for years.  The findings to this research study have shown 
that ongoing symptoms of FI and constipation are major determinants for poor quality 
of life in patients with ARA. However, contrary to our expectations, they share 
similar bowel and psychosocial functioning to patients with idiopathic constipation 
(IC) who unlike our ARA patients, have an intact sphincter mechanism. Despite the 
significant impairment of faecal continence and constipation in both ARA and IC 
groups, we found that adolescents have minimal psychiatric morbidity yet experience 
condition-specific psychosocial problems affecting their day to day life.  It is shown 
from our findings that the chronic nature of the patient’s problem appeared to have 
stimulated psychologically protective factors such as positive coping strategies to deal 
with their disease related stressors. Additionally, while the structural integrity of the 
anal sphincters (which may relate to surgical technique) is the major factor 
contributing to continence, this study confirms that extra-sphincteric mechanisms, 
particularly rectal sensory function, may be equally important. Prospective studies of 
operative techniques employed in patients with comparable anomalies are required.   
 
As our findings have indicated, to achieve the best outcome for our patients, a joint 
physical and psychological approach is needed to encourage the patient to deal with 
their condition.  At present the emphasis in clinical management of ARA is to ensure 
survival and normal bowel function for the child.  Further focus should be placed in 
achieving good quality of life for the child and family dealing with ARA.  This thesis 
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suggests that surgery is not the final point of treatment for children with ARA.  It is 
vital to call attention to the introduction of long-term regular follow of patients after 
surgery for ARA.  Good bowel functioning facilitates improvement for the quality of 
life for the adolescents with ARA, yet there is difficulty achieving this as emphasised 
by our results in the ACE population which is an advanced treatment modality.  
Living with ARA involves not only dealing with the underlying aetiology of the 
condition, but also the complications, stressors, confusion, hardship and emotional 
burden it places on the patient.  When treating an adolescent with ARA, medical 
professionals are not only obtaining outcomes for treating the bowel disorder but also 
capable of achieving the best quality of life for their patients and family.  
 
In conclusion, in the care of adolescents with chronic physical problems, one aim is to 
try to minimise the relationship between physical and emotional difficulties. This 
study has clearly shown that both FI and constipation produces effects on the 
adolescents/adult’s psychological adjustment.  A longitudinal study would confirm 
this. This research provides some insights into the factors associated with 
maladjustment among patients with ARA and may eventually prove to be of use in 
guiding intervention programs. Thus, outcome and compliance with treatment may be 
enhanced if, from an early age, psychological evaluation of the child and experienced 
advice and guidance for the families, regardless of the severity of the symptoms, 
becomes an integral part of their continuing care.  
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The purpose of this research study is to identify the reasons why some 
patients with anorectal anomalies, (like your child) can suffer from bowel 
difficulties after having surgery.  It will give us the opportunity to 
further understand our knowledge of what causes these bowel 
difficulties by investigating the anatomy and physiology of the anorectum.  
Most of all once we have identified this, we can offer better treatment 
for the future.   
 
Eleni Athanasakos 
Barts & The London Queen Mary 
Department of Paediatric Surgery  
The Royal London Hospital 
Fielden House 
Whitechapel 
London  
E1 1BB 
 
Tel: 078 13682226  
Main switchboard: 020 7377 7000 Ext 7799 
Fax: 0207 377 7743 
Email: e.athanasakos@qmul.ac.uk 
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Your child has been invited to this research study as they have been 
surgically corrected for ARA and followed up in clinics.  We will be able to 
identify what is causing some children to have these difficulties and 
offer future treatment suggestions.  At least 60 participants at the 
Royal London Hospital will be involved in this study that has been 
corrected with ARA.   
 
Participation in this project is voluntary if your child decides not to take 
part or decide to withdraw at any time this will not otherwise affect 
their relationship with the hospital or have any impact on the care your 
child may be receiving.   
 
I have attached a ‘Participants Information Sheet’ for your convenience.  
Please feel free to contact the research doctor in charge Eleni 
Athanasakos who will be able to answer any questions and further explain 
the research project if needed.  
 
If your child is interested in participating please call Eleni Athanasakos 
on 0207 882 2626 or 078 1368 2226. 
 
 
Thank you kindly 
 
 
 
 
 
Eleni Athanasakos 
Clinical Researcher 
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Appendix – C Letter of Invitation 
Patient Version for ARA 
      
 
 
 
 
 
Date: 
 
 
 
 
 
To: PARTICIPANT’S NAME/ADDRESS 
 
Title: Anorectal Function and Quality of Life with Patients with 
Anorectal Anomalies (ARA). 
 
Dear PARTICIPANT’S NAME,   
 
We would like to invite you to take part in a research study at Barts and 
The London, Queen Mary University of London.   
 
The purpose of this research study is to identify the reasons why some 
patients with anorectal anomalies, (like yourself) are suffering from 
bowel difficulties after having surgery.  It will give us the opportunity to 
further understand our knowledge of what causes these bowel 
difficulties by investigating the anatomy and physiology of the anorectum.  
Most of all once we have identified this, we can offer better treatment 
for the future.   
Eleni Athanasakos 
Barts & The London Queen Mary 
Department of Paediatric Surgery  
The Royal London Hospital 
Fielden House 
Whitechapel 
London  
E1 1BB 
 
Tel: 078 13682226  
Main switchboard: 020 7377 7000 Ext 7799 
Fax: 0207 377 7743 
Email: e.athanasakos@qmul.ac.uk 
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You have been invited to this research study as you have been surgically 
corrected for ARA and followed up in clinics.  We will be able to identify 
what is causing some patients to have these difficulties and offer future 
treatment suggestions.  At least 60 participants at the Royal London 
Hospital will be involved in this study that has been corrected with ARA.   
 
Participation in this project is voluntary if you decide not to take part or 
decide to withdraw at any time this will not otherwise affect your 
relationship with the hospital or have any impact on the care you may be 
receiving.   
 
I have attached a ‘Participants Information Sheet’ for your convenience.  
Please feel free to contact the research doctor in charge Eleni 
Athanasakos who will be able to answer any questions and further explain 
the research project if needed.  
 
If you are interested in participating please call Eleni Athanasakos on 
0207 882 2626 or 078 1368 2226. 
 
Thank you kindly 
 
 
 
 
 
Eleni Athanasakos 
Clinical Researcher 
 
 
 
 
 
 
 
 
 
 
 
  
 
303
 
Appendix – C Letter of Invitation 
Parent Version for IC 
      
 
 
 
 
 
 
Date 
 
 
 
 
To: FAMILY NAME/ADDRESS 
 
Title: Quality of life with patients with Idiopathic Constipation 
 
Dear FAMILY NAME,  
 
As discussed on the telephone, we would like to invite your child to take 
part in a research study at Barts and The London, Queen Mary University 
of London.   
 
The purpose of this research study is to access the quality of life of your 
child who has been diagnosed with idiopathic constipation.  It will give us 
the opportunity to further understand our knowledge of what life has 
been like for your child living with this condition and to compare results 
to other bowel diseases.   
 
Eleni Athanasakos 
Barts & The London  
Queen Mary University of London 
Department of Paediatric Surgery  
 
The Wingate Institute of Neurogastroenterology 
26 Ashfield Street 
Whitechapel 
London  
E1 2AJ 
 
Tel:0207 882 2626  
        Fax:0207 375 2103 
Email: e.athanasakos@qmul.ac.uk 
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Your child has been invited to this research study as they have been seen 
and followed up in clinics here at the Royal London Hospital.  At least 60 
participants at the Royal London Hospital will be involved in this study 
that have the same condition.   
 
Participation in this project is voluntary if your child decides not to take 
part or decide to withdraw at any time this will not otherwise affect 
their relationship with the hospital or have any impact on the care your 
child may be receiving.   
 
Please feel free to contact the research doctor in charge Eleni 
Athanasakos who will be able to answer any questions and further explain 
the research project if needed.  
 
Your appointment is on 21/08/08 at 10.30AM.  If you have any questions, 
please contact Eleni Athanasakos on 0207 882 2626 or on 07813 682226. 
 
 
Thank you kindly 
 
 
 
 
 
Eleni Athanasakos 
Clinical Researcher 
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Appendix – C Letter of Invitation 
Patient Version for IC 
      
 
 
 
 
 
 
 
 
Date 
 
 
 
To: PARTICIPANT’S NAME/ADDRESS 
 
Title: Quality of life with patients with Idiopathic Constipation 
 
Dear PARTICIPANT’S NAME  
 
As discussed on the telephone, we would like to invite you to take part in 
a research study at Barts and The London, Queen Mary University of 
London.   
 
The purpose of this research study is to access the quality of life with 
living with idiopathic constipation.  It will give us the opportunity to 
further understand our knowledge of what life has been like for you living 
with this condition and to compare results to other bowel diseases.    
 
You have been invited to this research study you have been seen and 
followed up in clinics here at the Royal London Hospital.  At least 60 
Eleni Athanasakos 
Barts & The London  
Queen Mary University of London 
Department of Paediatric Surgery  
 
The Wingate Institute of Neurogastroenterology 
26 Ashfield Street 
Whitechapel 
London  
E1 2AJ 
 
Tel:0207 882 2626  
        Fax:0207 375 2103 
Email: e.athanasakos@qmul.ac.uk 
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participants at the Royal London Hospital will be involved in this study 
that have the same condition.   
 
Participation in this project is voluntary if you decide not to take part or 
decide to withdraw at any time this will not otherwise your relationship 
with the hospital or have any impact on the care you may be receiving.   
 
Please feel free to contact the research doctor in charge Eleni 
Athanasakos who will be able to answer any questions and further explain 
the research project if needed.  
 
Your appointment is on 18/08/08 at 11AM at the above address (see 
attached map).  Please call Eleni Athanasakos on 0207 882 2626 or 07813 
682226 if needed. 
 
 
Thank you kindly 
 
 
 
 
 
Eleni Athanasakos 
Clinical Researcher 
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Appendix – C Letter of Invitation 
Parent Version for healthy controls 
      
 
 
 
 
 
 
 
 
 
Date: 
 
 
To: FAMILY NAME/ADDRESS 
 
 
Title: Quality of life of patients who have had an appendectomy 
 
Dear FAMILY NAME  
 
We would like to invite your child to take part in a research study at 
Barts and The London, Queen Mary University of London.   
 
The purpose of this research study is to access the quality of life after 
suffering from appendicitis.  It will give us the opportunity to further 
understand our knowledge of what life has been like for your child since 
having their operation for appendicitis and to compare results to other 
bowel diseases.  
 
Eleni Athanasakos 
Barts & The London  
Queen Mary University of London 
Department of Paediatric Surgery  
 
The Wingate Institute of Neurogastroenterology 
26 Ashfield Street 
Whitechapel 
London  
E1 2AJ 
 
Tel:0207 882 2626  
        Fax:0207 375 2103 
Email: e.athanasakos@qmul.ac.uk 
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Your child has been invited to this research study as they have been 
surgically corrected for appendicitis and followed up in clinics here at the 
Royal London Hospital.  At least 60 participants at the Royal London 
Hospital will be involved in this study that have been operated on for 
their appendicitis.   
 
Participation in this project is voluntary if your child decides not to take 
part or decide to withdraw at any time this will not otherwise affect 
their relationship with the hospital or have any impact on the care your 
child may be receiving.   
 
I have attached a ‘Participants Information Sheet’ for your convenience.  
Please feel free to contact the research doctor in charge Eleni 
Athanasakos who will be able to answer any questions and further explain 
the research project if needed.  
 
If your child is interested in participating please call Eleni Athanasakos 
on 0207 882 2626. 
 
 
Thank you kindly 
 
 
 
 
 
Eleni Athanasakos 
Clinical Researcher 
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Appendix – C Letter of Invitation 
Participant Version for healthy controls 
      
 
 
 
 
 
 
 
 
Date: 
 
 
 
 
To: PARTICIPANT’S NAME/ADDRESS 
 
Title: Quality of life of patients who have had an appendectomy 
 
Dear PARTICIPANT’S NAME 
We would like to invite you to take part in a research study at Barts and 
the London, Queen Mary University of London.   
 
The purpose of this research study is to access the quality of life after 
suffering from appendicitis.  It will give us the opportunity to further 
understand our knowledge of what life has been like for you since having 
your operation for appendicitis and to compare results to other bowel 
diseases. 
 
You have been invited to this research study as you have been surgically 
corrected for appendicitis and followed up in clinics here at the Royal 
London Hospital.  At least 60 participants at the Royal London Hospital 
Eleni Athanasakos 
Barts & The London  
Queen Mary University of London 
Department of Paediatric Surgery  
 
The Wingate Institute of Neurogastroenterology 
26 Ashfield Street 
Whitechapel 
London  
E1 2AJ 
 
Tel:0207 882 2626  
        Fax:0207 375 2103 
Email: e.athanasakos@qmul.ac.uk 
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will be involved in this study that have been operated on for their 
appendicitis.   
 
Participation in this project is voluntary if you decide not to take part or 
decide to withdraw at any time this will not otherwise affect your 
relationship with the hospital or have any impact on the care you may be 
receiving.   
 
I have attached a ‘Participants Information Sheet’ for your convenience.  
Please feel free to contact the research doctor in charge Eleni 
Athanasakos who will be able to answer any questions and further explain 
the research project if needed.  
 
If you are interested in participating please call Eleni Athanasakos on 
0207 882 2626. 
 
 
Thank you kindly 
 
 
 
 
 
Eleni Athanasakos 
Clinical Researcher 
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Appendix – D Patient Information Sheet 
Parents Version (ARA) 
      
 
Participant Information Sheet 
 
Project Title: Anorectal Function and Quality of Life of Patients with 
Anorectal Anomalies (ARA). 
 
 
Your child is being invited to take part in a research study.  Before you and your 
child decide it is important for you to understand why the research is being 
done and what it will involve for your child.  Please take time to read the 
following information carefully. Talk to others about the study if you wish.  This 
information sheet tells you the purpose of the study and what will happen to 
your child if they take part.  Ask us if there is anything that is not clear or if 
you would like more information.  Take time to decide whether or not you wish 
your child to take part. 
 
 
Q: What is the purpose of the study? 
Anorectal anomalies (or ARA) is a condition which affects how your child goes to 
the toilet.  People with ARA can suffer from bowel difficulties such as faecal 
incontinence (soiling).  Often ARA is treated surgically.  The purpose of this 
research study is to identify the reasons why patients with ARA suffer from 
these bowel difficulties after having surgery.  It will give us the opportunity to 
widen our understanding of what causes these bowel difficulties.   
 
Additionally, this research project will be towards a university research thesis 
(PhD) which is supervised by Mr Harry Ward and Professor Norman Williams.  
 
Q: Why has my child been chosen? 
Your child has been invited to this research study as your child has been 
surgically corrected for ARA and has been followed up in clinics.   We hope to 
identify what is causing some children to have these difficulties.  At least 60 
patients who have had similar surgery will be invited to participate in this study. 
 
Q: Does my child have to take part? 
No.  It is up to you and your child to decide whether or not to take part.  If you 
do, you will be given this information sheet to keep and be asked to sign a 
consent form with your child. Your child is still free to withdraw at any time and 
without giving a reason.  A decision to withdraw at any time, or a decision not to 
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take part, will not affect the standard of your child’s care. Your child will be 
expected to do all the tests since we need a good understanding of their current 
bowel function.    
 
Q: Does my child need to do anything before the appointment? 
Your child will be required to stop all laxative medication and the use of 
suppositories (if they are taking any) three days prior to their second 
appointment.  Otherwise, your child does not need to do anything different 
before their arrival at the Unit.  They can eat and drink as normal and continue 
to take any medication (not related to their bowels) that they would normally 
take.    
 
We will send you a small capsule in the post, which we will ask your child to 
swallow three days before their second appointment.  
 
Q: Does my child need to bring anyone with them? 
Yes.  It is important for you to come with your child in order for you to give 
consent.  
 
Q: What will happen when my child arrives for their appointment? 
Your child will be asked some questions relating to how their bowel works and 
the problems they may be having.  The clinical researcher (Eleni Athanasakos) 
will explain the procedures to you and your child then you and your child will be 
asked to sign a consent form, giving us permission to do the tests.   
 
Q: What will my child need do for the tests? 
In order for us to carry out the tests, your child will be asked to lie on a couch 
on their left side and we will explain what we are doing at each stage of every 
test.    
 
Q: Are these tests painful at all? 
No.  It can be embarrassing and a little uncomfortable to have these tests done 
to your back passage, but your child should not feel any pain.  These tests are 
carried out by Eleni Athanasakos whom you and your child will have already 
spoken to on a number of occasions.  She is committed to ensuring that any 
discomfort is minimised and that your child’s privacy is maintained at all times.  
 
Q: Why are these tests needed? 
These tests are an important part of the investigation and results will be 
available to your child’s doctor.  If you have any concerns or want further 
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information about these tests please do not hesitate to contact Eleni 
Athanasakos on 0207 882 2626.  
 
Q: So tell me about these tests: 
First of all you will get a call from the clinical researcher: Eleni Athanasakos.  
She will answer any questions you may have and organise a time for you and your 
child to come in.  The research study will be done over two days (but not 
consecutive days) at you and your child’s convenience.    
 
 
DAY 1  
We will require your child to come in for 1 hour.   Eleni Athanasakos will ask your 
child some questions about their quality of life living with ARA. These questions 
will ask your child about their everyday life, their views about the future and 
level of sadness and anxiety.   
DAY 2 
We will require your child to come for 1 hour to undergo some tests on their 
lower bowel/ back passage.  Each of the tests can tell the doctor something 
different about how your child’s bowel is working, and enable them to decide on 
the best treatment for their problem (if needed).  You and your child will have 
the chance to have a chat about any bowel difficulties they may be experiencing 
with Eleni Athanasakos who will be performing the tests and who will go through 
them step by step with you and your child.   
 
The tests will include: 
• Anal pressure measurements: this test measures the strength of the 
muscles in the back passage.  To do this, we insert a small tube (only 2mm 
thick) and ask your child either to relax or squeeze the muscles of their 
back passage.  This enables us to tell whether the muscles are 
functioning correctly.  
• Rectal Sensation & Barostat: this test enables us to measure how much 
volume the rectum can hold.  To do this a small tube with a small balloon 
attached to it is passed into the back passage.  We then inflate the 
balloon with air to determine what your child can feel and the size of 
their rectum.  During the test we also look to see if your child has a 
nerve reflex in their back passage.  
• Ultrasound: this test can tell if the muscles around the back passage are 
intact or if they are damaged.  To do this, a finger sized probe is 
inserted into the back passage and gently moved in and out so that we can 
take scans (pictures) at different positions in the back passage.  This 
procedure can be a little uncomfortable, but is not painful.  
• Colonic Transit: for this test your child will be asked to swallow a small 
capsule that we will send to your home.  This capsule contains 50 markers 
which can be seen on a standard x-ray.  On the day of the appointment 
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your child will have an x-ray of their stomach area, which will show up any 
markers left in their bowel.  Although your child will be exposed to 
radiation, this is a routine x-ray that we would do if they needed an x-ray 
in hospital, with minimal risk involved. 
 
Q: How long will these visits be?  
A maximum of 2 hrs. 
 
Q: Expenses and payments: 
As mentioned above, your child will be making two visits to the Gastrointestinal 
Unit at the Royal London Hospital.  Travelling expenses will be paid for you and 
your child and child-care expenses if needed.  If you or your child requires a 
letter of absence from work/school or any other commitments, this can also be 
arranged.   
 
Q: What are the side effects? 
There are no side effects of these tests for your child.  However, if any 
support is needed during or after these tests please contact Eleni Athanasakos 
on 0207 882 2626. 
 
Q: What are the other possible disadvantages and risks of taking part? 
As mentioned above, your child may be embarrassed and a little uncomfortable 
doing these tests but there are no risks involved and your child should not feel 
any pain. The presence of professional staff will ensure your child’s privacy at all 
times.    
 
Q: Will my child have an x-ray? 
Yes, as mentioned above they will have what is called a ‘colonic transit test’.  
This is not harmful but simply a chance to see how their bowel works.  However, 
if your child is pregnant they should not have this test because of exposure to 
radiation to their unborn baby.  If you are unsure whether your child is 
pregnant, we can perform a pregnancy test to clarify this prior to the x-ray.   
Although your child will be exposed to radiation, this is a routine x-ray that that 
they would have if they needed an x-ray in hospital, with minimal risk involved. 
  
Q: What are the possible benefits of taking part? 
The research project will provide an idea of what is causing your child to suffer 
from bowel difficulties (if any).  This research project will attempt to provide 
an answer as to why those with ARA suffer from bowel problems and how we can 
improve future management and other forms of treatment. We cannot promise 
that the study will help your child but the information we get might help improve 
the treatment of people with ARA.   
 
Q: What happens when the research study stops? 
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We will inform you of the results of your tests when completed and analysed. 
You will, at all times get feedback about your child’s participation.  After the 
research study you will have an idea of how your child is doing and why children 
with ARA after surgery can have bowel difficulties.  
 
The results of this research study will be written for a medical audience in the 
form of publications or presentations but your child’s name will not be revealed 
at any time.  You and your child will not be identified in any report or publication. 
 
Q: What if there is a problem? 
If your child is harmed by taking part in this research project, there are no 
special compensation arrangements. If your child is harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have to pay 
for it.   Regardless of this, if you wish to complain, or have any concerns about 
any aspect of the way you or your child have been approached or treated during 
the course of this study, the normal National Health Service complaints 
mechanisms are available to you.   
 
If you have a concern about any aspect of this study, you can speak to Eleni 
Athanasakos 0207 882 2626. You and your child can also contact the Patient 
Advisory Liaison Service (PALS) if you have any concerns regarding the care you 
and your child have received, or as an initial point of contact if you have 
a complaint.  Please telephone 020 7377 6335, minicom 020 7943 1350, or email 
pals@bartsandthelondon.nhs.uk, You can also visit PALS by asking at any hospital 
reception. 
 
Q: Will my child taking part in the study be kept confidential?  
Yes.  All the information about your child’s participation in this study will be 
kept confidential. All test results, questionnaire answers and records from your 
child’s hospital notes will be kept on a computer file.  This file can only be 
accessed by the researchers involved in this project.  
 
Q: What will happen if my child doesn’t want to carry on with the study? 
Please remember that your child doesn’t have to join the study and you and your 
child are free to decline our invitation.  If your child decides against joining the 
study, this will in no way affect their medical care.  If they decide to take part 
but at some stage wish to discontinue with the study, this will not affect their 
continuing medical care and all results will be discarded and not used for the 
research study.   
Q: Involvement of the General Practitioner/Family doctor (GP)  
Your child’s GP will be notified of your child’s participation in this research 
study, if you and your child consent.  If your GP requests the information or 
results from this research study this will only be with you and your child’s 
consent. 
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Q: Will any genetic tests be done?   
No.  
 
Q: Who has reviewed the study?  
This study was given a favourable ethical opinion for conduct in the NHS by the 
East London and the City Research Ethics Committee 3. 
 
Q: Contact Details: 
For further information about the study please call Eleni Athanasakos who is in 
charge of this research study on 0207 882 2626.  
 
 
 
Thank you for taking time to read this information sheet. 
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Appendix – D Patient Information Sheet 
Patient Version (ARA) 
      
Participant Information Sheet 
 
Project Title: Anorectal Function and Quality of Life of Patients with 
Anorectal Anomalies (ARA). 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully. Talk to 
others about the study if you wish.  This information sheet tells you the purpose 
of the study and what will happen to you if you take part.  Ask us if there is 
anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part. 
 
 
Q: What is the purpose of the study? 
Anorectal anomalies (or ARA) is a condition which affects how you go to the 
toilet.  People with ARA can suffer from bowel difficulties such as faecal 
incontinence (soiling).  Often ARA is treated surgically.  The purpose of this 
research study is to identify the reasons why patients with ARA, like yourself 
are suffering from these bowel difficulties after having surgery.  It will give us 
the opportunity to further understand what causes these bowel difficulties by 
investigating the anatomy and physiology of the anorectum.   
 
Additionally, this research project will be towards a university research thesis 
(PhD) which is supervised by Mr Harry Ward and Professor Norman Williams.   
 
Q: Why have I been chosen? 
You have been invited to this research study as you have been surgically 
corrected for ARA.  We hope to identify what is causing some patients to have 
difficulties with their condition.  At least 60 patients who have had similar 
surgery will be invited to participate in this study.   
 
Q: Do I have to take part? 
No.  It is up to you to decide whether or not to take part.  If you do, you will be 
given this information sheet to keep and be asked to sign a consent form. You 
are still free to withdraw at any time and without giving a reason.  A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard 
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of care you receive. You will be expected to do all the tests since we need a 
good understanding of your current bowel function.    
 
Q: Do I need to do anything before the appointment? 
You will be required to stop all laxative medication and the use of suppositories 
(if taking any) three days prior to your second appointment.  Otherwise, you do 
not need to do anything before your arrival at the Unit.  You can eat and drink 
as normal and continue to take any medication (not related to your bowels) that 
you would normally take.  You do not need to use any bowel preparation (laxative, 
enemas).   We will send you a small capsule in the post, which we will ask you to 
swallow three days before your second appointment.  
 
Q: Do I need to bring anyone with me? 
No.  There is no reason why the tests should have any adverse effects.  
However, you are welcome to bring along somebody for support if you so require.  
 
Q: What will happen when I arrive for my appointment? 
You will be asked some questions relating to how your bowel works and any 
problems you may be having.  The clinical researcher (Eleni Athanasakos) will 
explain the procedures to you and you will be asked to sign a consent form, 
giving us permission to do the tests.   
 
Q: What will I need do for the tests? 
In order for us to carry out the tests, you will be asked to lie on a couch on your 
left side and we will explain to you what we are doing at each stage of every 
test.    
 
Q: Are these tests painful at all? 
No.  It can be embarrassing and a little uncomfortable to have these tests done 
on your back passage, but you should not feel any pain.  These tests are carried 
out by Eleni Athanasakos whom you will have already spoken to on a number of 
occasions prior to doing these tests.  She is committed to ensuring that any 
discomfort is minimised and that your privacy is maintained at all times.  
 
Q: Why are these tests needed? 
These tests are an important part of the investigation and your results will be 
available to your doctor taking care of you..  If you have any concerns or want 
further information about these tests please do not hesitate to contact Eleni 
Athanasakos on 0207 882 2626.  
 
  
 
319
Q: So tell me about these tests: 
First of all you will get a call from the clinical researcher: Eleni Athanasakos.  
She will answer any questions you may have and organise a time to come in.  The 
research study will be done over two days (but not consecutive days) at your 
convenience.    
 
DAY 1: 
We will require you to come in for 1 hour.   Eleni Athanasakos will ask you some 
questions about your quality of life living with ARA. These questions will ask you 
about your everyday life, your views about the future and level of sadness and 
anxiety.   
 
DAY 2: 
We will require you to come for 1 hour to undergo some tests on your lower 
bowel/ back passage.  Each of the tests can tell the doctor something different 
about how your bowel is working, and enable them to decide on the best 
treatment for your problem (if needed).  You will have the chance to have a chat 
about the bowel difficulties you may be experiencing with Eleni Athanasakos who 
will be performing the tests and who will thoroughly go through each test step 
by step with you.   
 
The tests will include:  
• Anal pressure measurements: this test measures the strength of the 
muscles in the back passage.  To do this, we insert a small tube (only 2mm 
thick) and ask you either to relax or squeeze the muscles of the back 
passage.  This enables us to tell whether the muscles are functioning 
correctly.  
• Rectal Sensation & Barostat: this test enables us to measure how much 
volume your rectum can hold.  To do this a small tube with a small balloon 
attached to it is passed into your back passage.  We then inflate the 
balloon with air to determine what you can feel and the size of your 
rectum.  During the test we also look to see if you have a nerve reflex in 
your back passage.  
• Ultrasound: this test can tell if the muscles around your back passage are 
intact or if they are damaged.  To do this, a finger sized probe is 
inserted into your back passage and gently moved in and out so that we 
can take scans (pictures) at different positions in your back passage.  
This procedure can be little uncomfortable, but is not painful.   
• Colonic Transit: for this test you will be asked to swallow a small capsule 
that we will send to your home.  This capsule contains 50 markers which 
can be seen on a standard x-ray.  On the day of your appointment you will 
have an x-ray of your stomach area, which will show up any markers left 
in your bowel. Although you will be exposed to radiation, this is a routine 
x-ray that we would do if they needed an x-ray in hospital, with minimal 
risk involved. 
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Q: How long will these visits be?  
A maximum of 2 hours. 
 
Q: Expenses and payments: 
As mentioned above, you will be making two visits to the Gastrointestinal 
Physiology Unit at the Royal London Hospital.  Your travelling expenses will be 
paid for and if needed child-care expenses.  If you require a letter of absence 
from work or any other commitment, this can be also arranged for you if 
required.   
 
Q: What are the side effects? 
There are no side effects after these tests for you.  However, if any support is 
needed during or after these tests please contact Eleni Athanasakos on 0207 
882 2626. 
 
Q: What are the other possible disadvantages and risks of taking part? 
As mentioned above, you may be embarrassed and a little uncomfortable doing 
these tests but there are no risks involved.  The presence of professional staff 
will ensure your privacy at all times.    
 
Q: Do I have an x-ray? 
Yes, as mentioned above you will have what is called a ‘colonic transit test’.  This 
is not harmful, but simply a chance to see how your bowel works.  However, if 
you are pregnant, you should not have this test due to exposure to radiation to 
your unborn baby.  If you are unsure if you are pregnant, we can perform a 
pregnancy test to clarify this prior to the x-ray.  As indicated, you will be 
exposed to radiation on your stomach area, however this is a routine x-ray that 
you would have if they needed an x-ray in hospital, with minimal risk involved. 
 
Q: What are the possible benefits of taking part? 
The research project will provide an idea of what is causing you to suffer from 
bowel difficulties.  It will attempt to provide an answer as to why those with 
ARA suffer from bowel problems and how we can improve future management 
and other forms of treatment. We cannot promise the study will help you but 
the information we get might help improve the treatment of people with ARA.   
 
 
Q: What happens when the research study stops? 
We will inform you of the results of your tests when completed and analysed.  
You will at all times get feedback about your participation.  After the research 
study you will have an idea why you are having bowel difficulties.   
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The results of this research study will be written for a medical audience in the 
form of publications or presentations, but your name will not be revealed at any 
time.  You will not be identified in any report or publication. 
 
Q: What if there is a problem? 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s negligence, 
then you may have grounds for legal action but you may have to pay for it.  
Regardless of this, if you wish to complain, or have any concerns about any 
aspect of the way you have been approached or treated during the course of 
this study, the normal National Health Service complaints mechanisms are 
available to you.   
 
If you have a concern about any aspect of this study, you can to Eleni 
Athanasakos on 0207 882 2626.  You can also contact Patient Advisory Liaison 
Service (PALS) if you have any concerns regarding the care you have received, 
or as an initial point of contact if you have a complaint.  Please telephone 020 
7377 6335, minicom 020 7943 1350, or email pals@bartsandthelondon.nhs.uk, 
you can also visit PALS by asking at any hospital reception. 
 
 
Q: Will my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept 
confidential. All test results, questionnaire answers and records from your 
hospital notes will be kept on a computer file.  This file can only be accessed by 
the researchers involved in this project.   
 
Q: What will happen if I don’t want to carry on with the study? 
Please remember that you do not have to join the study and are free to decline 
our invitation.  If you decide against joining the study, this will in no way affect 
your medical care.  If you decide to take part but at some stage wish to 
discontinue with the study, this will not affect your continuing medical care and 
all results will be discarded and not used for the research study. 
Q: Involvement of the General Practitioner/Family doctor (GP)?  
Your GP will be notified of your participation in this research study, with your 
consent.  If your GP requests information or results from this research study 
this will be with your consent also.   
 
 
Q: Will any genetic tests be done?   
No.  
 
Q: Who has reviewed the study?  
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This study was given a favourable ethical opinion for conduct in the NHS by the 
East London and the City Research Ethics Committee 3. 
 
Q: Contact Details: 
For further information about the study please call Eleni Athanasakos who is in 
charge of this research study on 0207 882 2626. 
 
 
Thank you for taking time to read this information sheet. 
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Appendix – D Patient Information Sheet 
Parents Version (IC) 
   
Participant Information Sheet 
 
Project Title: Quality of life with patients with Idiopathic 
Constipation 
 
Your child is being invited to take part in a research study.  Before you and your 
child decide it is important for you to understand why the research is being 
done and what it will involve for your child.  Please take time to read the 
following information carefully. Talk to others about the study if you wish.  This 
information sheet tells you the purpose of the study and what will happen to 
your child if they take part.  Ask us if there is anything that is not clear or if 
you would like more information.  Take time to decide whether or not you wish 
your child to take part. 
 
 
Q: What is the purpose of the study? 
Constipation is passage of small amounts of hard, dry bowel movements, usually 
fewer than three times a week. People who are constipated may find it difficult 
and painful to have a bowel movement. Idiopathic constipation is a condition that 
refers to an inability to regularly pass stool. The term ‘idiopathic’ means that 
the origin of the problem is unknown.  It is one of the most common bowel 
movement disorders among children and adolescents.  The purpose of this 
research study is to access the quality of life of your child who has been 
diagnosed with idiopathic constipation.  It will give us the opportunity to further 
understand our knowledge of what it has been like for your child living with this 
condition and to compare results to other bowel diseases.    
 
Additionally, this research project will be towards a university research thesis 
(PhD) which is supervised by Mr Harry Ward and Professor Norman Williams.  
 
Q: Why has my child been chosen? 
Your child has been invited to this research study as they have been seen and 
followed up in clinics here at the Royal London Hospital.  At least 60 participants 
at the Royal London Hospital will be involved in this study that have the same 
condition.   
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Q: Does my child have to take part? 
No.  It is up to you and your child to decide whether or not to take part.  If 
you do, you will be given this information sheet to keep and be asked to sign a 
consent form with your child. Your child is still free to withdraw at any time 
and without giving a reason.  A decision to withdraw at any time, or a decision 
not to take part, will not affect the standard of your child’s care.  
 
Q: Does my child need to do anything before the appointment? 
Your child does not need to do anything before their appointment with us.   
 
Q: Does my child need to bring anyone with them? 
Yes.  It is important for you to come with your child in order for you to give 
consent.  
 
Q: What will happen when my child arrives for their appointment? 
Your child will be asked some questions about their general quality of life.  The 
clinical researcher (Eleni Athanasakos) will explain the questionnaires to you and 
your child then you and your child will be asked to sign a consent form, giving us 
permission to continue with the questionnaires.   
 
Q: So tell me about the appointment: 
First of all you will get a call from the clinical researcher: Eleni Athanasakos.  
She will answer any questions you may have and organise a time for you and your 
child to come in.  The research study will be done in one day at you and your 
child’s convenience. We will require your child to come in for 1 hour.   Eleni 
Athanasakos will ask your child some questions about their quality of life living 
with idiopathic constipation. These questions will ask your child about their 
everyday life, their views about the future and level of sadness and anxiety.   
 
Q: How long will these visits be?  
A maximum of 1 hr. 
 
Q: Expenses and payments: 
Travelling expenses will be paid for you and your child and child-care expenses if 
needed.  If you or your child requires a letter of absence from work/school or 
any other commitments, this can also be arranged.   
 
Q: What are the possible disadvantages and risks of taking part? 
There are no risks involved and the presence of professional staff (Eleni 
Athanasakos) will ensure your child’s privacy at all times.    
 
Q: What are the possible benefits of taking part? 
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The research project will provide an idea how your child is coping with everyday 
life living with idiopathic constipation.   
 
Q: What happens when the research study stops? 
We will inform you of the results of your tests when completed and analysed. 
You will, at all times get feedback about your child’s participation.     
 
The results of this research study will be written for a medical audience in the 
form of publications or presentations but your child’s name will not be revealed 
at any time.  You and your child will not be identified in any report or publication. 
 
Q: What if there is a problem? 
If your child is harmed by taking part in this research project, there are no 
special compensation arrangements. If your child is harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have to pay 
for it.   Regardless of this, if you wish to complain, or have any concerns about 
any aspect of the way you or your child have been approached or treated during 
the course of this study, the normal National Health Service complaints 
mechanisms are available to you.   
 
If you have a concern about any aspect of this study, you can speak to Eleni 
Athanasakos 0207 882 2626. You and your child can also contact the Patient 
Advisory Liaison Service (PALS) if you have any concerns regarding the care you 
and your child have received, or as an initial point of contact if you have 
a complaint.  Please telephone 020 7377 6335, minicom 020 7943 1350, or email 
pals@bartsandthelondon.nhs.uk, You can also visit PALS by asking at any hospital 
reception. 
 
Q: Will my child taking part in the study be kept confidential?  
Yes.  All the information about your child’s participation in this study will be 
kept confidential. All questionnaire answers and records from your child’s 
hospital notes will be kept on a computer file.  This file can only be accessed by 
the researchers involved in this project.  
 
Q: What will happen if my child doesn’t want to carry on with the study? 
Please remember that your child doesn’t have to join the study and you and your 
child are free to decline our invitation.  If your child decides against joining the 
study, this will in no way affect their medical care.  If they decide to take part 
but at some stage wish to discontinue with the study, this will not affect their 
continuing medical care and all results will be discarded and not used for the 
research study.   
 
Q: Involvement of the General Practitioner/Family doctor (GP)  
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Your child’s GP will not be notified of your child’s participation in this research 
study. 
 
Q: Will any genetic tests be done?   
No.  
 
Q: Who has reviewed the study?  
This study was given a favourable ethical opinion for conduct in the NHS by the 
East London and the City Research Ethics Committee 3. 
 
Q: Contact Details: 
For further information about the study please call Eleni Athanasakos who is in 
charge of this research study on 0207 882 2626.  
 
 
 
Thank you for taking time to read this information sheet. 
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Appendix – D Patient Information Sheet 
Patient Version (IC) 
 
      
 
Participant Information Sheet 
 
 
Project Title: Quality of life with patients with Idiopathic 
Constipation 
 
You are being invited to take part in a research project.  Before you decide it is 
important for you to understand why the research is being done in the first 
place and what it will involve.  Please take time to read this information sheet 
carefully. Have a chat to others about the study if you wish.  This information 
sheet tells you about the research project and what will happen to you if you 
take part.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part.  You 
should have a chat with your parent/s or carer/s before deciding to become 
involved.  
 
 
Q: What is the purpose of the study? 
Constipation is passage of small amounts of hard, dry bowel movements, usually 
fewer than three times a week. People who are constipated may find it difficult 
and painful to have a bowel movement. Idiopathic constipation is a condition that 
refers to an inability to regularly pass stool. The term ‘idiopathic’ means that 
the origin of the problem is unknown.  It is one of the most common bowel 
movement disorders among children and adolescents.  The purpose of this 
research study is to access your quality of life with idiopathic constipation.  It 
will give us the opportunity to further understand our knowledge of what it has 
been like for you living with this condition and to compare results to other bowel 
diseases.   
 
Additionally, this research project will be towards a university research thesis 
(PhD) which is supervised by Mr Harry Ward and Professor Norman Williams.  
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Q: Why have I been chosen? 
You have been invited to this research study as you have been seen and followed 
up in clinics here at the Royal London Hospital.  At least 60 participants at the 
Royal London Hospital will be involved in this study that have the same condition.   
 
 
Q: Do I have to take part? 
No.  It is up to you to decide whether or not to take part.  If you do, you will be 
given this information sheet to keep and be asked to sign a consent form. You 
are still free to withdraw at any time and without giving a reason.  A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard 
of your care.  
 
Q: Do I need to do anything before the appointment? 
You do not need to do anything before the appointment with us.   
 
Q: Do I need to bring anyone with them? 
No, unless you would like to.   
 
Q: What will happen when I arrive for their appointment? 
You will be asked some questions about your general quality of life.  The clinical 
researcher (Eleni Athanasakos) will explain the questionnaires to you and then 
you will be asked to sign a consent form, giving us permission to continue with 
the questionnaires.   
 
Q: So tell me about the appointment: 
First of all you will get a call from the clinical researcher: Eleni Athanasakos.  
She will answer any questions you may have and organise a time for you to come 
in.  The research study will be done in one day at your convenience. We will 
require you to come in for 1 hour.   Eleni Athanasakos will ask you some questions 
about your quality of life living with idiopathic constipation. These questions will 
ask you about your everyday life, your views about the future and level of 
sadness and anxiety.   
 
Q: How long will these visits be?  
A maximum of 1 hr. 
 
Q: Expenses and payments: 
Travelling expenses will be paid for you and child-care expenses if needed.  If 
you require a letter of absence from work/school or any other commitments, 
this can also be arranged.   
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Q: What are the possible disadvantages and risks of taking part? 
There are no risks involved and the presence of professional staff (Eleni 
Athanasakos) will ensure your privacy at all times.    
 
Q: What are the possible benefits of taking part? 
The research project will provide an idea how you are coping with everyday life 
living with idiopathic constipation.   
 
Q: What happens when the research study stops? 
We will inform you of the results of your tests when completed and analysed. 
You will, at all times get feedback about your participation.     
 
The results of this research study will be written for a medical audience in the 
form of publications or presentations but your child’s name will not be revealed 
at any time.  You will not be identified in any report or publication. 
 
Q: What if there is a problem or something goes wrong? 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s negligence, 
then you may have grounds for legal action but you may have to pay for it.  
Regardless of this, if you wish to complain, or have any concerns about any 
aspect of the way you have been approached or treated during the course of 
this study, the normal National Health Service complaints mechanisms are 
available to you.   
 
If you have a concern about any aspect of this study, you can to Eleni 
Athanasakos on 0207 882 2626.  You can also contact Patient Advisory Liaison 
Service (PALS) if you have any concerns regarding the care you have received, 
or as an initial point of contact if you have a complaint.  Please telephone 020 
7377 6335, minicom 020 7943 1350, or email pals@bartsandthelondon.nhs.uk, 
you can also visit PALS by asking at any hospital reception. 
 
Q: Will my taking part in the study be kept confidential?  
Yes.  All the information about you in this study will be kept confidential. All 
questionnaire answers and records from your hospital notes will be kept on a 
computer file.  This file can only be accessed by the researchers involved in this 
project.   
 
Q: What will happen if I don’t want to carry on with the study? 
Please remember that you do not have to join the study and are free to say no.  
If you decide against joining the study, this will not affect your medical care.  
If you decide to take part but at some stage wish to drop out of the study, this 
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will not affect your continuing medical care and all results will be discarded and 
not used for the research study. 
Q: Involvement of the General Practitioner/Family doctor (GP)  
Your GP will not be notified of your child’s participation in this research study. 
 
Q: Will any genetic tests be done?   
No.  
 
Q: Who has reviewed the study?  
This study was given a favourable ethical opinion for conduct in the NHS by the 
East London and the City Research Ethics Committee 3. 
 
Q: Contact Details: 
For further information about the study please call Eleni Athanasakos who is in 
charge of this research study on 0207 882 2626.  
 
 
 
Thank you for taking time to read this information sheet. 
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Appendix – D Patient Information Sheet 
Parents Version (healthy controls) 
   
Participant Information Sheet 
 
Project Title: Quality of life of patients who have had an 
appendectomy 
 
Your child is being invited to take part in a research study.  Before you and your 
child decide it is important for you to understand why the research is being 
done and what it will involve for your child.  Please take time to read the 
following information carefully. Talk to others about the study if you wish.  This 
information sheet tells you the purpose of the study and what will happen to 
your child if they take part.  Ask us if there is anything that is not clear or if 
you would like more information.  Take time to decide whether or not you wish 
your child to take part. 
 
 
Q: What is the purpose of the study? 
Appendicitis is an inflammation of the appendix, a small worm-like pouch 
attached to the large bowel. Surgical removal of the appendix (appendicectomy) 
is the most common procedure.  The purpose of this research study is to access 
the quality of life after suffering from appendicitis.  It will give us the 
opportunity to further understand our knowledge of what life has been like for 
your child since having their operation for appendicitis and to compare results 
to other bowel diseases.    
 
Additionally, this research project will be towards a university research thesis 
(PhD) which is supervised by Mr Harry Ward and Professor Norman Williams.  
 
Q: Why has my child been chosen? 
Your child has been invited to this research study as they have been surgically 
corrected for appendicitis and followed up in clinics here at the Royal London 
Hospital.  At least 60 participants at the Royal London Hospital will be involved 
in this study that have been operated on for their appendicitis.   
 
Q: Does my child have to take part? 
No.  It is up to you and your child to decide whether or not to take part.  If 
you do, you will be given this information sheet to keep and be asked to sign a 
consent form with your child. Your child is still free to withdraw at any time 
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and without giving a reason.  A decision to withdraw at any time, or a decision 
not to take part, will not affect the standard of your child’s care.  
 
Q: Does my child need to do anything before the appointment? 
Your child does not need to do anything before their appointment with us.   
 
Q: Does my child need to bring anyone with them? 
Yes.  It is important for you to come with your child in order for you to give 
consent.  
 
Q: What will happen when my child arrives for their appointment? 
Your child will be asked some questions about their general quality of life.  The 
clinical researcher (Eleni Athanasakos) will explain the questionnaires to you and 
your child then you and your child will be asked to sign a consent form, giving us 
permission to continue with the questionnaires.   
 
Q: So tell me about the appointment: 
First of all you will get a call from the clinical researcher: Eleni Athanasakos.  
She will answer any questions you may have and organise a time for you and your 
child to come in.  The research study will be done in one day at you and your 
child’s convenience. We will require your child to come in for 1 hour.   Eleni 
Athanasakos will ask your child some questions about their general quality of 
life. These questions will ask your child about their everyday life, their views 
about the future and level of sadness and anxiety.   
 
Q: How long will these visits be?  
A maximum of 1 hour. 
 
Q: Expenses and payments: 
Travelling expenses will be paid for you and your child and child-care expenses if 
needed.  If you or your child requires a letter of absence from work/school or 
any other commitments, this can also be arranged.   
 
Q: What are the possible disadvantages and risks of taking part? 
There are no risks involved and the presence of professional staff (Eleni 
Athanasakos) will ensure your child’s privacy at all times.    
 
Q: What are the possible benefits of taking part? 
The research project will provide an idea how your child is coping with everyday 
life..   
Q: What happens when the research study stops? 
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We will inform you of the results of your tests when completed and analysed. 
You will, at all times get feedback about your child’s participation.     
 
The results of this research study will be written for a medical audience in the 
form of publications or presentations but your child’s name will not be revealed 
at any time.  You and your child will not be identified in any report or publication. 
 
Q: What if there is a problem? 
If your child is harmed by taking part in this research project, there are no 
special compensation arrangements. If your child is harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have to pay 
for it.   Regardless of this, if you wish to complain, or have any concerns about 
any aspect of the way you or your child have been approached or treated during 
the course of this study, the normal National Health Service complaints 
mechanisms are available to you.   
 
If you have a concern about any aspect of this study, you can speak to Eleni 
Athanasakos 0207 882 2626. You and your child can also contact the Patient 
Advisory Liaison Service (PALS) if you have any concerns regarding the care you 
and your child have received, or as an initial point of contact if you have 
a complaint.  Please telephone 020 7377 6335, minicom 020 7943 1350, or email 
pals@bartsandthelondon.nhs.uk, You can also visit PALS by asking at any hospital 
reception. 
 
Q: Will my child taking part in the study be kept confidential?  
Yes.  All the information about your child’s participation in this study will be 
kept confidential. All questionnaire answers and records from your child’s 
hospital notes will be kept on a computer file.  This file can only be accessed by 
the researchers involved in this project.  
 
Q: What will happen if my child doesn’t want to carry on with the study? 
Please remember that your child doesn’t have to join the study and you and 
your child are free to decline our invitation.  If your child decides against 
joining the study, this will in no way affect their medical care.  If they decide 
to take part but at some stage wish to discontinue with the study, this will 
not affect their continuing medical care and all results will be discarded and 
not used for the research study.   
Q: Involvement of the General Practitioner/Family doctor (GP)  
Your child’s GP will not be notified of your child’s participation in this research 
study. 
 
Q: Will any genetic tests be done?   
No.  
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Q: Who has reviewed the study?  
This study was given a favourable ethical opinion for conduct in the NHS by the 
East London and the City Research Ethics Committee 3. 
 
Q: Contact Details: 
For further information about the study please call Eleni Athanasakos who is in 
charge of this research study on 0207 882 2626.  
 
 
 
Thank you for taking time to read this information sheet. 
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Appendix – D Patient Information Sheet 
Participant Version  (healthy controls) 
      
 
Participant Information Sheet 
 
Project Title: Quality of life of patients who have had an 
appendectomy 
 
 
You are being invited to take part in a research project.  Before you decide it is 
important for you to understand why the research is being done in the first 
place and what it will involve.  Please take time to read this information sheet 
carefully. Have a chat to others about the study if you wish.  This information 
sheet tells you about the research project and what will happen to you if you 
take part.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part.  You 
should have a chat with your parent/s or carer/s before deciding to become 
involved.  
 
 
Q: What is the purpose of the study? 
Appendicitis is an inflammation of the appendix, a small worm-like pouch 
attached to the large bowel. Surgical removal of the appendix (appendicectomy) 
is the most common procedure.  The purpose of this research study is to access 
the quality of life after suffering from appendicitis.  It will give us the 
opportunity to further understand our knowledge of what life has been like for 
you since having their operation for appendicitis and to compare results to other 
bowel diseases. 
 
Additionally, this research project will be towards a university research thesis 
(PhD) which is supervised by Mr Harry Ward and Professor Norman Williams.  
 
Q: Why have I been chosen? 
You have been invited to this research study as you have been surgically 
corrected for appendicitis and followed up in clinics here at the Royal London 
Hospital.  At least 60 participants at the Royal London Hospital will be involved 
in this study that have been operated on for their appendicitis.   
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Q: Do I have to take part? 
No.  It is up to you to decide whether or not to take part.  If you do, you will be 
given this information sheet to keep and be asked to sign a consent form. You 
are still free to withdraw at any time and without giving a reason.  A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard 
of your care.  
 
Q: Do I need to do anything before the appointment? 
You do not need to do anything before the appointment with us.   
 
Q: Do I need to bring anyone with them? 
No, unless you would like to.   
 
Q: What will happen when I arrive for their appointment? 
You will be asked some questions about your general quality of life.  The clinical 
researcher (Eleni Athanasakos) will explain the questionnaires to you and then 
you will be asked to sign a consent form, giving us permission to continue with 
the questionnaires.   
 
Q: So tell me about the appointment: 
First of all you will get a call from the clinical researcher: Eleni Athanasakos.  
She will answer any questions you may have and organise a time for you to come 
in.  The research study will be done in one day at your convenience. We will 
require you to come in for 1 hour.  Eleni Athanasakos will ask you some questions 
about your general quality of life. These questions will ask you about your 
everyday life, your views about the future and level of sadness and anxiety.   
 
How long will these visits be?  
A maximum of 1 hour. 
 
Q: Expenses and payments: 
Travelling expenses will be paid for you and child-care expenses if needed.  If 
you require a letter of absence from work/school or any other commitments, 
this can also be arranged.   
 
Q: What are the possible disadvantages and risks of taking part? 
There are no risks involved and the presence of professional staff (Eleni 
Athanasakos) will ensure your privacy at all times.    
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Q: What are the possible benefits of taking part? 
The research project will provide an idea how you are coping with everyday life 
living with idiopathic constipation.   
 
Q: What happens when the research study stops? 
We will inform you of the results of your tests when completed and analysed. 
You will, at all times get feedback about your participation.     
 
The results of this research study will be written for a medical audience in the 
form of publications or presentations but your child’s name will not be revealed 
at any time.  You will not be identified in any report or publication. 
 
Q: What if there is a problem or something goes wrong? 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s negligence, 
then you may have grounds for legal action but you may have to pay for it.  
Regardless of this, if you wish to complain, or have any concerns about any 
aspect of the way you have been approached or treated during the course of 
this study, the normal National Health Service complaints mechanisms are 
available to you.   
 
If you have a concern about any aspect of this study, you can to Eleni 
Athanasakos on 0207 882 2626.  You can also contact Patient Advisory Liaison 
Service (PALS) if you have any concerns regarding the care you have received, 
or as an initial point of contact if you have a complaint.  Please telephone 020 
7377 6335, minicom 020 7943 1350, or email pals@bartsandthelondon.nhs.uk, 
you can also visit PALS by asking at any hospital reception. 
 
Q: Will my taking part in the study be kept confidential?  
Yes.  All the information about you in this study will be kept confidential. All 
questionnaire answers and records from your hospital notes will be kept on a 
computer file.  This file can only be accessed by the researchers involved in this 
project.   
 
Q: What will happen if I don’t want to carry on with the study? 
Please remember that you do not have to join the study and are free to say no.  
If you decide against joining the study, this will not affect your medical care.  
If you decide to take part but at some stage wish to drop out of the study, this 
will not affect your continuing medical care and all results will be discarded and 
not used for the research study. 
Q: Involvement of the General Practitioner/Family doctor (GP)  
Your GP will not be notified of your child’s participation in this research study. 
 
Q: Will any genetic tests be done?   
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No.  
 
Q: Who has reviewed the study?  
This study was given a favourable ethical opinion for conduct in the NHS by the 
East London and the City Research Ethics Committee 3. 
 
Q: Contact Details: 
For further information about the study please call Eleni Athanasakos who is in 
charge of this research study on 0207 882 2626.  
 
 
 
Thank you for taking time to read this information sheet. 
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Appendix – E  Consent Form 
For ARA, IC and healthy controls 
      
 
CONSENT FORM  (Version 1  01/08/2006       ) 
 
Title of project:  
Investigator:  Eleni Athanasakos 
 
Centre Number:     Study Number:                Patient Identification Number for this 
trial: 
   
Please initial box to indicate agreement 
 
 
1. 
I confirm that I have read and understand the information sheet 
dated ............................ (version ............) for the above study. I have had the 
opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
 
2. 
I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected. 
 
 
 
3. 
I understand that relevant sections of any of my medical notes and data collected 
during  the study, may be looked at by responsible individuals from Barts and the 
London from regulatory authorities or from the Barts and the London/ Queen Mary 
University of London , where it is relevant to my taking part in this research.  I 
give permission for these individuals to have access to my records.  
 
4. I agree to my GP being informed of my participation in the study.  
5. I agree to take part in the above study.  
 
 
________________ ________________            _____________ 
Name of Patient Date Signature 
 
 
________________ ________________            _____________ 
Name of Person taking consent Date Signature 
(if different from Investigator) 
 
 
 
________________ ________________            _____________ 
Investigator Date  Signature 
 
 
 
 
1 copy for Patient, 1 for Investigator and original to be kept in medical notes 
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Appendix – E  Ascent Form 
For ARA, IC and healthy controls 
      
 
ASSENT FORM  (Version 1  01/08/2006       ) 
 
Title of project:  
Investigator:  Eleni Athanasakos 
 
Child (or if unable, parent on their behalf)/young person to circle all they agree with please: 
 
Centre Number:     Study Number:                Patient Identification Number for this 
trial: 
                                                                  
Please circle Yes or No 
 
1. Have you read (or had read to you) about this project?      Yes/No 
2. Has somebody else explained this project to you?         Yes/No 
3. Do you understand what this project is about?                Yes/No 
4. Have you asked all the questions you want?        Yes/No 
5. Have you had your questions answered in a way you understand? Yes/No 
6. Do you understand it’s OK to stop taking part at any time?  Yes/No 
7. Are you happy to take part?                  Yes/No 
 
If any answers are ‘no’ or you don’t want to take part, don’t sign your name! 
If you do want to take part, please write your name and today’s date  
 
Your name   ___________________________        
 
Date             ___________________________ 
 
Your parent or guardian must write their name here too if they are happy for you to do the project 
Print Name  ___________________________ 
 
Sign               ___________________________ 
 
Date              ___________________________ 
 
The doctor who explained this project to you needs to sign too: 
Print Name    ___________________________ 
 
Sign               ___________________________ 
 
Date              ___________________________ 
 
________________________ ________________                __________________ 
Name of Patient Date Signature 
 
1 copy for Patient, 1 for Investigator and original to be kept in medical notes 
 
  
 
341
Appendix – F Knowles-Eccersley-Scott-Symptom (KESS) questionnaire 
Duration of constipation   Time (minutes in lavatory / attempt) 
0-18 months   0 < 5 minutes    0  
18 months to 5 years   1 5-10 minutes    1  
5-10 years    2 10-30 minutes    2  
10-20 years   3 > 30 minutes    3  
>20 years (or all life)   4 
 
 
Assistance (laxatives)   Difficulty: painful evacuation effort (%) 
none    0 never     0  
laxatives prn or short duration  1 rarely     1  
laxatives regular, long duration   2 occasionally    2  
laxatives long duration, failed  3 usually     3  
     always     4  
 
Freq bowel movement with assistance  Rectal      
1-2 times / 1-2 days   0 Vaginal      
2 or less times / week   1 Perineal  
less than once per week  2 Anal 
less than once per 2 weeks  3 Other 
 
 
Unsuccessful evacuatory attempts (%)  Stool consistency without laxatives 
never    0 soft / loose/ normal    0  
occasionally   1 occasionally hard    1  
usually    2 always hard    2  
always = manual evacuation  3 always hard, usually  pellets   3  
 
 
Feeling incomplete evacuation (%) 
never    0  
rarely    1  
occasionally   2  
usually    3  
always    4  
 
 
Abdominal pain (%) 
Never    0  
Rarely    1  
Occasionally   2  
Usually    3  
Always    4  
 
 
 
 
 
 
 
 
Bloating 
never    0  
perceived    1  
visible    2  
severe + effect on satiety or nausea 3  
severe + vomiting   4  
 
 
Family history 
not known    0 
none    1 
yes    2 
 
 
Assistance 
none    0 
enemata or suppositories prn  1 
enemata or suppositories regular  2 
manual evacuation as required  3 
manual evacuation always  4 
 
KESSTOTAL     / 39 
 
 
KESSMONITORING     / 35 
 
 
NOTES 
 
Laxatives: 
 
 
Supp/enema: 
 
 
Bhabit in days: 
 
 
FHx: brief detail: 
 
 
Other: 
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Appendix – G Vaizey Incontinence Questionnaire 
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Appendix – H  Gastrointestinal Quality of Life Index (GIQOL) 
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Appendix – H  Gastrointestinal Quality of Life Index (GIQOL) 
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Appendix – H  Gastrointestinal Quality of Life Index (GIQOL) 
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Appendix – I Children’s Depression Inventory (CDI)
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Appendix – I Children’s Depression Inventory (CDI)   
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Appendix – J Beck Depression Inventory (BDI) 
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Appendix – J Beck Depression Inventory (BDI) 
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Appendix – K General Health Questionnaire-28 (GHQ-28) 
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Appendix – K General Health Questionnaire-28 (GHQ-28)  
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Appendix – L State-Trait Anxiety Inventory for Children (STAIC) 
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Appendix – L State-Trait Anxiety Inventory for Children (STAIC) 
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Appendix – M State-Trait Anxiety Inventory (STAI) 
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Appendix – M State-Trait Anxiety Inventory (STAI)  
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Appendix – N Pennebaker Inventory of Limbic Languidness 
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Directions: Read each sentence.  Circle the answer that describes you the best. Use the following scale to help you answer each statement: 
1 = Strongly Disagree – you strongly disagree with the sentence; it really does not describe you at all. 
2 = Disagree – you disagree with the sentence; it does not describe you. 
3 = In-between – you are not sure whether you agree or disagree with this sentence; you are undecided.   
4 = Agree – you agree with this sentence; it describes you. 
5 = Strongly Agree - you strongly agree with the sentence; it really describes you. 
Remember, answer all of the questions honestly. All of your answers will be kept confidential. No parent or teacher will ever see your individual  
answers. 
 
 
Strongly 
Disagree 
Disagree In-
Between 
Agree Strongly 
Agree 
1. I try to get along with other people, even if I don’t agree with them. 1 2 3 4 5 
2. I am always very careful when I am doing school work. 1 2 3 4 5 
3.  My mood goes up and down more than most people. 1 2 3 4 5 
4. I like meeting new people. 1 2 3 4 5 
5. I like to learn about new ways of doing things. 1 2 3 4 5 
6. I sometimes make fun of other kids in school. 1 2 3 4 5 
7. I always finish everything I start. 1 2 3 4 5 
8. Sometimes I don't feel like I'm worth much. 1 2 3 4 5 
9. It is hard for me to make new friends. 1 2 3 4 5 
10. I would like to keep going to school for many years just to learn new 
things. 
1 2 3 4 5 
11. People who know me well think  I am a very nice, kind person. 1 2 3 4 5 
12. I like to plan things before I do them. 1 2 3 4 5 
13. I often feel tense or stressed out. 1 2 3 4 5 
14. I am very outgoing and talkative. 1 2 3 4 5 
15. I like to read books on different subjects. 1 2 3 4 5 
16. If anybody says something mean to me, I say something mean right 
back to them. 
1 2 3 4 5 
17. I am always on time for meetings with other people. 1 2 3 4 5 
18.  I sometimes feel like everything I do is wrong or turns out bad    1 2 3 4 5 
19. I smile a lot when I am around other people. 1 2 3 4 5 
Appendix – O Big Five Inventory Transition to College (BFI-TTC) 
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20. I like to try new things. 1 2 3 4 5 
21. I am very easy to get along with. 1 2 3 4 5 
22. I try to be very neat and organized in my homework and class 
assignments. 
1 2 3 4 5 
23.  I feel like I can’t handle everything that is going on in my life.  1 2 3 4 5 
24. I like to go to big parties where there are a lot of people. 1 2 3 4 5 
25. I like to take classes where I learn something I never knew before. 1 2 3 4 5 
26. I sometimes trick other people into doing what I want them to do. 1 2 3 4 5 
27. My teachers can always count on me to do what they ask me to do in 
class. 
1 2 3 4 5 
28. I sometimes feel like I'm going crazy. 1 2 3 4 5 
29. It is fun for me to talk to people I have just met. 1 2 3 4 5 
30. I like to work on problems and puzzles. 1 2 3 4 5 
31. I am always polite to other people. 1 2 3 4 5 
32. I like to keep everything I own in its proper place. 1 2 3 4 5 
33. I get mad easily. 1 2 3 4 5 
34. I am a fairly quiet person in most group settings. 1 2 3 4 5 
35. I like to visit new places. 1 2 3 4 5 
36. I sometimes like to argue with other people just for fun. 1 2 3 4 5 
37. I put away all of my things when I am done with them. 1 2 3 4 5 
38. I sometimes feel sad or blue. 1 2 3 4 5 
39. If I am in a group and no one says anything, I will say something first. 1 2 3 4 5 
40. I like  to find out how people live in other places in the world. 1 2 3 4 5 
41. I like to help other people whenever they need it. 1 2 3 4 5 
42. I always clean up after I have made a mess. 1 2 3 4 5 
43. I feel good about myself most of the time. 1 2 3 4 5 
44. I am usually a cheerful person. 1 2 3 4 5 
45. I would like to learn how to read and speak  a foreign language. 1 2 3 4 5 
46. I like to learn new games and hobbies. 1 2 3 4 5 
47. Sometimes I say things on purpose to hurt other people's feelings. 1 2 3 4 5 
48. I enjoy coming up with new solutions for everyday problems. 1 2 3 4 5 
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 Appendix – O Big Five Inventory (BFI) 
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Appendix – P Hunter Opinions and Personal Expectations Scale (H.O.P.E.S) 
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Appendix – Q Cognitive Emotion Regulation Questionnaire (CERQ) 
CERQ 
© Garnefski, Kraaij & Spinhoven, 2001 
 
How do you cope with events?         
Everyone gets confronted with negative or unpleasant events now and then and everyone responds to them in his or her own way. By the following questions you are asked to indicate what you 
generally think, when you experience negative or unpleasant events. 
 
 
 
(almost) 
never 
 
some- 
times 
regu-
larly 
 
often 
(almost) 
always 
  1. 1 feel that I am the one to blame for it 1 2 3 4 5 
  2. I think that I have to accept that this has happened 1 2 3 4 5 
  3. I often think about how I feel about what I have experienced 1 2 3 4 5 
  4. I think of nicer things than what I have experienced 1 2 3 4 5 
  5. I think of what I can do best 1 2 3 4 5 
  6. I think I can learn something from the situation 1 2 3 4 5 
  7. I think that it all could have been much worse 1 2 3 4 5 
  8. I often think that what I have experienced is much worse than what others have experienced 1 2 3 4 5 
  9. I feel that others are to blame for it 1 2 3 4 5 
10. I feel that I am the one who is responsible for what has happened 1 2 3 4 5 
11. I think that I have to accept the situation 1 2 3 4 5 
12. I am preoccupied with what I think and feel about what I have experienced  1 2 3 4 5 
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13. I think of pleasant things that have nothing to do with it 1 2 3 4 5 
14. I think about how I can best cope with the situation  1 2 3 4 5 
15. I think that I can become a stronger person as a result of what has happened 1 2 3 4 5 
16. I think that other people go through much worse experiences 1 2 3 4 5 
17. I keep thinking about how terrible it is what I have experienced 1 2 3 4 5 
18. I feel that others are responsible for what has happened 1 2 3 4 5 
19. I think about the mistakes I have made in this matter  1 2 3 4 5 
20. I think that I cannot change anything about it 1 2 3 4 5 
21. I want to understand why I feel the way I do about what I have experienced 1 2 3 4 5 
22. I think of something nice instead of what has happened 1 2 3 4 5 
23. I think about how to change the situation 1 2 3 4 5 
24. I think that the situation also has its positive sides 1 2 3 4 5 
25. I think that it hasn’t been too bad compared to other things 1 2 3 4 5 
26. I often think that what I have experienced is the worst that can happen to a person 1 2 3 4 5 
27. I think about the mistakes others have made in this matter  1 2 3 4 5 
28. I think that basically the cause must lie within myself 1 2 3 4 5 
29. I think that I must learn to live with it 1 2 3 4 5 
30. I dwell upon the feelings the situation has evoked in me 1 2 3 4 5 
31. I think about pleasant experiences 1 2 3 4 5 
32. I think about a plan of what I can do best  1 2 3 4 5 
33. I look for the positive sides to the matter 1 2 3 4 5 
34. I tell myself that there are worse things in life 1 2 3 4 5 
35. I continually think how horrible the situation has been 1 2 3 4 5 
36. I feel that basically the cause lies with others 1 2 3 4 5 
Thank you for filling out the questionnaire! 
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Appendix – Q Cognitive Emotion Regulation Questionnaire - kids (CERQ-kids) 
CERQ-kids 
© Garnefski & Kraaij, 2005 
How do you cope with events?         
Sometimes nice things happen in your life and sometimes unpleasant things might happen. 
When something unpleasant happens, you can think about it for a long time. 
When something unpleasant happens to you, what do you usually think? 
 
 
 
(almost) 
never 
 
some- 
times 
regu-
larly 
 
often 
(almost) 
always 
  1. I think that I am to blame 1 2 3 4 5 
  2. I think that I have to accept it 1 2 3 4 5 
  3. Again and again, I think of how I feel about it 1 2 3 4 5 
  4. I think of nicer things 1 2 3 4 5 
  5. I think about what would be the best for me to do 1 2 3 4 5 
  6. I think that I can learn from it 1 2 3 4 5 
  7. I think that worse things can happen 1 2 3 4 5 
  8. I often think that it’s much worse than what happens to others 1 2 3 4 5 
  9. I think that others are to blame 1 2 3 4 5 
10. I think that I have been stupid 1 2 3 4 5 
11. It just happened; there is nothing I can do about it 1 2 3 4 5 
12. I often think of what I am thinking and feeling about it 1 2 3 4 5 
13. I think of nicer things that have nothing to do with it 1 2 3 4 5 
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14. I think of how I can cope with it  1 2 3 4 5 
15. I think that it makes me feel ‘older and wiser’ 1 2 3 4 5 
16. I think that worse things happen to others 1 2 3 4 5 
17. Again and again, I think about how terrible it all is 1 2 3 4 5 
18. I think that others have been stupid 1 2 3 4 5 
19. I think that it’s my own fault 1 2 3 4 5 
20. I think that I can’t change it  1 2 3 4 5 
21. All the time, I think that I want to understand why I feel that way 1 2 3 4 5 
22. I think of something nice and not about what happened 1 2 3 4 5 
23. I think of how I can change it 1 2 3 4 5 
24. I think that there are good sides to it as well 1 2 3 4 5 
25. I think that it’s not as bad as other things that could happen 1 2 3 4 5 
26. All the time, I think that this is the worst thing that can happen to you 1 2 3 4 5 
27. I think that it’s the fault of others 1 2 3 4 5 
28. I think that it’s all caused by me 1 2 3 4 5 
29. I think that I can’t do anything about it 1 2 3 4 5 
30. I often think of how I feel about what happened 1 2 3 4 5 
31. I think of nice things that have happened to me  1 2 3 4 5 
32. I think of what I can do best  1 2 3 4 5 
33. I think that it’s not all bad 1 2 3 4 5 
34. I think that there are worse things in the world 1 2 3 4 5 
35. I often think about how horrible the situation was 1 2 3 4 5 
36. I think that it’s all caused by others 1 2 3 4 5 
 
Thank you for filling out the questionnaire! 
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Appendix – R Weinberger Adjustment Inventory 
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